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 1. Summaries 
 
1.I. Summary 
 The coordinated action of multiple guidance cues controls the migration of neural crest 
cells (NCC) and outgrowth of axons in embryonic development to build a functional 
peripheral nervous system (PNS). Previous studies from our laboratory have shown that the 
particular isoforms (V0/V1) of the extracellular matrix hyalectan ‘versican’ are selectively 
associated to barrier tissues of migrating NCC and growing axons in the embryonic chick 
hind limb in vivo and act as potent inhibitors of NCC migration in vitro. Moreover, the V0/V1 
versican splice-variants widely expressed in early hind limbs disappear when axons invade 
the embryonic limb suggesting an involvement of the proteases of the ADAMTS family (a 
disintegrin and metalloprotease with thrombospondin type 1 motifs), which specifically cleave 
some hyalectans including versican. 
To elucidate the role of versican function and its turnover in axonal guidance of the PNS, we 
first analysed the inhibitory effect of versicans V0/V1 on neurite growth of dorsal root ganglia 
in vitro and showed that ectopic injection of versican into the chick hind limb in ovo severely 
disturbs the patterns of growing axons. Furthermore, we detected an intriguing correlation 
between ADAMTS9 expression, versican disappearance and axons extension. However, no 
versican processing was observed with different chick recombinant ADAMTS9 variants in 
vitro. Besides, versican turnover and axonal guidance of developing axons in vivo were not 
affected, when chick ADAMTS9 cDNA expression constructs were in vivo-electroporated in 
the hind limb or in the spinal cord of chick embryos. These results suggest that versicans 
V0/V1 act as axon guidance molecules in the peripheral nervous system and indicates that 
ADAMTS9 alone may not be the major protease involved in versican turnover during 
innervation of limb bud.  
Recent genetic studies have revealed collaborative functions of ADAMTS members for 
versican processing in vivo. Interestingly, the versicanase ADAMTS5 was described to be 
specifically expressed in the peripheral nerve components during mouse embryogenesis. 
Taking together these studies and our results, in which a clear spatio-temporal correlation 
was established between the expression profile of ADAMTS9, versican distribution and 
outgrowing axons in chick hind limb development, let us suspect that ADAMTS9 expressed 
in mesenchymal tissues of the developing limb bud might interact with ADAMTS5 and/or 
other versicanases to regulate versican function in axonal guidance in vivo. 
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 1.II. Zusammenfassung 
 Um ein funktionelles peripheres Nervensystem (PNS) zu bilden, ist die koordinierte 
Tätigkeit verschiedenster Moleküle in der embryonalen Entwicklung nötig. Dabei 
müssen die Neuralleistenzellen (NCC) in die vorgesehene Richtung migrieren und 
das axonale Wachstum muss präzise gelenkt werden. Frühere Studien unserer Gruppe 
haben gezeigt, dass bestimmte Versican Isoformen (V0/V1), welche zur Familie der 
extrazellulären Matrix Hyalektane gehören, mit Barrierengeweben von migrierenden NCCs 
und wachsenden Axone in den Beinanlagen von Hühnerembryonen assoziiert sind und dass 
aufgereinigte Versicane die Migration von NCCs und das Wachstum von Neuriten in vitro 
unterdrückt. Die Versicane V0/V1, die in den frühen Beinanlagen weit verbreitet sind, 
verschwinden kurz vor dem Eindringen der Axone in die embryonale Hinterextremität. Dieses 
Verschwinden weist auf einen Abbauprozess hin, der zur Regulation von Versican-
Funktionen möglicherweise Metalloproteasen der ADAMTS Familie (a disintegrin and a 
metalloprotease with thrombospondin type 1 motif) involviert.  
Um die Rolle von Versican in der Lenkung von Axonen des PNS aufzuklären, haben wir 
zuerst den hemmenden Effekt von Versican V0/V1 auf das Neuritenwachstum der 
Rückenwurzelganglien in vitro analysiert. In weiteren Experimenten in ovo konnten wir 
zudem zeigen, dass die Injektion von Versican in das Hühnerhinterbein die Profile der 
auswachsenden Nervenbahnen ernsthaft stört. Des Weiteren haben wir eine klare 
Korrelation zwischen dem Auftreten der Metalloprotease ADAMTS9 und dem Abbau von 
Versicanen in der unmittelbaren Umgebung von wachsenden Axonen detektiert. In in vitro 
Experimenten konnten wir jedoch keinen Versican-Abbau durch rekombinantes ADAMTS9 
beobachten. Ausserdem haben wir nach Injektion und in vivo-Elektroporation von ADAMTS9 
cDNA Expressionskonstrukten in Hinterbein oder Rückenmark von Hühnerembryonen weder 
eine Beeinflussung des Versican-Abbaus noch des Axonwachstums festgestellt. Diese 
Ergebnisse lassen darauf schliessen, dass Versican V0/V1 zwar als Leitmolekül im PNS 
fungieren kann, dass ADAMTS9 - trotz passendem Expressionsmuster - als Einzelenzym 
aber eher nicht als regulatorisches Protein dieser Versican-Funktion in Frage kommt.  
Neuere genetische Studien haben tatsächlich funktionelle Wechselwirkungen verschiedener 
ADAMTS Metalloproteasen in der Prozessierung von Versican in vivo aufgedeckt. 
Interessanterweise wurde beschrieben, dass ADAMTS5 während der Embryogenese von 
Mäusen in peripheren Nervenzellen ebenfalls hochreguliert wird. Zusammen mit unseren 
Ergebnissen zeigen sie eine deutliche räumliche und zeitliche Korrelation zwischen der 
Expression dieser ADAMTSs, dem Versican-Abbau und dem Einwachsen von Axonen in die 
Hinterbeinanlagen. Diese Resultate lassen vermuten, dass ADAMTS9 die Funktion von 
Versican in der Axonlenkung in vivo allenfalls nur zusammen mit ADAMTS5 und/oder 
anderen Versicanasen reguliert.  
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 2. Introduction 
2.I. Axon pathfinding 
 During development of the peripheral nervous system, trunk neural crest cells emigrate 
from the dorsal neural tube and differentiate into distinct cellular subpopulations including 
sensory and sympathetic neurons. These newly formed neurons interact with each other and 
other neuronal and non-neuronal cells to participate in the building of a functional network. 
One of the big challenges of the set-up of the nervous system consists in the difficult task of 
neuronal processes to reach their individual targets. The growth cone, a highly dynamic 
structure at the tip of the axons plays a key role in the pathfinding by selectively responding 
to multiple extracellular signals. This has already been realised more than a century ago by 
Ramόn y Cajal, who described the growth cone as the element able to interpret chemotactic 
cues to steer the axons. Indeed, the growth cone recognises guidance cues via specific cell-
surface receptors, integrates the different signals and promptly remodels the cytoskeleton to 
finally adjust the trajectory of the axon (reviewed in (Lowery and Van Vactor, 2009)). In 
consequence, the growing axons follow stereotypic pathways and eventually extend over 
considerable distances to reach their proper targets. On the lumbosacral level of the trunk for 
instance, sensory axons originating from the dorsal root ganglions join the motor axons 
exiting from the ventral neural tube and form together the crural and the sciatic plexuses from 
where they innervate the hind limb (reviewed in (Bonanomi and Pfaff, 2010)). In the spinal 
cord, motoneurons are arranged into longitudinal columns along the rostro-caudal axis. The 
lateral motor columns (LMC) contain also the limb-innervating motor neurons that project to 
the plexus at the base of the limb. As the axons emerge from the plexus region, their 
trajectories bifurcate either ventrally or dorsally within the limb mesenchyme. The lateral 
division of LMC send axons to dorsally derived muscles, whereas the motor neurons from 
the medial LMC project axons to ventral limb muscles. This initial bifurcation in the proximal 
limb tissue is followed by numerous additional pathway decisions at selective choice-points 
until the final target has been reached by the navigating growth cone. 
Another impressive example of a highly precise axon guidance process can be observed at 
the spinal cord midline (reviewed in (Chedotal, 2010)). The commissural neurons extend 
their axons from the dorsal part of the spinal cord, first laterally then ventrally to reach and 
cross the midline. Afterwards they turn to project rostrally towards the brain.  
How do axons from the same pool of motoneurons select their specific pathways? How do 
the commissural axons recognise their predetermined ventral trajectory and cross only once 
the midline before projecting rostrally? To respond to these questions, the molecular basis of 
axon pathfinding has been extensively studied during the last three decades. Many guidance 
cues have been discovered and the subjacent cellular mechanisms have been partially 
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 described (reviewed in (Chilton, 2006; Dickson, 2002; Kolodkin and Tessier-Lavigne, 2010; 
Tessier-Lavigne and Goodman, 1996)). 
In the current concepts, guidance molecules are divided in short and long-range cues, which 
participate in four principle types of regulatory mechanisms: contact attraction, 
chemoattraction, contact repulsion, and chemorepulsion (Fig.1).  
 
 
Figure 1. Different  guidance molecules  control  the  trajectories of  the  axons  to  their  targets. All 
together, short  (by contact) and  long‐range  (by chemotropism) cues mediate  the axon pathfinding 
(from (Kolodkin and Tessier‐Lavigne, 2010)). 
 
The repulsive cues push the axons and may provoke turning, collapse and retraction of the 
growth cone, while diffusible chemoattractants serve to pull the growing axons to particular 
regions. In an otherwise permissive environment, the repulsive cues permit to channel and 
thus, direct axons or to enforce route selection of pioneer axons and nerve fascicules at 
specific choice-points. Both repulsive and attractive short-range signals play together to 
maintain the growing axons in their predetermined corridors. In the following chapter I will 
present the principal molecules involved in axon guidance and growth, considering the two 
examples mentioned above as main model processes. 
 
 
2.I.1 “Classical” guidance molecules 
2.I.1.a Netrins 
 In vertebrates Netrins build a family of four secreted (1-4) and two membrane-bound 
molecules (G1-G2). Secreted Netrins form concentration gradients that are interpreted by 
navigating axons to reach their targets (Killeen and Sybingco, 2008; Livesey, 1999). In 
vertebrates, Netrins were first found as factor(s) secreted from the floor plate that selectively 
attract  commissural neurons to the ventral midline (Tessier-Lavigne et al., 1988). Later, 
Netrin-1 and -2 were purified from chick brain or expressed as recombinant proteins and 
shown to exhibit chemoattractant properties for the commissural axons (Kennedy et al., 
1994; Serafini et al., 1994). 
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 The sequences of these two vertebrate netrins (Netrin-1 and Netrin-2) turned out to be highly 
homologous to the Caenorhabditis elegans Uncoordinated-6 (UNC-6) protein acting as a bi-
functional axon guidance cue in conjunction with its receptors UNC-5 and UNC-40 
(Hedgecock et al., 1990; Ishii et al., 1992). The worm mutants for the unc-5, unc-6 and unc-
40 genes display all deficiencies in circumferential movement of cells and pioneer axons: 
unc-40 affects mainly the ventral migration, unc-5 the dorsal migration, and unc-6 both 
directions. UNC-6 and the vertebrate netrins primarily serve as diffusible attractive ligands 
(Kennedy et al., 1994). Interestingly, netrins were later recognised also as chemorepellents 
for certain types of neurons (Colamarino and Tessier-Lavigne, 1995; Varela-Echavarria et 
al., 1997), for example the trochlear motoneurons (Colamarino and Tessier-Lavigne, 1995). 
The first receptors for netrin to be identified belong to the DCC (Deleted in Colorectal 
Cancer) family (Keino-Masu et al., 1996), including UNC40 in C.elegans and Frazzled in 
Drosophila (Chan et al., 1996; Kolodziej et al., 1996). The vertebrate homologue of UNC-40, 
DCC is required for the functioning of Netrin as attractant (Keino-Masu et al., 1996). Unc-5 
on the contrary, is necessary to mediate the repulsive effect of Netrin (Leonardo et al., 1997) 
(Fig.2). The immunoglobulin repeats of Unc-5 proteins are required for Netrin binding 
(Geisbrecht et al., 2003). Vertebrates have four Netrin-1 receptors (Unc5A-D) that are 
homologous to the UNC-5 receptor present in C.elegans (Hedgecock et al., 1990; Leonardo 
et al., 1997). 
 
 
Figure  2. Bi‐functionality  of Netrin‐1  is mediated  through  the  interactions with UNC‐5  and DCC 
receptors in the CNS (from (Cirulli and Yebra, 2007). 
Attraction  is  triggered  by  Netrin‐1  interacting  exclusively  with  DCC  receptors  that  permits  their 
clustering via  their P3  cytoplasmic domains  (panel A), while  repulsion  is either mediated at  short‐
range by UNC‐5 alone (panel B) or UNC‐5 and DCC, UNC5 interacting with the P1 intracellular domain 
of DCC impedes the DCC clustering and this complex mediated long‐range repulsion (panel C).  
 
More recently, another putative receptor for Netrins has been described. The Down’s 
syndrome cell adhesion molecule (DSCAM) is a type I transmembrane receptor that 
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 contains ten immunoglobulin domains and six fibronectin III repeats in its extracellular 
domain (Yamakawa et al., 1998). DSCAM may functions as an additional receptor for 
Netrin-1 and contributes to the netrin-dependent axon guidance during development 
(Andrews et al., 2008; Liu et al., 2009; Ly et al., 2008). Netrin-1 binds to the Ig 
domains of DSCAM in vitro (Ly et al., 2008). DSCAM is expressed by commissural 
axons in invertebrates and vertebrates as they extend to and across the floor plate 
(Andrews et al., 2008; Liu et al., 2009; Ly et al., 2008). Epitope-tagged recombinant 
Netrin protein from fruit fly, chick or human bind to recombinant Dscam/DSCAM in a 
cell overlay assay (Andrews et al., 2008; Liu et al., 2009; Ly et al., 2008). Liu et al. 
showed that the netrin-induced axon outgrowth is almost abolished by introducing 
DSCAM-specific siRNA into neurons of a spinal cord explant culture and that the 
downregulation of DSCAM inhibits the commissural axon attraction mediated by 
Netrin-1 in a commissural axon turning assay. Moreover, they have demonstrated 
that the knockdown of DSCAM in ovo interferes with commissural axon pathfinding in 
the chick neural tube (Andrews et al., 2008; Liu et al., 2009; Ly et al., 2008). Besides, 
Ly and colleagues put in evidence that the turning of axons is only completely 
abolished, when the DCC expression is down-regulated simultaneously. They also 
showed that DCC and DSCAM could interact in a heterophilic complex in the dorsal 
spinal cord. This complex seems, however, to dissociate in the presence of Netrin-1 
(Andrews et al., 2008; Liu et al., 2009; Ly et al., 2008). From these data, it appears 
that DSCAM and DCC collaborate in the floor plate-attraction of commissural axons 
in response to Netrin-1 (Andrews et al., 2008; Liu et al., 2009; Ly et al., 2008).  
 
2.I.1.b Slits and the Roundabout receptors (Robos) 
 Genetic analyses of the Drosophila mutants led to first identification of the Robos, 
receptors of a repellent guidance cue at the ventral midline. In Robo mutants, commissural 
axons are insensitive to midline repulsion and consequently cross and re-cross several times 
the midline, generating a "roundabout" phenotype (Seeger et al., 1993). The Robos, a novel 
receptor subfamily of the immunoglobulin superfamily, control the axon crossing of the 
midline in vertebrates and invertebrates (Kidd et al., 1998; Zallen et al., 1998). Later, 
secreted glycoproteins named Slits were recognised as the Robo ligands.  
Twenty years ago, Slit had already been identified as a secreted factor from the midline glia, 
which is necessary for the proper path finding of commissural axons (Rothberg et al., 1990). 
In Slit mutants, axons never cross the midline and join together into a single longitudinal 
bundle in Drosophila (Kidd et al., 1999). It has been shown that mammalian Slit2 is able to 
bind Robos in a co-culture system and it was demonstrated that olfactory bulb axons from 
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 mouse embryos turn away from cells expressing recombinant Slit (Li et al., 1999). These and 
other observations indicated that Slits are directly involved in axonal repulsion in Drosophila 
and vertebrates (Brose et al., 1999; Kidd et al., 1999; Li et al., 1999). Another role for Slit as 
branching factor for sensory axons in vertebrates has been described (Wang et al., 1999). 
The branching activity of Slits, observed for both axons and dendrites, is also mediated by 
Robo family members (Ma and Tessier-Lavigne, 2007; Whitford et al., 2002).  
Slits and Robos have been found in the nervous system from invertebrates such as 
Drosophila and C.elegans to vertebrates (Brose et al., 1999; Hao et al., 2001; Itoh et al., 
1998; Long et al., 2004). From the collected data of the different species, a concept has 
emerged, in which axonal tips carrying the Robo receptor are repelled by the Slit-ligand 
present in the floor plate. To allow the initial crossing of the midline, Robo is first virtually 
absent from the growth cone of the commissural axons approaching the floor plate. It is, 
however, upregulated as soon as the axons are reaching the contralateral side. The 
increasing robo-slit interactions subsequently prevent the re-crossing of the longitudinally 
turning and extending axons (Kidd et al., 1998).  
Another protein, Commissureless (Comm) seems to participate in the Robo-Slit guidance at 
the midline in Drosophila. By disrupting the expression of the protein Comm via gene 
mutation, all left-right connections are abolished in the ventral nerve cord, the fly homolog of 
the spinal cord (Tear et al., 1996). By silencing axon responses to the midline repellent Slit, 
Comm promotes midline crossing (Gilestro, 2008; Keleman et al., 2002). Comm seems to do 
so by controlling the trafficking of Robo receptor and thus, regulate its exposure on the 
surface of the commissural growth cones (Fig.3).  
 
Figure  3.  Comm  controls  the  coordinated  actions  of  Slit/Robos  and  Netrin  at  the  Drosophila 
midline (adapted from (Dickson and Gilestro, 2006)).  
The  ipsilateral neurons, which do not express Comm display Robo  receptors at  their growth cones 
and are consequently repelled from crossing the midline by Slit  ligands  (a). As the growth cones of 
commissural axons reach the midline, Comm is expressed and triggers the Robo in the endosomes (b 
and  insert).  That  impedes  the  Slit/Robo  interaction  and  allows  axons  to  go  across. After  crossing, 
Comm  is  down‐regulated  in  commissural  axons  permitting  the  new  synthesised  Robo  to  be 
accumulated  in  the growth cones and  to  interact with Slit  (c). Thus, Slit/Robo  interaction hampers 
axons attracted by Netrin to re‐cross the midline. 
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In comm mutants the Robo receptors appear on the axonal tip already on the ipsilateral side 
and interact with Slit secreted at the midline too early. Consequently, the axons project 
ipsilaterally while being prevented from crossing the midline. In wildtype flies commissural 
neurons begin to express the protein Comm as they approach the midline, and then reduce 
Comm expression after crossing to allow a continuous axonal growth (Gilestro, 2008).  
No Comm homolog has yet been found in vertebrates, but a different mechanism seems to 
regulate the crossing at the midline. In vertebrates, the Robo family member Robo3 
possesses a splice variant, Robo3.1, which seems to neutralise the repulsive actions of 
Robo1 and Robo2, when axons approach and cross the midline (Chen et al., 2008; Marillat 
et al., 2004; Sabatier et al., 2004; Tamada et al., 2008) (Fig.4). Robo3.1 is expressed at high 
levels on commissural axons until they have crossed the floor plate, while the concentrations 
of Robo1 and Robo2 increase only after axons have reached the contralateral side (Chen et 
al., 2008; Marillat et al., 2004; Sabatier et al., 2004; Tamada et al., 2008). A similar “anti-
Robo” function of Robo2 has been proposed from genetic analyses in Drosophila as well 
(Spitzweck et al., 2010). 
 
 
Figure  4.  Coordinated  actions  of  Slit/Robos  and  Netrin  to  control  the  midline  crossing  of 
commissural axons (adapted from (Dickson and Gilestro, 2006)). 
Netrin  attracts  through  DCC  the  growth  cones  of  commissural  axons  to  the  floor  plate.  The 
commissural  axons  cross  the  midline.  After  crossing  the  Robo1  and  Robo2  expression  are  up‐
regulated in the growth cones, the Robo1 and Robo2 interactions with Slit ligands distributed in the 
floor plate repel the commissural axons, preventing the re‐crossing of the midline. Robo3.1, which is 
highly  expressed  before  crossing  and  after  that  low  expressed,  participates  in  the  control  of  the 
cross‐guiding by down‐regulating Robo1 and Robo2 expression. 
 
2.I.1.c Semaphorins and their receptors 
 Semaphorins are a large family of phylogenetically conserved secreted and trans-
membranous proteins (reviewed in (Raper, 2000; Yazdani and Terman, 2006)), 
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 characterised by the sema domain, a specific cystein-rich region of about 500 amino acids 
length (Gherardi et al., 2004). Semaphorins members are regrouped in eight major classes: 
the classes 3, 4, 6 and 7 are found in vertebrates only, classes 1 and 2 are both present in 
invertebrates and vertebrates, while class V is specific to viruses. Sema-1 (previously named 
Fasciclin IV), the first member identified in the grasshopper embryo, was described as a 
preferential substrate to the growth cone of Ti1 neurons (Kolodkin et al., 1992). Isolated from 
chicken brain, collapsin 1, the chick orthologue of the mammalian Semaphorin3A (Sema3A), 
caused sensory ganglion growth cones to collapse in vitro (Luo et al., 1993). 
Semaphorins function through multimeric receptor complexes (Raper, 2000). Membrane-
associated Semaphorins bind to plexins (Winberg ML, 1998), whereas secreted class 3 
Semaphorins interact with one of the four class A Plexins only in conjunction with the co-
receptor of the Neuropilin (Npn) family (Sema3A/Npn1, Sema3F/Npn-2) (Chen et al., 1997; 
Giger et al., 1998; Kolodkin et al., 1997). Neuropilins act as the ligand-binding subunits, 
whereas plexins function as signal-transducting subunits. Plexin interactions with Neuropilin 
form a receptor complex that has a higher affinity for Semaphorin3A than Neuropilin alone 
(Takahashi et al., 1999). Semaphorins usually deflect axons from inappropriate regions, but 
some may also act as attractants. For instance, Wong and colleagues showed that trans-
membranous Sema-1 ectopically expressed by epithelial cells in the grasshopper limb bud 
could promote axonal outgrowth during development, while the application of its extracellular 
domain as a soluble factor perturbed the axon pathfinding in vivo (Wong JT, 1999; Wong JT, 
1997). 
The secreted class 3 Semaphorins are the most studied group of axonal guidance molecules 
(reviewed in (Derijck et al., 2010; Mann and Rougon, 2007; Shim and Ming, 2007)). Secreted 
semaphorins are repulsive towards different types of neurons in vitro, including motor, 
sensory, olfactory and hippocampal neurons (reviewed in (Chilton, 2006)). Especially, the 
Sema3A/Npn-1 and Sema3F/Npn-2 complexes control distinct steps of motor axon growth 
and guidance during the formation of spinal motor connections (Huber AB, 2005). In Npn-
1Sema- knockout mice the absence of Sema3A/Npn-1 signalling leads to an aberrant 
defasciculation of the axons of LMC neurons and an early projection into the limb 
mesenchyme. In Npn-2-Sema- mutants no impairment of fasciculation was observed and the 
axons enter into the limb at the right time-point but the axons from the LMCm neurons show 
aberrant projections in the dorsal part of the limb. Moreover, the ectopic expression of Nnp-2 
in LMC neurons promotes the selection of a ventral axonal trajectory into the forelimb. In 
summary, Sema3A/Npn-1 signalling seems to regulate the timing of motor axon growth into 
the forelimb. Sema3A possibly acting through a “surround repulsion” mechanism maintains 
fasciculation as axons grow toward the plexus and into the forelimb (Fig.5). The restricted 
expression of Sema3F in the dorsal part of the limb later in development, finally pushes the 
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 motor axons expressing Npn-2 away from the dorsal towards the ventral region of the limb. 
Recently, Sema3F has been also described as a bifunctional guidance cue for axons of 
dopaminergic neurons in the mesodiencephalon (mdDA) of mouse embryos (Kolk et al., 
2009). During early developmental stages, Sema3F chemorepulsion controls certain aspects 
of mdDA axons pathway development through both Npn-2-dependent (axon fasciculation and 
channelling) and Npn-2-independent (rostral growth) mechanisms. Later on, chemoattraction 
mediated by Sema3F and Npn-2 is required to orient mdDA axon projections in the cortical 
plate of the medial prefrontal cortex. 
 
2.I.1.d Ephrins and Eph receptors 
 The Eph receptors and the ephrin ligands are cell-surface signalling molecules that 
play important roles in a large number of developmental events including axon guidance 
(reviewed in (Klein, 2004)). The EphA and EphB proteins are receptors tyrosine kinases, 
grouped together on the basis of high sequence similarities of their extracellular domains and 
on their preferential in vitro-binding to the GPI-linked ephrinA and transmembrane ephrinB 
ligand families, respectively (Pasquale, 2004). Ephrin-Eph heterodimers have to further 
cluster to engage bi-directional signalling. Soluble Ephrins released from the cell surface, do 
not appear to activate the Eph receptors. Consequently, ephrins and Eph receptors are 
thought to function only as short-range cues. The dimmer complexes can progressively 
aggregate, first to tetramers and then to larger clusters. This permits a modulation of the 
Eph-ephrin signalling in a concentration-dependent manner (reviewed in (Pasquale, 2005)). 
The Eph-ephrin complexes function usually as repellents for some axons, but can also be 
attractants for others (Eberhart et al., 2004; Hansen et al., 2004; McLaughlin et al., 2003). 
Ephrin signalling plays an important role in topographic mapping of different sensorial 
systems, as the visual or the olfactory system (reviewed in (Klein, 2004)). In the optic tectum 
(chick, frog) or in the retina and in the superior colliculus (in mammals), gradients of EphA 
and EphrinA influence the topographic mapping along the anterioposterior tectal axis, while 
EphB and Ephrin B gradients control the dorsoventral projection pattern (Frisen et al., 1998; 
Hindges et al., 2002; Mann et al., 2002; Monschau et al., 1997; Nakamoto et al., 1996). Eph-
ephrins complexes participate as well in the pathfinding of motor axons (Fig.5). Genetic 
analyses of multiple mouse mutants and the study of the overexpression or downregulation 
of different Eph-ephrins complexes in the hindlimb mesenchyme in chick embryo, have 
provided evidence that EphB1 and EphB3 are key contributors to the ventral trajectory of 
LMC axons within the developing limb (Luria et al., 2008). Luria and colleagues 
demonstrated that EphB receptors are concentrated on the axons of medial LMC neurons 
while the ephrin-B2 ligand is preferentially expressed by cells of the dorsal limb 
mesenchyme. They showed that axons of medial LMC neurons expressing EphB are indeed 
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 repelled by ephrin ligands concentrated dorsally in the limb. In fact, they revealed a 
molecular symmetry in the dorsoventral guidance of the medial and lateral LMC axons: 
EphB-ephrinB signalling directing medial LMC axons ventrally, and EphA-ephrinA signalling 
directing lateral LMC axons dorsally. The reduction in EphA4 levels promotes the selection of 
ventral trajectories by LMC axons in both lumbar plexuses, but only under conditions of low 
EphA4 expression. A concomitant elevation of EphB1 levels and a reduction of EphA4 levels 
in lateral LMC neurons direct a significantly larger proportion of lateral LMC axons into the 
ventral nerve than reduced EphA4 expression alone. This emphasises the importance of a 
concerted action of EphB-ephrinB and EphA-ephrinA receptor-ligand pairs at this 
dorsoventral branch-point. 
 
  
Figure 5. Coordinated actions of Sema3F/Npn‐2, ephrinBs/EphBs, ephrinAs/EphAs and GDNF/c‐Ret 
control  the  ventral  and  dorsal pathfindings  of motor  axons  innervating  the  limb  (adapted  from 
(Bonanomi and Pfaff, 2010)). 
The  axons  from  medial  LMC  (LMCm)  Isl1  positive  neurons  expressing  EphB1,  EphB3  and  Npn‐2 
receptors  are  repelled  from  the  dorsal  limb  by  ephrin‐Bs  ligands  such  as  ephrinB2  and  Sema3F 
preferentially expressed  in dorsal  limb mesenchyme. Conversely, ephrin‐As  in ventral mesenchyme 
repel  lateral LMC axons (LMCl Lim1 positive) through axonal EphA4 to the dorsal region. The EphAs 
expressed in the dorsal limb push forward the LMCl axons expressing ephrinAs. GDNF concentrated 
at  the  base  of  the  limb  drives  dorsally  extending  LMCl  axons  through  interaction with  the  c‐Ret 
receptors. 
 
2.I.2 Morphogens acting as guidance molecules 
 Morphogens are secreted proteins produced in a restricted region of a tissue and move 
away from their source to form a long-range concentration gradient. They act in 
concentration-dependent manner on susceptible groups of precursor cells to induce their 
differentiation to a specific cell fate (reviewed in (Teleman et al., 2001)). Recently, four 
morphogen families have been described to play a second role later in development by 
acting as guidance cues for some growing axons: the Hedgehog-, the Wnt-, the DPP/bone 
morphogenic protein/transforming growth factor- (TGF)- and the fibroblast growth factor 
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 (FGF)- families (Stoeckli, 2006). In this section I will mainly focus on the involvement of 
Hedgehog-, Wnt- and TGF-signalling (Fig.6). 
Sonic hedgehog (Shh in mammals, Hh in Drosophila) is a Hedgehog family member 
secreted by the notochord and by floor-plate cells at the ventral midline of the neural tube 
and functions as a graded signal for the generation of distinct classes of ventral neurons 
along the dorsoventral axis of the neural tube (Ingham and McMahon, 2001; Jessell, 2000; 
Marti and Bovolenta, 2002). For this purpose, Shh acts through the receptor Patched (Ptc), 
which is bound to the Smoothened (Smo) protein. Inactivation of Ptc by interaction with Shh 
activates Smo, which in turn activates the transcription factors of Shh target genes (Ci in 
Drosophila and Gli in mammals). Smo associates directly with Ci-containing complex (kinesin 
costal2 (Cos2) and the protein Fused (Fu) to specify the fate of particular cells (reviewed in 
(Lum and Beachy, 2004)). 
The roof-plate cells express members of Wnt family. Wnt ligands can activate several 
different signal transduction pathways (reviewed in (Endo and Rubin, 2007)). The most 
extensively studied is the canonical Wnt pathway, which controls gene expression by 
stabilising -catenin. The Frizzled (Fz) proteins are seven-transmenbrane-domain molecules 
that function as Wnt receptors. When Wnts are absent, -catenin is phosphorylated by 
GSK3 activity, thus stabilizing -catenin. Accumulated -catenin converts the lymphoid 
enhancer factor LEF/TcF from a transcriptional repressor to an activator. In addition of the 
canonical signalling, Wnt presents two non-canonical pathways, the Wnt/Ca2+ pathway and 
the planar cell polarity (PCP) pathway. The PCP pathway involves a non-canonical, -
Catenin-independent, Wnt/Fz pathway that requires Dsh. The Wnt/Ca2+ pathway functions 
via heterotrimeric G-proteins to mobilise intracellular Ca2+ and to stimulate the protein kinase 
C (PKC). Another receptor can transduce Wnt-signals: the Ryk receptor related to tyrosine 
kinase receptor carrying a glycosylated extracellular domain (reviewed in (Bovolenta et al., 
2006)). 
DPP/BMP/TGF members are also secreted from the roof plate at the dorsal midline of the 
neural tube around the time when dorsal neurons are generated (Augsburger 1999). In their 
classical signalling pathways, BMPs members signal through heterodimeric complexes of 
type I and II BMP receptors belonging to the serine/threonine kinases, to specify the cell fate 
(Ebendal et al., 1998; Irving et al., 2002). After ligand binding, this BMPR complex 
phosphorylates the receptor-regulated Smads (R_Smads) (Heldin et al., 1997). After release 
from the receptor, the phosphorylated Smad proteins associate with the related protein 
Smad4, which acts as a shared partner. This complex translocates into the nucleus and 
participates in gene transcription with other transcription factors (Chen et al., 2004). 
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Figure  6.  Morphogens  signalling  pathways  involved  in  the  cell  specification  (adapted  from 
(Sanchez‐Camacho and Bovolenta, 2009)). 
A) Shh by binding to the twelve transmembrane Patched (Ptch) receptors relieves Ptch inhibition of 
the  transmembrane  Smo  protein.  Smo  in  absence  of  Shh  binding  is  inactivated  and  processed 
repressor forms of the Gli family (GliR ) inhibit the transcription of Hh target genes. After Shh binding, 
Smo is activated inducing accumulation of GliA forms, which activate Hh target genes.  
B)  The  Wnt  binding  to  Frizzled  seven  transmembrane  proteins  activates  either  the  canonical  β‐
catenin pathway, the planar cell polarity (PCP) pathway or the Ca2+ pathway. The canonical β‐catenin 
pathway  promotes  nuclear  translocation  of  β‐catenin  through  inhibition  of  the GSK3β  to  activate 
Wnt target genes. The PCP pathway induces cytoskeleton changes by activation of small GTPases Rho 
and Rac, which activate the Rho kinase  (ROCK) and the c‐JNK  (JNK), respectively. The Ca2+ pathway 
induces activation of protein  kinase C  (PKC),  calmodulin dependent protein  kinase  II  (CamKII) and 
calcinurin, which activate the nuclear factor of activated T cells (NF‐AT). 
C)  TGFβ  /BMP  signalling  induce  dimerisation  of  BMPR  type  I  and  type  II  receptors  that  induce 
phosphorylation  of  BMPRI  and  in  turn  activate  the  phosphorylation  of  Smad  proteins,  which 
associate with co‐Smad proteins to translocate to the nucleus and regulate the transcription of target 
genes. 
 
2.I.2.a The Hedgehog family in axonal guidance 
Shh is a chemoattractant for precommissural axons in rodents 
 As mentioned earlier, commissural axons, which differentiate in the dorsal neural tube, 
send axons that project toward and subsequently across the floor plate, forming axon 
commissures. These axons project toward the midline because they are attracted by Netrin-1 
(Placzek et al., 1990; Serafini et al., 1994; Tessier-Lavigne et al., 1988). In mice mutants for 
Netrin 1 or its receptor DCC, many commissural axon trajectories fail to invade the ventral 
spinal cord and are misrouted (Fazeli et al., 1997; Serafini et al., 1996). However, some of 
them reach the midline, suggesting that another chemoattractant guides these axons. 
Further analyses of the mice mutants have shown that the floor plate expresses an additional 
diffusible guidance cue for commissural axons, Shh (Charron et al., 2003; Serafini et al., 
1996). Shh was indeed shown to function as an axonal chemoattractant that can mimic the 
Netrin-1 independent chemoattractant activity of the floor plate in in vitro assays (Charron et 
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 al., 2003). Like floor plate cells and COS cells expressing secreting Netrin-1, COS cells 
secreting Shh can reorient and attract the growth of commissural axons within explants of 
E11 rat spinal cord. This effect is blocked by cyclopamine, a specific inhibitor of Smo, 
indicating the requirement for Smo in mediating this effect. Similarly, when embryonic spinal 
axons from Xenopus are exposed to a gradient of a bioactive fragment of Shh, N-Shh, the 
growth cones turned toward the source of N-Shh. While cyclopamine neutralised the effect of 
Shh, it did not affect the axonal attraction induced by BDNF in the Xenopus spinal axon 
turning assay. Moreover, the growth cones of isolated Xenopus spinal axons were similarly 
attracted by recombinant N-Shh in a cyclopamine-dependent manner. Taken together, these 
results prove that Shh can act as a chemoattractant to the commissural axons via a Smo 
signalling mechanism in vitro (Charron et al., 2003). Besides, Charron and colleagues 
showed that the projections of commissural axons in the ventral spinal cord were also 
disturbed in a conditional KO mouse model in which the Smo expression in the dorsal spinal 
cord was specifically deleted. These results suggest that in vivo, these axons are normally 
guided by a Smo-dependent Shh pathway (Charron et al., 2003) (Fig.7). 
In another in vitro assay, Yam et al. confirmed that Shh can act as a chemoattractive 
guidance cue for axons from primary DRG and commissural rat neurons (Yam et al., 2009). 
These dissociated neurons exposed to a stable Shh-gradient in a Dunn cultivation chamber 
turned to the source of Shh in a few minutes. The velocity of Shh effect on axon turning 
suggests that the effect may be independent of transcriptional activity and does not trigger a 
downstream transcriptional regulation. They argue that a new non-canonical Shh-induced 
pathway mediates this chemoattraction involving members of the Src-Family kinases (SFKs).  
SFKs were present in the growth cone of commissural axons and the level of phospho-SFK 
was increased in presence of Shh in a polarised manner, the distribution of phospho-SFK 
being more concentrated on the side of the growth cone exposed to higher Shh levels. 
Moreover, the specific inactivation of SFKs blocked the ability of commissural axons to turn 
up to the Shh gradient in the in vitro Dunn chamber assay (Fig.7). 
The attractive effect of Shh in guidance of commissural axons go through binding to Boc and 
Ptc receptors, which then activate Smo (Charron et al., 2003; Okada et al., 2006). The 
activation of Smo would activate SFKs in a graded manner. The activated SFKs can mediate 
signalling to rearrange the cytoskeleton of the growth cone and play a role in Eph or Netrin 
guidance pathways. They hypothesise that the Shh gradient interferes through a non-
canonical pathway with the remodelling of growth cone cytoskeleton and consequently adapt 
the growth cone trajectory according to the Shh gradient (Fig.7). 
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 Shh is a chemorepellent for post-commissural axons in chicken 
 In early stage of development, Shh morphogen secreted from the floor plays a role in 
cell patterning. Bourikas et al. showed that it is again expressed later in development during 
a restrictive time window corresponding to the time-point of commissural axon crossing 
(Bourikas et al., 2005). By in vitro and in vivo experiments, they showed that Shh expression 
has a direct effect on the longitudinal guidance. When Shh was downregulated, instead of 
turning rostrally the commissural axons stalled at the exit point of the midline or turned 
randomly to caudal or rostral side. The ectopic expression of Shh in the thoracic and upper 
lumbosacral levels on one side of the spinal cord interfered with the normal crossing pathway 
as well. In presence of high Shh concentrations most of the commissural axons either could 
not leave the floor plate or turned caudally after crossing to avoid the high level of Shh 
protein. This repulsive activity of Shh was also demonstrated in vitro. Spinal cord explants 
were cultivated in collagen gels and exposed to beads coated with Shh. In this assay, no 
commissural axons were growing from the side of the explant in presence of Shh or they 
turned away to avoid the Shh-coated beads. Finally, Bourikas et al. showed that the 
repulsive effect of Shh on postcommissural axons is mediated by the Hip receptor, while its 
chemoattractive activity on precommissural axons is transduced by the Ptc-Smo complex, 
whose expression is downregulated when they reach the floor plate (Fig.7).  
 
Figure  7.  Shh  signalling  components  involved  in  axon  guidance  (from  (Sanchez‐Camacho  and 
Bovolenta, 2009)). 
Shh mediates attraction of pre‐commissural axons by  recruitment of Boc and Smo  to activate  the 
kinases  of  Src  family.  Smo  is  constitutively  inactived  by  Ptch1  in  absence  of  Shh.  Oxyterols, 
arachidonates metabolites  and  Vitamine D3  can mediate  Smo  activation.  The  activated  signalling 
pathway  induces modifications of  intracellular cAMP concentration and  inhibition of PKA  leading to 
the  repulsion of growth  cones. Shh by  interacting with Hhip  receptor  inhibits  the growth of post‐
commissural axons. 
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 2.I.2.b The Wnt family in axonal guidance 
Wnt4 controls the antero-posterior guidance of commissural axons in mice (post-crossing) 
 Lyuksyutova and colleagues found that Wnt4 mRNA is expressed in a decreasing 
anterior-to-posterior gradient in the floor plate of mouse embryos, and that a directed source 
of Wnt4 protein attracted post-crossing commissural axons in explant cultures (Lyuksyutova 
et al., 2003). Commissural axons in mice lacking the Wnt receptor Frizzled3 have normal 
pre-crossing commissural axon behaviour, but display anterior-posterior guidance defects 
after midline crossing. Thus, Wnt-Frizzled signalling participates in the guidance of 
commissural axons along the anterior-posterior axis of the spinal cord. A recent study 
suggests that an atypical protein kinase C (aPKC) is required to further transduce the 
Wnt4/frzz3 guidance signalling (Wolf et al., 2008) (Fig.8). 
 
Figure  8.  Wnt  signalling  pathway  involved  in  axon  guidance  of  post‐commissural  axons  (from  
(Sanchez‐Camacho and Bovolenta, 2009)). 
Wnt4  and  Wnt7b  by  binding  to  the  Frizzled3  transmembrane  protein  activate  a  non‐canonical 
pathway,  which  induces  activation  of  the  aPKC  complex  and  leads  to  attraction  of  commissural 
axons. 
 
Wnt5a and Wnt7a are attractive cues for post-crossing commissural axons regulated by Shh 
 In the chick embryo Wnt5a and Wnt7a are expressed in and adjacent to the floor plate, 
respectively, while Wnt4 is completely absent from this region. The downregulation of Wnt5a 
and Wnt7a by in ovo RNAi indeed disturbs the routing of post-crossing commissural axons, 
suggesting a direct role in longitudinal axonal guidance. Unlike the graded expression of 
Wnt4 in mouse, Wnt5a and Wnt7a in chick are uniformly distributed along the anteroposterior 
axis in the lumbosacral region. In contrast, inhibitors of Wnt receptors, Secreted frizzled-
related protein (Sfrp) family members, are expressed in a rostrocaudal gradient in the chick 
spinal cord. In vitro, the attractive effect of recombinantly expressed Wnt5a and Wnt7a on 
post-crossing commissural axons is blocked by recombinant Sfrp1. Along with the growth-
promoting effect, the preferred outgrowth of post-crossing commissural axons towards rostral 
floor plate explants in relation to their caudal counterpart is lost upon addition of Sfrp1-
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 containing medium as well. The ectopic expression of Sfrps1 at thoracic and upper 
lumbosacral level of the spinal cord in vivo, induces turning of commissural axons at the 
upper lumbosacral levels. Taken together, the post-crossing commissural axons are guided 
by a functional gradient of Wnt-signalling linked to a graded expression of the inhibitory Sfrp. 
As mentioned above, a Shh repulsive gradient participates in the longitudinal guidance of 
commissural axons (Bourikas et al., 2005). Interestingly, an ectopic expression of Shh in the 
developing spinal cord also induces Sfrp1 and Sfrp2 expression in ovo. These results taken 
together, strongly suggest that a caudo-rostral gradient of Shh controls directly the 
commissural axons guidance by repulsion and indirectly by generating a functional rostro-
caudal gradient of Wnt5a- and Wnt7a-signalling (Domanitskaya et al., 2010) (Fig.9). 
 
 
Figure  9. Wnts  gradient  controls  post‐commissural  axons  guidance  (from  (Domanitskaya  et  al., 
2010)). 
A) In mouse embryo, Wnt4 gradient attracts post‐commissural axons to the rostral part of the spinal 
cord. 
B) In chick embryo, the Wnt5a and Wnt7a are homogeneously expressed along the spinal cord. The 
graded  expression  of  Shh  in  the  floor  plate  induced  as  well  a  graded  expression  of  the  Wnt 
antagonist Sfrp1 that regulates in turn the Wnt activity in a graded manner. 
C) Consequently,  the post‐commissural axons  repelled by Shh at  the  floor plate are directed along 
the spinal cord by Wnt5a and Wnt7a highly active in the rostral region. 
R, Rostral; Ca, caudal. 
 
 
2.I.2.c The Dpp/BMP/TGF family in axonal guidance 
BMPs are chemorepellents for commissural axons 
 Butler and co-workers provided evidence for a repulsive role of BMP family members in 
the guidance of commissural axons in vertebrates (Augsburger et al., 1999; Butler and Dodd, 
2003; Yamauchi et al., 2008). The commissural axons originating close to the roof plate 
extend their axons away from the dorsal midline suggesting that the floor plate participates 
by chemorepulsion. Indeed, explants of the roof plate repel the commissural axons in vitro. 
Intriguingly, three members of BMP morphogen family (BMP7, BMP6 and GDF7) are 
expressed by the roof plate in the rat spinal cord at the time (E11-E13), when the 
commissural axon extension occurs (Augsburger et al., 1999). Particularly BMP7 deviates 
the trajectories of commissural axons from spinal cord explants, mimicking the 
chemorepellent activity of the roof plate in vitro without causing changes in neuronal cell fate 
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 at the doses required for chemorepulsion. The repulsion is neutralised by soluble inhibitors of 
BMP activity, BMP7-blocking antibodies and by genetic inactivation of Bmp7. This indicates, 
that of the three BMPs expressed in the roof plate, only BMP7, but not BMP6 or GDF7 alone, 
are able to exert a chemorepellent activity towards commissural axons (Augsburger et al., 
1999).  
BMP7 induces the collapse of commissural axon growth cones eliciting a rapid change in 
cytoskeletal organisation of dissociated dorsal spinal cord cell culture (Augsburger et al., 
1999). Genetic inactivation studies of single and double knockout mouse mutants of the 
BMPs members, BMP7, BMP6 and GDF7, have later revealed that the expression of both, 
BMP7 and GDF7 is required for the fidelity of commissural axon growth in vivo (Butler and 
Dodd, 2003). Moreover, they showed that BMP7 and GDF7 heterodimerize in vitro and that, 
under these conditions, GDF7 enhances the axon-orienting activity of BMP7. They finally 
conclude that a GDF7:BMP7 heterodimer functions as the roof plate-derived repellent that 
adds to the establishment of the initial ventral trajectory of commissural axons (Butler and 
Dodd, 2003). 
The BMP signalling pathway, which controls cellular specification during early neural 
development, seems to act via transcriptional activation. In contrast, the BMP pathway that 
triggers growth cone collapse and thus regulates axon routing seems to be too rapid to 
involve transcription in the regulatory process (Augsburger et al., 1999) (Fig.10).   
 
Figure  10.  BMP  signalling  components  involved  in  axon  guidance  (from  (Sanchez‐Camacho  and 
Bovolenta, 2009)). 
Attraction and  repulsion of  the growth  cones  can be mediated  through BMPRII  receptors. BMPRII 
interacting  with  LIM  kinase1  inhibits  its  activity.  Ligand  binding  activates  LIMKI,  cdc42  and  Rho 
GTPase  that  induces  cytoskeleton  changes  and  attraction  of  the  growth  cone.  The  repulsion  is 
mediated by calcium signalling and activation of Shh, which in turn inhibits the LIMK1 activation and 
the cofilin signalling. 
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 Yamauchi and colleagues recently demonstrated that both pathways depend on the type I 
and type II BMP-receptors. Nevertheless, using loss and gain-of-function approaches, they 
provided evidence that the BMP7/GDF7-induced chemorepulsion of the commissural axons 
is principally mediated by BMPRIB/BMPRII-heteromeric complexes (Yamauchi et al., 2008), 
brates a 
imilar coordinated long-range repulsion is unlikely to guide commissural axons, which grow 
 direct the axons of spinal accessory motoneurons. 
while both, BMPRIA/BMPRII- and BMPRIB/BMPRII-heterodimers, control the cell fate earlier 
in embryogenesis (Yamauchi et al., 2008).  
A connection between the chemorepulsion mediated by Netrin and by members of the TGF 
family has been previously proposed by Culotti and co-workers who searched in C.elegans 
for genes functionally linked with unc-5, a receptor for UNC-6/Netrin. The molecule they 
found indeed participated in axon guidance along the dorso-ventral axis and was identified 
as the TGF related gene unc-129 (Colavita and Culotti, 1998; Colavita et al., 1998). They 
recently provided further evidence that UNC-129 facilitates the long-range axonal repulsion 
exerted by UNC-6 by enhancing the more effective “UNC-5 + UNC-40” signalling in 
comparison to “UNC-5 alone” signalling. They also showed that UNC-129 interacts with the 
UNC-5 but not with UNC-40 receptor and consequently modulates the UNC-6 repulsion via 
UNC-5. These results provide some hints on how the sensitivity of growth cones of motor 
axons to UNC-6/Netrin in C.elegans could be regulated as they simultaneously migrated up 
the UNC-129 gradient and down the UNC-6 gradient (MacNeil et al., 2009). In verte
s
in the opposite direction, but may
 
2.I.3 Neurotrophic factors 
 Several neurotrophins and some growth factors are required to promote neuronal 
survival, growth cone motility and axon outgrowth. Even if they could not be defined as 
emblematic guidance cues, a variety of neurotrophic factors take part in attraction of specific 
populations of axons in the peripheral and central nervous systems of vertebrates. They 
consist of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), 
neurotrophin-3 and -4 (NT-3, NT-4), glial-derived neurotrophic factor (GDNF), neuregulin 
(NRG), hepatocyte growth factor (HGF), and stem cell factor (SCF) (Kolodkin and Tessier-
Lavigne, 2010). Each of the vertebrate neurotrophins interacts with one or more members of 
the Trk family of receptor tyrosine kinase (TrkA, TrkB and TrkC) and the p75 neurotrophin 
receptor (reviewed in (Reichardt, 2006)). The p75 neurotrophin receptor (p75NTR), a 
transmembrane protein of the tumour necrosis receptor superfamily, regulates three major 
signalling pathways by interacting with different proteins. Some promote neuronal survival, 
while others activate apoptosis (NfkB and c-Jun kinase, respectively). The p75 receptor can 
upon binding with neurotrophins activate the Rho pathway that controls the growth cone 
motility. Recently, its role in retinal mapping via interaction with EphrinA has been 
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 demonstrated. Therefore, the p75 receptor appears as a multifunctional modulator either 
idance of EphA4 expressing neurons, 
e, they showed that recombinant SCF could promote the outgrowth only of post-
rossing commissural axons indicating a restricted guidance role of SFC after midline 
crossing.  
esives between cells, but also as specific cues that activate specific 
promoting or inhibiting axon growth and guidance according to its partners (Schecterson and 
Bothwell, 2008).  
The first neurotrophin identified was NGF from snake venom. It was shown to promote axon 
growth and survival on sensory and sympathetic axons in vitro (Gundersen and Barrett, 
1979; Levi-Montalcini and Cohen, 1956). Barde et al. isolated BDNF from pig brain. This 
neurotrophin was later in combination with NT-3 recognised as component of the Maxillary 
factor, promoting growth of trigeminal sensory axons in vitro and permitting them to reach 
their targets (O'Connor and Tessier-Lavigne, 1999). HGF, a diffusible ligand of the c-Met 
receptor tyrosine kinase, acts as chemoattractant for the motoraxon outgrowth in developing 
limb bud (Ebens et al., 1996). GDNF and its receptor Ret were shown to mediate the 
signalling pathway of the lateral motor column axons that are repelled from the ventral limb 
mesoderm (Kramer et al., 2006). In motor axons gu
GDNF/ret cooperates with ephrinA/EphA4 signalling to direct motoraxons into the dorsal limb 
mesenchyme (Kramer et al., 2006) (shown in Fig.5).  
Another growth factor, SCF, has been identified as a guidance cue for commissural axons 
(Gore et al., 2008). Gore and colleagues demonstrated by genetic studies on mice that 
interactions between SCF secreted from the floor plate and the Kit receptor expressed by 
commissural axons are required for the exit of commissural axons from the floor plate. 
Furthermor
c
 
2.I.4 Cell adhesion molecules  
 First studies on axon guidance focused on the potential role of the cell adhesion 
molecules (CAMs). Indeed, the CAMs (IgCAM and cadherins) expressed by developing 
neurons at their growth cones signal through homophilic or heterophilic interactions in 
diverse processes during nervous system development. The action on axon growth has often 
also been demonstrated with their recombinant soluble forms, indicating that CAMs do not 
act solely as adh
signalling pathways to enhance distinct growth cone control mechanisms participating in 
axonal guidance. 
The roles of CAMs in fasciculation, axon growth and guidance, synaptogenesis and synapse 
plasticity have been particularly described (reviewed in (Chedotal and Richards, 2010; 
Kolodkin and Tessier-Lavigne, 2010; Skaper, 2005)). The function of axonin-1 and NrCAM 
as cooperative short attractive guidance cues for commissural axons was demonstrated in 
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 vivo in chick embryos (reviewed in (Stoeckli and Landmesser, 1998)). Indeed, injection of 
soluble axonin-1 or function-blocking antibodies against axonin-1 and NrCAM into the spinal 
cord strongly disturbed the pathfinding of commissural axons that extend to the floor plate 
causing their inappropriate turning on the ipsilateral side. Landmesser and coworkers 
established that axonin-1 expressed on the growth cone of commissural axons interacts with 
NrCAM present on the floor plate, permitting axons to cross the midline. Moreover, they 
showed that in absence of a functional balanced interaction between these two proteins, the 
short negative guidance cues emanating from the floor plate prevail and impede the 
commissural axons from entering the floor plate. More recent studies revealed that the 
NrCAM and L1-proteins participate as co-receptors in Semaphorin receptor complexes to 
guide commissural axons crossing the midline (reviewed in (Mann et al., 2007)). Lately, a 
soluble form of CAM (sNrCAM) has been described to mediate the Sema3B/Nrp2 repulsion 
pathways signalling at the vertebrate ventral midline (Nawabi et al., 2010). In the brain, close 
nd regulates axon guidance at early stages, whereas 
cadherin-6B promotes later axon branching, acting via the phosphatidylinositol 3-kinase 
(PI3K) pathway (Barnes et al., 2010). 
homologue of L1 (CHL1) and Neurofascin 186, both members of L1-CAM family control the 
targeting of different interneurons (reviewed in (Chedotal and Richards, 2010)).  
Homophilic binding of N-cadherin guides the optic nerve fibers. Like NCAM and L1, N-
cadherin can also interact with the fibroblast growth factor receptor (FGFR) in neurons to 
stimulate axon growth (Doherty et al., 2000). After FGFR activation, the local calcium level in 
the growth cone is changed and triggers the response by activating different signalling 
pathways to adapt the actin cytoskeleton. Other cadherins were shown to play a role in motor 
axon patterning, like the calcium–dependent cell surface T-cadherin for spinal motor 
neurons. T-cadherin expression is restricted to the caudal half of the sclerotome suggesting 
that T-cadherin acts as negative guidance cue for the sensory and motor axon projections. 
Indeed, T-cadherin inhibits motor axon growth in vitro (Fredette et al., 1996). Spinal motor 
neurons from explants at different stages of chick development were only inhibited by T-
cadherin substrata at stages when the axons usually grow across the sclerotome. The 
inhibitory responses corresponded to neuronal T-cadherin expression in the axons, 
suggesting a homophilic binding mechanism. Sympathic and sensory ganglion neurons in 
culture were inihibited by T-cadherin substrata as well. Other cadherins (cadherin-7 and 
cadherin-6B, cadherin-11) can also regulate axon guidance. For instance, cadherin-11 
promotes axon growth and impedes the interactions between growing axons (Marthiens et 
al., 2005). Consistent with their different expression profiles (cadherin-7 and cadherin-6B in 
early and late phases of chick branchiomotor neuron development, respectively), they play 
different roles in guidance and branching of cranial motor axons. Cadherin-7 promotes the 
growth of a single unbranched axon a
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 2.I.5 ECM associated molecules in development 
 During nervous system development, the extracellular matrix molecules laminin and 
fibronectin simply support axonal growth, while other molecules such as tenascins appear to 
guide them (reviewed in (Barros et al., 2010)). 
Laminin together with type IV collagen, nidogen and perlecan, is one of the main 
components of the basement membrane (Miner, 2008). Laminins are glycoproteins 
assembled in α-β-γ heterotrimers that interact with integrins and non-integrin receptors 
(reviewed in (Durbeej, 2010)). In vertebrates, fifteen isoforms of these cell adhesion proteins 
have been described. The laminins α-2, α-4 and α-5 are mainly expressed in the peripheral 
nervous system (reviewed in (Durbeej, 2010)). Laminins act as permissive substrates for 
cultured neurons. The neurite outgrowth promoting function occurs in a integrin-dependent 
manner (reviewed in (Barros et al., 2010)). Laminins have also been implicated in axonal 
guidance in vivo. For instance, downregulation of laminin A in Drosophila results in 
pathfinding errors of sensory nerves. Similarly in mice, mutants for α-2 laminin or α-4 laminin 
(constituents of laminins 2 and 10 from the basal lamina in the PNS) display several defects 
in axon branching, axon sorting and migration of neuronal cells. Only some of these 
observations were made, when the β1 subunit of integrin receptors was deleted in mice, 
suggesting that β1-containing integrins mediate only a part of the laminin function. 
Fibronectin is another adhesive glycoprotein largely distributed in the ECM of mesenchymal 
tissues. Fibronectin can mediate cell migration, differentiation and adhesion by binding to 
other ECM components and to different integrin-receptors. During development, fibronectin is 
expressed in the CNS and the PNS. Like laminin, fibronectin also supports neurite outgrowth 
in vitro but the growth cones advance on fibronectin more slowly than on laminin (Kuhn et al., 
1995). 
Tenascins, another family of glycoproteins associated with the ECM, also participates in 
axonal growth. The tenascin family comprises TN-C, TN-R, TN-W, TN-X, TN-Y (reviewed in 
(Joester and Faissner, 2001)). Under physiological conditions, tenascins are expressed only 
during embryogenesis and tissue regeneration. Tenascin-R found only in the CNS, is 
expressed during late development by oligodendrocytes (Pesheva et al., 1997) and 
participates in the interaction between neurons and oligodendrocytes. Tenascin-C is 
expressed in the central nervous system as well, but at earlier stages and contributes to 
neuronal migration. Tenascin-C is, for instance, present in the barrel boundaries of the 
somato-sensory cortex and at the interface between compartments in the developing nigro-
striatal pathway, when these structures are modified suggesting tenascin-C implication in 
these remodelling events. 
The tenascins R and C can both promote or inhibit neurite growth in vitro, depending on the 
type of neurons. In vivo, no axonal pathfinding error was observed in tenascin-R deficient 
mice, whereas a repellent function for the growth of optic axons was suggested in zebrafish. 
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 Some defects in peripheral nerves in tenascin-C mutant mice were described (Cifuentes-
Diaz et al., 2002) and a recent study provided evidence for a role as boundary molecule in 
the developing olfactory bulb (Treloar et al., 2009). 
Apart from laminins, fibronectin and tenascins, some of ECM-molecules with thrombospondin 
type1 repeats take part in axon growth and guidance (reviewed in (Barros et al., 2010)). For 
example, F-spondin secreted from the floor plate and expressed in developing nerves, 
promotes migration and outgrowth by inhibiting cellular adhesion. Another member of this 
family, thrombospondin-1 secreted by astroglia, promotes neurite outgrowth of many types of 
cultured neurons and facilitates migration of oligodendrocyte precursors.  
Collagens are also expressed during nervous system development and participate in axon 
growth promotion (reviewed in (Hubert et al., 2009)). For instance, collagen I and collagen 
XVIII support neurite growth in vitro. Moreover, collagen IV regulates the axon targeting in 
zebrafish. 
Finally, the proteoglycans, another group of extracellular matrix molecules, play an important 
role during development of the nerve system. These molecules will be discussed more into 
details in the next chapter. 
 
In conclusion, many molecules directly participate in axon guidance and growth. Among 
them, some act as bi-functional cues, either attractive/permissive or repellent/inhibiting, 
depending on the partners and time they interact. Additionally, several cues that have 
antagonistic effects may be expressed in the same spatiotemporal context. Hence, a 
particular guidance response does not rely exclusively on a single cue, but is rather the result 
of the reinforced action of multiple guidance cues, which function via different growth cone 
receptors and their distinct intracellular signal transducing pathways. 
 
 
2.II. Proteoglycans  
2.II.1 Structure 
 Proteoglycans are major components of the cell surface and the extracellular matrix. 
They consist of a core protein, to which dissacharide polymers termed glycosaminoglycans 
(GAGs) are covalently linked at specific sites. 
The glycosaminoglycan chains are composed of repeated units of alternating N-acetylated 
hexosamine and an uronic acid (glucuronic acid or iduronic acid) or a galactose. Except for 
hyaluronan (also hyaluronic acid; HA), these sugar polymers are usually sulphated at various 
positions and bound to a central protein core. The four main classes distinguished among the 
sulphated glycosaminoglycans are chondroitin sulphate (CS) and dermatan sulphate (DS) 
resulting from the epimerization of the glucuronic acid to iduronic acid in CS, heparan 
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 sulphate (HS) and its epimerized counterpart heparin and finally keratan sulphate (KS), a 
sulphated N-acteyllactosamine polymer (Fig.11).  
 
 
 
Figure 11. Types of dissacharide repeat units of glycosaminoglycans (GAGs). 
Modifications and enzymes that catalyse the reactions are depicted in colour (modified from (Bulow 
and Hobert, 2006)). 
 
2.II.2 Biosynthesis of proteoglycans 
 Apart from the hyaluronan that exists on the cell surface and in the extracellular matrix 
as a free high molecular weight glycosaminoglycan, the GAGs are covalently attached to a 
protein core. CS, DS and HS are linked to serine residues of the protein core via a specific 
tetrasaccharide (xylose-2xgalactose-glucuronic acid). The xylosyl transferase initiates the 
biosynthesis of these glycosaminoglycans by addition of xylose to a specific serine residue in 
the core protein and then two galactoses and one glucuronic acid are inserted by 
galactosyltransferase-I and II, and glucuronyltransferase I, respectively (Fig.12). 
Subsequently, specific co-polymerases elongate the disaccharides in the Golgi apparatus. In 
the case of chondroitin sulphate, six enzymes (three chondroitin sulphate synthases, one 
chondroitin sulphate glucuronyltransferase and two chondroitin sulphate N-
acetylgalactosaminyl-transferase) may collaborate in the polymerisation process. Different 
sulphotransferases are involved in 2-O, 3-O, 4-O and 6-O-sulphation as well as in N-
deacetylation/N-sulphations, while epimerases may catalyse the conversion of glucuronic 
acid to iduronic acid. The KS are attached to the core protein through an N-
acetylglucosamine to asparagine or through N-acetylgalactosamine to serine or threonine 
residues.  
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Figure 12. Tetrasaccharide  linker region of the proteoglycans (from Molecular Biology of the Cell, 
5th edition (Alberts B et al., 2008)).  
 
Since proteoglycans could differ in terms of type, size and composition of GAG chains, 
primary sequence and domain arrangement of the protein core, degree of substitution of the 
GAG chains along the protein core, an enormous variety of proteoglycans is expressed and 
distributed in the tissues. Thus, the traditional GAG-oriented classification into heparan 
sulphate proteoglycans (HSPGs), chondroitin/dermatan sulphate proteoglycans 
(CSPG) and keratan sulphate proteoglycans (KSPGs) has meanwhile been superseded 
by a functionally more relevant separation into distinct families based on core protein 
homology. For instance, the cell surface associated HSPGs have been grouped into the 
trans-membranous syndecans and the GPI-linked glypicans and the major extracellular 
matrix CSPGs have been divided into the families of lecticans/hyalectans and SLRPs (small 
leucine-rich repeat proteoglycans). These subgroups include sometimes also “part-time” 
proteoglycans, which may or may not carry glycosaminoglycans depending on the 
physiological context. 
 
2.II.3 Heparan sulphate proteoglycans in nervous tissues 
 HSPGs are generally known to interact with various guidance molecules and the 
deficient mouse for the gene encoding for the major HS glycosyltransferase (Ext1) displays 
severe defects in patterning and guidance of commissural tracts (Inatani et al., 2003). Since 
cell surface heparan sulphate proteoglycans may act as co-receptors for morphogens, 
neurotrophins and various growth factors they are good candidates to modulate different 
aspects of nervous system development (reviewed in (Holt and Dickson, 2005; Lee and 
Chien, 2004)) (Fig.13). 
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Figure 13. Examples of HSPGs family members (adapted from Essentials of Glycobiology, 2nd edition 
(Esko et al., 2009)).  
 
Agrin is a heparan sulphate proteoglycan with a core protein of approximately 220 kDa. 
Agrin was first identified in the basal lamina of neuromuscular junctions being involved in 
clustering of acetylcholine receptors and formation of synapses at this site (Nitkin et al., 
1987; Smith et al., 1987). Indeed the secreted isoform, neural agrin expressed by embryonic 
motoneurons participates in stabilisation of the synapses (Magill-Solc and McMahan, 1988; 
Ngo et al., 2007). Agrin downregulation in mutant mice leads to striking defects in 
postsynaptic differentiation such as a reduction in size and number of AchR aggregates at 
the neuromuscular junctions. Agrin-deficient mice die at E18 (Gautam et al., 1996).  
 
Perlecan another secreted HSPG is abundantly expressed in basal lamina. This large 
proteoglycan (core protein of about 400 kDa) may bind cellular receptors such as integrins 
and α-dystroglycan. Perlecan-null mice are not viable and die either around E10-12 or at 
birth because of heart and cephalic development impairment or respiratory defects, 
respectively (Arikawa-Hirasawa et al., 1999; Costell et al., 1999). Indeed, perlecan 
expressed in the choroid plexus and in the neuroepithelium during development is needed to 
separate the brain tissue from the overlaying ectoderm. In deficient mice, the absence of 
perlecan leads to diverse cerebral development defects because of the fusion of the brain 
tissue with the adjacent mesenchyme resulting in abnormal expansion of the 
neuroepithelium, neuronal ectopias and exencephaly. More recently, a role for perlecan, 
potentially interacting with Shh and FGF2, has been suggested for the neurogenesis of the 
cortical progenitors (Giros et al., 2007). 
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Among the HSPGs, the families of glypicans and syndecans are cell-surface associated 
molecules linked via a GPI anchor or embedded by a type I transmembrane domain, 
respectively.  
 
The Glypican family is constituted of six members in vertebrates and two in Drosophila and 
C.elegans. All of them are expressed at least transiently in the nervous system. Glypican-1 is 
the most abundant in developing brain (Litwack et al., 1998; Litwack et al., 1994; Niu et al., 
1996). It is present in neuroepithelial precursors and differentiated neurons and participates 
in FGF signalling during early neurogenesis (Jen et al., 2009). The glypican-2 expression is 
restricted to the developing brain. It is particularly found in immature neurons disappearing 
after completion of cell migration and axon outgrowth (Stipp et al., 1994). Interestingly, 
glypican-2 is present on a polarised way on growth cones of axons suggesting a role in axon 
guidance (Ivins et al., 1997). Glypican-1 binds Slit in vitro and both molecules co-localise on 
the surface of reactive astrocytes in a model of injured brain (Hagino et al., 2003; Liang et al., 
1999). Furthermore, glypican-1 is upregulated and mainly presented on the cellular 
membrane of sensory neurons after injury in either PNS or CNS, while Slit1 and Robo2 are 
upregulated in DRGs after peripheral axotomy (Bloechlinger et al., 2004; Yi et al., 2006). 
These data suggest a participative role for glypican in axonal growth control and guidance 
mediated by the Slit/Robo pathways. 
 
Syndecans are small type I transmembrane cell surface heparan sulphate proteoglycans 
with core protein sizes of 20 to 40 kDa. In mammals, four syndecans are present. All 
vertebrate syndecans are expressed during development in the brain by different cell 
populations (Hsueh and Sheng, 1999). They are involved in neural migration, axonal growth 
and synaptic plasticity (reviewed in (Hacker et al., 2005; Reizes et al., 2008)). Syndecan 2 
and syndecan 3 are expressed by neurons but are distributed in a distinct manner on the 
neuronal surface. The syndecan 2 distribution is restricted to the dendrites, while syndecan 3 
is present mainly on axons. Syndecan 2, phosphorylated in neurons by EphB2, takes part in 
the maturation of the synapse inducing the formation of mature dendritic spines (Ethell et al., 
2001; Ethell and Yamaguchi, 1999). 
Syndecan 3 seems to participate in axonal growth and synaptogenesis processes, since 
syndecan 3 expression on the axon surface is specifically downregulated once the axons 
have reached their targets. Recently, the role of syndecan 3 in promoting cortical neuron 
migration and neurite outgrowth by interacting with the GDNF has also been shown 
(Bespalov et al., 2011). Besides in a co-culture model system, syndecan 3 expressed by 
Schwann cells is enriched at the nodes of Ranvier, but syndecan 3-deficient mice do not 
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 display particular defects in node formation (Asundi et al., 2003; Melendez-Vasquez et al., 
2005). Different studies in Drosophila indicate a role of syndecans in Slit/Robo signalling by 
facilitating the Slit/Robo interaction (Johnson et al., 2004; Steigemann et al., 2004). In 
C.elegans the sole syndecan controls the neural migration and the guidance of growing 
axons of midline interneurons and motoneurons (Rhiner et al., 2005).  
 
2.II.4 Chondroitin sulphate proteoglycans in nervous tissues 
 Chondroitin sulphate proteoglycans represent the principal group of proteoglycans in 
the nervous system. Among them, members of the lectican (hyalectan) family are the main 
components of a unique ECM found only in the central nervous system (reviewed in 
(Yamaguchi, 2000; Zimmermann and Dours-Zimmermann, 2008)). During brain 
development, the proteoglycans play a role in morphogenesis by regulating the interactions 
between cells, of the cells to the extracellular matrix and to growth factors and morphogens 
of the environment. The function of CSPGs (hyalectans, NG2 and phosphacan) in the control 
of axonal growth and neural regeneration has been investigated in different in vitro models.  
 
2.II.4.a NG2 and Phosphacan, two CSPGs involved in development and regeneration 
of the nervous tissues 
 
Figure  14. Depiction  of NG2  and  receptor‐like protein  tyrosine phosphatase  β  (RPTPβ)  isoforms 
(adapted from (Couchman, 2010; Peles et al., 1998)). 
 
NG2 is a membrane proteoglycan with a large core protein (330kDa) (Fig.14). During 
development also some non-neural cells display NG2 expression for example also 
chondroblasts. In adult mammalian brain and spinal cord, NG2 is expressed mainly by 
progenitors of glial cells such as the oligodendrocytes precursor cells that give rise in vitro to 
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 the mature oligodendrocytes and the type II astrocytes (Nishiyama et al., 1991). These 
progenitors are called in vivo polydendrocytes because of their astrocyte-like structure and 
their oligodendrocyte antigenic features (Nishiyama et al., 1991; Nishiyama et al., 2002). The 
intracellular domain of NG2 may bind to the glutamate receptor interacting protein-1 GRP1 
mediating clustering of NG2 and AMPA glutamate receptors to potentially modulate the glial 
neuronal signalling (reviewed in (Trotter et al., 2010)). Role of NG2 during nervous system 
development and brain regeneration is not yet well understood. Several studies provided 
evidence for a NG2 inhibitory function on neurites and axon growth in vitro and suggested a 
role in inhibiting axonal regeneration in CNS after injury (Chen et al., 2002; de Castro et al., 
2005; Dou and Levine, 1994; Fidler et al., 1999; Jones et al., 2002; Ughrin et al., 2003). A 
recent study showed a putative role of NG2 in blocking the conduction in axons after spinal 
injury (Hunanyan et al., 2010). Even if the increased expression of NG2 in injury sites of CNS 
is unequivocal, the function and consequences of that increment are not clear. More recently, 
accumulating data have identified NG2 as promoter of nerve regeneration. NG2-deficient 
mice generated by Stallcup and colleagues did not show any obvious defects, neither in 
nervous system development nor later in adult (Grako et al., 1999). However, in a model of 
spinal axon injury, axons seemed to penetrate the developing scar tissue more easily in wild-
type mice than in NG2 knockout mutants, suggesting a stimulatory function of NG2 in nerve 
regeneration (de Castro et al., 2005). In another study, NG2-cells promoted the extension of 
regenerating axons in a graft after spinal cord injury (Jones et al., 2003). In line with these 
results, Yang et al. demonstrated that rat polydendrocytes did not repel growing axons from 
hippocampal and cortical neurons, but promoted their growth in vitro (Yang et al., 2006). In 
addition, they showed that in vivo, growing axons were in a much bigger proportion directly in 
membrane-contact with NG2 cells than with astrocytes of the developing corpus callosum. 
Besides, NG2 appears also to be involved in glioma progression (reviewed in (Stallcup and 
Huang, 2008)). 
 
PTPζ/RPTBβ/Phosphacan 
PTPζ/RPTBβ is a receptor-type protein tyrosine phosphatase that is synthesized as a 
chondroitin sulphate proteoglycan. Alternative splicing of the single gene coding for 
PTPζ/RPTBβ generates three isoforms (Levy et al., 1993; Maeda et al., 1995; Margolis et al., 
1996): the full length PTPζ/RPTBβ, a shorter receptor (sRPTBβ) missing the part carrying the 
attachment region of CS chains, and an extracellular secreted variant called phosphacan 
lacking the transmembrane and the intracellular domains. Phosphacan represents a major 
soluble chondroitin/keratan sulphate proteoglycan in the developing and adult brain and is 
mainly synthesized by glial cells (Canoll et al., 1993; Canoll et al., 1996; Maeda et al., 1995; 
Margolis et al., 1996; Maurel et al., 1994; Rauch et al., 2001; Sakurai et al., 1996). Indeed, 
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 phosphacan seems to be involved in different developmental processes such as cell 
migration, axon growth and myelination (Garwood et al., 2003; Grumet et al., 1994; Harroch 
et al., 2002; Harroch et al., 2000; Maeda and Noda, 1998). The PTPζ/RPTBβ receptor is 
constituted of several domains, especially in the extracellular portion. These domains play 
also a role in the functions of phosphacan in cell migration and axonal growth. For instance, 
the CAH domain of phosphacan present in the longest transmembrane isoform of 
PTPζ/RPTBβ and in phosphacan functions as a ligand to contactin (Peles et al., 1995). The 
binding of phosphacan via CAH domain with the contactin/NrCAM complex on the neuronal 
surface induces neuritic growth of chick primary tectal neurons (Peles et al., 1995; Sakurai et 
al., 1997). By contrast, phosphacan binding neurons via Ng-CAM/L1, may also inhibit neurite 
outgrowth in vitro (Milev et al., 1994) and may suppress adhesion of glioma cells on their 
preferential Ng-CAM/L1 substrate. Similarly, Maeda and Noda showed that phosphacan acts 
as bi-functional molecule, promoting the outgrowth of neurites and dendrites of cortical 
neurons but not of thalamic neurons, while inhibiting adhesion of both types of neurons 
(Maeda and Noda, 1996). Phosphacan also interacts with pleiotrophin/HB-GAM via the 
spacer (S) domain and this binding interferes with the neurite outgrowth-inducing properties 
of pleiotrophin on cortical neurons (Maeda and Noda, 1998). Phosphacan can also bind the 
extracellular matrix molecule tenascin and form a complex which may participate in different 
mechanisms of development and repair of the nervous tissues (Barnea et al., 1994; Garwood 
et al., 2001; Grumet et al., 1994). Even if many in vitro studies indicate a significant role for 
phosphacan in different developmental and regenerative processes in the nervous system, 
no obvious effect of the deletion of the three isoforms has been observed in the knock-out 
mouse model. Only a slight impairment of long-term potentiation (LTP) associated with 
memory and learning has been described (Harroch et al., 2000; Niisato et al., 2005; Shintani 
et al., 1998). 
 
2.II.4.b Expression and functions of lecticans/hyalectans in nervous tissues 
 In mammals, four lectican genes have been identified that encode aggrecan, versican 
and the two neuronal-tissue specific members, neurocan and brevican (Doege et al., 1991; 
Rauch et al., 1992; Yamada et al., 1994; Zimmermann and Ruoslahti, 1989) (Fig.15). All of 
them are spatially and temporally regulated during embryonic development and in the adult. 
Their core proteins share several structural domains. Close to the N-terminus, an Ig-like loop 
and two link-protein-like tandem repeats form the globular domain G1 that binds to 
hyaluronan and to different link proteins. Near the C-terminal end, another globular domain 
(G3) consists of one or two EGF-repeat domains, a C-type lectin element and a complement 
regulatory protein (CRP or Shushi) domain, respectively. The central core protein between 
the two terminal globular domains is quite flexible. This region carries the GAG chains and 
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 numerous O- and N-glycans, which are covalently bound. The GAG-attachment domains of 
the distinct lecticans differ, greatly in primary sequence, peptide length as well as structure 
and number of the attached GAG chains. In addition, alternative splicing of the versican gene 
VCAN and the brevican gene BCAN enlarge the variety of the lecticans (versican isoforms 
V0, V1, V2, V3 and secreted and GPI-linked variants of brevican, respectively).  
 
  
 
Figure 15. The lectican‐family (from (Zimmermann and Dours‐Zimmermann, 2008)). 
ADAMTS: A disintegrin and metalloprotease with thrombospondin type 1 motif. 
 
Brevican, a “part-time” proteoglycan (not always carrying GAGs), is restrained to the CNS 
and displays a much shorter central core protein domain than the other lectican members 
(Yamada et al., 1994). Brevican isoforms exist either as secreted or GPI-anchored 
proteoglycans (Seidenbecher et al., 1995). In adult, brevican is found in many regions of the 
brain associated with the perineural nets (PNNs), subcomponents of the central nervous 
ECM surrounding the soma and proximal neurites of large neurons (Bruckner et al., 2000). 
The secreted form is preferentially found in the gray matter structures, such as cerebellar 
and cerebral cortex, hippocampus and thalamic nuclei, while the GPI-anchored glycoproteins 
are mainly present in white matter and expressed by glial cells (Seidenbecher et al., 1998). 
The expression of secreted brevican is in rodents as well as in human upregulated during 
peri- and postnatal development. Brevican is deposited as long as the brain develops  
reaching a constant level only in mature brain. Its expression coincides spatio-temporally 
with the production of glial cells (Gary et al., 2000; Jaworski et al., 1995). Yet the GPI-
anchored isoform displays the same level of expression during development. In case of 
gliomas, tumours derived from glial cells, both brevican isoforms are highly overexpressed 
with some preference for the secreted isoform (Gary and Hockfield, 2000). Furthermore, the 
role of cleaved brevican in mediating tumour invasion and reinforcing tumour expansion was 
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 revealed in gliomas (Nutt et al., 2001; Zhang et al., 1998). Besides, a potential inhibitor 
function of purified brevican for neurite outgrowth has been demonstrated in vitro (Yamada et 
al., 1997). Together, these data suggest that this lectican may participate in the regulation of 
cell adhesion and migration during brain development with different functions in relation to 
the isoform being expressed. Surprisingly however, the knock-out mice display only mild 
defects in long term potentiaton (LTP) but no morphological or behavioural changes were 
noticeable (Brakebusch et al., 2002). 
 
Neurocan, another nervous-tissue specific hyalectan, is secreted as an intact proteoglycan 
with a 275 kDa core glycoprotein during early rodent brain development. At the end of CNS 
development, it is mostly cleaved into two fragments, a N-terminal fragment of 130 kDa and 
a C-terminal fragment of 150 kDa, which are mainly detectable in adult tissues (Matsui et al., 
1994; Milev et al., 1998b; Rauch et al., 1992). Neurocan expressed by neurons, astrocytes 
and oligodendrocytes displays in vitro neurite growth inhibitory activities (Asher et al., 2000; 
Engel et al., 1996; Friedlander et al., 1994; Sango et al., 2003). In the context of mechanical 
stress and injury, neurocan expression is also upregulated corroborating a potential inhibitory 
function in axon regeneration (Asher et al., 2000; Davies et al., 2004; Tang et al., 2003). 
Neurocan can bind to tenascins-C and -R, NCAM, Ng-CAM/L1 and TAG-1 proteins (Milev et 
al., 1998a; Milev et al., 1997; Milev et al., 1996). The interactions with NCAM and Ng-
CAM/L1 are suggested to mediate the inhibitory functions of neurocan on axon growth and 
cell adhesion processes (Rauch et al., 2001). Besides, its participation in axonal pathfinding 
in retino-tectal mapping was suggested (Leung et al., 2004; Popp et al., 2004; Sango et al., 
2003). Surprisingly, although neurocan is widely expressed in brain and appears to be 
involved in different processes during development, no particular defect has been identified 
in the neurocan-deficient mouse model except for some LTP deficits (Zhou et al., 2001). 
 
Aggrecan, which has first been described and mainly known for its function in cartilage 
maintenance and the involvement of its degradation in arthritis, is also expressed by neurons 
and glial cells of the central nervous system ((Domowicz et al., 1996; Domowicz et al., 2008) 
and reviewed in (Kiani et al., 2002; Schwartz et al., 1996)). The nervous-tissue specific 
aggrecan carries only chondroitin sulphate chains and in general fewer glycosaminoglycans 
than the cartilage counterpart, its core protein runs at a relative size of about 370 kDa on 
SDS-PAGE. Aggrecan is present in the brain and the notochord of chick embryos and it 
forms aggregates with hyaluronan and link protein like in the ECM of cartilage. The 
expression in chick brain begins at HH-stage 31 to reach a plateau at HH39 and then 
decreases after HH42 to be absent post-hatching (Li et al., 1996). In vitro, cartilage-derived 
aggrecan and its respective core glycoprotein depleted of the GAG side chains can inhibit 
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 axon growth from spinal cord in an injury assay (Lemons et al., 2003). Through its GAG 
chains, aggrecan may participate in adhesion and migration of neurons during development, 
since aggregating neurons in culture display high levels of aggrecan expression and removal 
of the GAG chains with chondroitinase ABC leads to smaller aggregates (reviewed in 
(Schwartz and Domowicz, 2004)). Besides, the expression pattern of aggrecan during 
development coincides with the formation of neuronal nuclei in the chick telencephalon.  
In the mature CNS, aggrecan is the major proteoglycan expressed in the perineural nets 
(PNNs) (Carulli et al., 2006; Carulli et al., 2007). The PNNs are potential organisers of 
synaptic connections. Their formation after birth coincides with maturation of the synapses 
suggesting that PNNs may participate in the stabilisation of the synapses (reviewed in 
(Faissner et al., 2010)). Interestingly, aggrecan seems to modulate the function of the 
different PNNs, since its glycosylation pattern varies according to the types of neurons and 
the activity of those neurons (Giamanco et al., 2010; Matthews et al., 2002). 
 
2.II.4.c Versican 
(1) Gene structure and distribution of versican 
 Versican originally identified as large fibroblast proteoglycan was first cloned from a 
human placental cDNA library (Zimmermann and Ruoslahti, 1989) and later also 
characterised in other species, such as mouse, bovine, chick (previously named PG-M). As 
for the other lectican members, the gene structure follows a modular organisation in direct 
correlation between the exons and the different domains of versican core protein (Naso et 
al., 1994). The versican gene localised on the chromosome 5 in human is under control of a 
promoter displaying a typical TATA box and different binding sites for transcription factors 
such as AP2, CCAAT enhancer protein and cAMP-responsive element. 
Four versican isoforms (V0, V1, V2 and V3) have been identified resulting from alternative 
splicing of a single gene (Fig.16). The two giant exons 7 and 8 code for the GAG-attachment 
domains (GAGα and GAGβ). The longest versican (V0) contains both exons, while only exon 
8 is present in versican V1 and versican V2 possesses exon 7, but not exon 8 (Dours-
Zimmermann and Zimmermann, 1994; Ito et al., 1995; Schmalfeldt et al., 1998; Shinomura et 
al., 1993). The smallest splice-variant V3 is not a proteoglycan, since both exons carrying the 
GAG attachment regions are absent (Zako et al., 1997a). A PLUS domain has exclusively 
been described for chick versican. It is located between the hyaluronan-binding region and 
the GAGα domain. The respective size of the transcripts and the core proteins of human 
versican isoforms are for V0 (11.8 kb - 372 kDa), V1 (8.2 kb - 265 kDa), V2 (5.9 kb - 182 
kDa), V3 (2.1 kb - 75 kDa). 
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Figure 16. Gene structure of versican isoforms V0, V1, V2 and V3. 
Exons encoding the different domains of versican splice‐variants are mentioned below the respective 
motifs, and the globular domains in the proteoglycans are named above. 
 
Versican is widely distributed in adult tissues and in almost all mesenchymal tissues at some 
stage during development (Bode-Lesniewska et al., 1996; Dours-Zimmermann and 
Zimmermann, 1994; Yamagata et al., 1993a; Zimmermann et al., 1994). Versican expression 
is subjected to a fine regulation, especially in regions actively modulated during 
development, such condensing mesenchyme in limb bud, the perinotochordal mesenchyme 
between notochord and neural tube or next to the basement membranes facing 
neuroepithelial cells (Kimata et al., 1986; Yamagata et al., 1993a; Yamagata et al., 1993b; 
Zako et al., 1997b). 
In central and peripheral nervous systems, specific splice-variants are transiently expressed. 
Versican V2 is the major isoform in adult brain and is associated with myelin, while versican 
V0 and V1 are the main forms detected in the embryonic CNS and PNS (Dours-Zimmermann 
and Zimmermann, 1994; Landolt et al., 1995; Milev et al., 1998b; Schmalfeldt et al., 1998). 
 
(2) Binding partners and putative functions 
 Versican can bind to several molecules including hyaluronan, tenascin-R and -C, 
fibulin-1 and -2, fibrillin, fibronectin, CD44, selectins, and link proteins through the different 
modules of the core protein or frequently also mediated by the GAG side chains (reviewed in 
(Wu et al., 2005)). In addition to functions in the structural assembly of the extracellular 
matrix, these interactions, may play important roles in different cellular processes such as 
migration, adhesion, proliferation and, in the specific context of the nervous tissues, in the 
control of neurite growth, axon regeneration and synaptogenesis (reviewed in (Wight, 2002; 
Yamaguchi, 2000; Zimmermann and Dours-Zimmermann, 2008)). 
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 Versican and the ECM of the nervous system 
 By involving both globular domains G1 and G3, versican participates in assembling the 
specialised extracellular matrix in nervous tissues, especially at level of the nodes of Ranvier. 
The binding between hyaluronan and versican is stabilised by the interaction with link 
proteins such as HAPLN1/Ctrl1 (Matsumoto et al., 2006). In the brain, the protein Bral1 
predominantly expressed by neurons joins the specific ECM at the nodes of Ranvier and 
reinforces the hyaluronan-binding of versican V2 expressed by oligodendrocytes (Bekku et 
al., 2010; Oohashi et al., 2002). Besides, versican also interacts via its C-type lectin with the 
fibronectin type III motif 3-5 of tenascin-R from oligodendrocytes (Aspberg et al., 1995; 
Aspberg et al., 1997), which in turn binds to phosphacan. Versican V2 in fact recruits 
tenascin-R and phosphacan for the specialised ECM at the nodes of Ranvier in vivo 
underlining its role in ECM assembly at this location (Dours-Zimmermann et al., 2009). 
  
Versican and cell proliferation, cell adhesion 
 The expression of versican V0/V1 in the proliferating zone in the epidermis and its 
inverse correlation to cell density in culture suggests a role in cell proliferation (Zimmermann 
et al., 1994). Its colocalisation with hyaluronan, tenascin-C and CD44 in different fibroblasts 
cultures seems to be linked to the formation of a specialised pericellular matrix (Yamagata et 
al., 1993a). Indeed, the versican/hyaluronan/CD44 interaction involving the tandem loop in 
the G1 domain of versican and the link protein binding to its Ig-like domain seems to 
stimulate cell proliferation of astrocytoma cells and reduce the cell adhesion of NIH3T3 cells 
(Ang et al., 1999; Yang et al., 1999). Yang and colleagues confirmed the proliferative effect 
of full-length versican V1 expressed in NIH3T3 cells, which evidently upregulates the 
epidermal growth factor receptor (EGFR) expression and activates the Erk pathway (Sheng 
et al., 2005). This effect appears to be dependent on the GAGβ domain, while versican V2 
containing only the GAG domain inhibits EGFR signalling and by consequence the 
proliferation of NIH3T3 cells. Intriguingly, over-expression of versican V1, but not V2, in 
PC12 cells induces neuronal differentiation and promotes neurite outgrowth by enhancing 
EGFR and integrin expression (Wu et al., 2004). Similarly, co-culture of astroglia cells over-
expressing versican V1 with neural stem cells or hippocampal neurons induce differentiation 
and neurite outgrowth, respectively. In line with a promoting function of versican in adhesion 
and differentiation of cells of the nervous system, recombinant expression of the versican G3 
domain alone in glial cells promotes neural cell attachment and neurite growth of 
hippocampal neurons in culture (Xiang et al., 2006).  
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 Versican and synaptogenesis 
 In parallel, G3 domain was shown to play a role in synaptogenesis as well, since 
neurons grown on G3 coated dishes displayed more dendritic spines and filopodia than on 
dishes coated with buffer alone (Xiang et al., 2006). An earlier study provided already 
evidence for an impact of versican on synaptogenesis of retinal ganglion cells (Yamagata 
and Sanes, 2005). In vitro, versican V0 inhibits neurite growth of retinal ganglion cells (RGC), 
but promotes the enlargement of presynaptic varicosities in retinal axons. Conversely, its 
downregulation by RNA interference results in smaller varicosities on retinal axons. In the 
chick optic tectum, versican V0 may provide a lamina-specific cue by regulating synapse 
structure and encouraging the presynaptic maturation on ingrowing retinal axons.  
 
Versican and neural crest cells migration 
 Several studies indicated a putative function of versican in the migration of neural crest 
cells (NCCs). Versican is present in barrier tissues that inhibit the migration of the NCCs and 
the outgrowth of motor and sensory axons in the trunk of chick embryos. For instance, V0/V1 
expressed in the posterior half of the sclerotome is completely absent from the regions 
invaded by the neural crest cells (Landolt et al., 1995). Perris and colleagues indicated that, 
in contrast to fibronectin, versican alone does not support the migration and adhesion of 
neural crest cells in culture (Perris et al., 1996). These observations suggesting a role for 
versican in guiding the migration of NCCs, were then challenged by Perissinotto et al, who 
suggested that neural crest cells actually invade versican-rich matrices and remove it from 
the pathways (Perissinotto et al., 2000). This latter hypothesis was again not confirmed by 
Dutt et al. demonstrating that isolated versican V0/V1 and versican V1 in fact override the 
migration promoting activity of fibronectin already at low concentrations in a stripe-choice 
assay (Dutt et al., 2006). No evidence for a function-inactivating versican-degradation by the 
neural crest cells was provided in this study. Also the phenotypic analysis of a Pax3 mutant 
mouse (Splotch) further supported the notion of a crucial role for versican in controlling 
neural crest cell migration (Henderson et al., 1997). In the Splotch mouse NCCs display 
aberrant migration patterns. In this Pax3-deficient mutant versican is abnormally expressed 
in the usual pathways and blocks or deviates migratory NCCs. Pax 3 appears to modulate 
the expression of the large versican isoforms (Mayanil et al., 2001) by regulating the TGFβ2 
pathway in early embryonic development in mouse (Mayanil et al., 2006). Taken together, 
these data suggest that versican regulated by TGFβ2 signalling may interfere with neural 
crest cell migration. 
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Versican and neurite growth and axon regeneration 
 Versican is believed to play a significant role during development of the central nervous 
system and in impeding axon regeneration. Indeed, versican V2 expressed by 
oligodendrocytes or by precursors of oligodendrocytes can inhibit neurite growth of neurons 
from both central and peripheral nervous system in in vitro assays (Asher et al., 2002; 
Niederost et al., 1999; Schmalfeldt et al., 2000). In addition, since versican V2 is the main 
component of the extracellular matrix in the adult CNS and is late upregulated in brain 
development (Schmalfeldt et al., 1998), it could play a major function in suppressing 
excessive axonal growth and impede axon regeneration in CNS after traumas (Schmalfeldt 
et al., 2000). In accordance with that, versicans are upregulated in different models of neural 
tissues injury (Asher et al., 2002; Beggah et al., 2005). For instance, lesion in rat cerebral 
cortex induced versican upregulation around the injury site (Asher et al., 2002). Among the 
hyalectans present in the extracellular matrix of the dorsal root entry zone (DREZ), the 
border between PNS and CNS, versicans V1 and, to a lesser extent, V2 show an increased 
expression after injury of the dorsal root (Beggah et al., 2005; Waselle et al., 2009). These 
newly expressed proteoglycans can be detected during several days after lesion. 
 
The diverse and sometimes opposing effects of versicans on cell migration, adhesion and 
proliferation observed in vitro, may be explained by the multitude of interactions between the 
different domains of the distinct versican isoforms and their binding partners, and emphasise 
the importance of in vivo studies. Nevertheless, the notion that the large versican isoforms 
may mainly function as an inhibitor of neural crest cell migration and axonal extension, has 
become little disputed lately. It is therefore tempting to assume that this lectican plays a role 
as a general cue in axonal guidance. 
 
 
2.III. Catabolism of hyalectans 
 In the previous chapter, the different hyalectans expressed in the extracellular matrix of 
the nervous system during development and in adult were described. Their distributions vary 
during development and cleavage products are detected in physiological and pathological 
contexts. Moreover, like other molecules, proteoglycans are catabolised to permit the 
recycling of their subcomponents. Indeed, different proteases participate in the proteoglycan 
catabolism. Metzincin proteases appear to specifically degrade the hyalectans, in particular 
the ADAMTS family are involved in this process (reviewed in (Flannery, 2006)). 
 2.III.1 The ADAMTS family 
 The recently identified ADAMTSs (a disintegrin and metalloprotease with 
thrombospondin type I motifs) build a separate family among the metzincins clan (reviewed 
in (Apte, 2009)). At present, nineteen members have been identified in the human genome, 
with different roles in various biological processes such as homeostasis of connective 
tissues, angiogenesis, inflammation, ovulation and fertilisation or cleavage of von Willebrand 
factor (vWF). These enzymes are related to the surface-bound ADAMs and they likewise 
display sequence similarities with the reprolysin snake venom proteases. In addition to the 
classical domains present in ADAMs such as the pro-domain, the zinc ion-dependent 
metalloprotease domain, and the disintegrin-like domain, ADAMTSs contain also a distinctive 
thrombospondin type-1 like repeat (TSP-1) motif, which is followed by a cysteine-rich 
element and a cysteine-free sequence, the spacer region (Fig.17). Except for ADAMTS4, 
which terminates after this spacer region, at least one additional TSP-like motif is present in 
the C-terminal portion. Other domains as cubilin (CUB) module, protease and lacunin (PLAC) 
motif and mucin-like domain are as well included in some ADAMTS members.  
The pro-domain of ADAMTS members ends with a furin cleavage site that is processed to 
activate the zymogen forms. This occurs commonly in the trans-Golgi or for ADAMTS9 at the 
cell-surface allowing the secretion of the active proteinases (Wang et al., 2004; Zeng et al., 
2006). 
 
Figure  17.  Domains  structure  of metzincin  families MMP,  ADAM  and  ADAMTS  (modified  from 
(Jones and Riley, 2005)). 
Matrix  metalloproteases  (MMP),  ADAMs  (a  disintegrin  and  metalloprotease)  and  ADAMTSs  (a 
disintegrin and metalloprotease with thrombospondin type  I motifs) comprise as typical metzincins 
the  Zn2+  binding  consensus  sequence  HExxHxxxxH  in  their  catalytic  domain.  Prodomain  of  all 
ADAMTS contains at least one furin consensus cleavage site involved in regulation of the proteolytic 
activity (arrow). TSP‐1: thrombospondin type‐1 motif. 
 
The catalytic domain contains an extended zinc-binding sequence (HExxHxxxxxHD) and 
provides generally the cleavage site specificity. Downstream of the reprolysin zinc-binding 
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 consensus motif, a conserved methionine residue forms the characteristic “Met-turn” (VMA) 
arrangement that is believed to maintain the structural integrity of the catalytic domain. The 
ancillary domains usually supply the substrate-binding specificity and may participate in the 
modulation of the protease activity (Gao et al., 2002; Gendron et al., 2007; Kashiwagi et al., 
2004; Somerville et al., 2003). Especially, the TSP-1 motifs can bind to heparin or heparan 
sulphate, and this binding is potentially involved in the interaction with the GAG chains of the 
proteoglycans. 
Every ADAMTS (apart from ADAMTS4) are subjected to N-glycosylation in their ancillary 
domains and this post-translational modification is essential for ADAMTS9 secretion 
(Somerville et al., 2003). Akin to many metalloproteases, ADAMTS are inhibited by TIMP3 
and their activity can be regulated by this classical metalloprotease inhibitor ((Wang et al., 
2006; Westling et al., 2002) and reviewed in (Brew and Nagase, 2010)).  
 
2.III.2 Different phylogenic and functional sub-groups of ADAMTS family 
 The nineteen members of ADAMTS family are regrouped in four clades suggesting an 
evolution by exon shuffling and duplication of ancestral genes. These different subgroups 
correlate quite precisely with the functional clustering derived from functional studies and 
mutation analyses (Fig.18).  
ADAMTS2, -3 and -14 form a separate branch among the ADAMTS all exhibiting pro-
collagen N-proteinase activities (Colige et al., 2002). They are able to cleave the specific 
Pro-Gln/Ala-Glu bound in different types of collagens (I, II and III), which is hydrolysed for 
converting the pro-collagens to the mature proteins. Mutations in the ADAMTS2 gene, the 
aminopropeptidase of procollagen I, II and III, result in the accumulation of non-fully 
processed type I procollagen, causing human Ehlers-Danlos syndrome type VIIC and 
dermatosparaxis (fragility of the skin) in animals (Colige et al., 2004). Besides, ADAMTS2, -3 
and -14 are upregulated in the nodules of Dupuytren’s disease, a syndrome characterised by 
an abnormal thickening of the tissues beneath the skin corresponding to a fibrosis of the 
palmar fascia (Johnston et al., 2007).  
The function of another member, ADAMTS13 was demonstrated by mutations analysis in a 
congenital disorder, the thrombotic thrombocytopenic purpura, in which mutations of 
ADAMTS13 lead to defects in the regulation of von Willebrand factor proteolysis (Levy et al., 
2001). ADAMTS13 is a distinctive member of the family by the presence of CUB motifs 
among its ancillary domains. It binds specifically through its spacer domain to the ultra-large 
vWF (ULVWF) multimers. The ULVWF multimers are involved in adhesion between platelets 
themselves and between platelets and the vascular subendothelium. To permit a right 
balance between haemorrhage and thrombosis, ADAMTS13 cleaves these multimers into 
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 smaller fragments to avoid excessive platelet aggregation under shearing stress and thus 
properly adjusts coagulation (reviewed in (Zhou et al., 2010)).  
 
 
 
Figure  18.  The  human  ADAMTS  family,  organisation  and  functions  (adapted  from  (Apte,  2009; 
Jones and Riley, 2005). 
The different members of ADAMTS  (a disintegrin and metalloprotease with thrombospondin type  I 
motifs)  family  are  regrouped  according  to  their  evolutionary  relationships  and putative  functions. 
PLAC: protease and lacunine; CUB: complement C1r/C1s, Uegf (epidermal growth factor‐related sea 
urchin protein) and BMP‐1 (bone morphogenic protein‐1); vWF von Willebrand factor. 
 
The ADAMTS7 and -12 are evolutionary related members, which represent another cluster. 
They are both identified as specific proteases of the cartilage oligomeric matrix protein 
COMP (reviewed in (Liu, 2009)).  
ADAMTS1, -4, -5, -8, -9, -15 and -20 compose the largest clade, in which members have 
been first described to display anti-angiogenic properties or anti-tumoral activities. This group 
is actually defined and characterised by its proteoglycanase activity. Indeed, all these 
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 ADAMTS members can actively process one or several lecticans in a specific manner 
(Table.1). 
 
Table 1. Different identified cleavage‐sites in human hyalectans and the respective hyalectanases 
AGGRECAN  BREVICAN (rat) VERSICAN 
(Glu373‐Glu374)  (Asn 341‐Phe 342), (Glu1771‐1772)  (Glu395‐Glu396)  V1 (Glu441‐Ala442)  V0 (Glu1428‐Ala1429) 
ADAMTS1  ADAMTS4  ADAMTS4  ADAMTS1  ADAMTS1 
ADAMTS4  ADAMTS5    ADAMTS4  ADAMTS4 
ADAMTS5      ADAMTS5  ADAMTS5 
ADAMTS8      ADAMTS9  ADAMTS9 
ADAMTS15      ADAMTS20  ADAMTS20 
 
2.III.3 Hyalecatanase functions in development 
 The ADAMTS-1 gene was first described in the mouse cachexigenic colon 
adenocarcinoma subline and then identified in human (Kuno et al., 1997). Further studies 
lead by Kuno and colleagues revealed that ADAMTS1 is an active metalloprotease, secreted 
and associated with the extracellular matrix through the TSP-1 motifs and the spacer domain 
(Kuno and Matsushima, 1998; Kuno et al., 1999). They and others also demonstrated that 
ADAMTS1 can cleave aggrecan at different sites in vitro (Kuno and Matsushima, 1998; Kuno 
et al., 2000; Kuno et al., 1999; Rodriguez-Manzaneque et al., 2002). ADAMTS1 is expressed 
in different tissues during development and in particular in the limb bud of mice (Kuno and 
Matsushima, 1998; Kuno et al., 1999; Thai and Iruela-Arispe, 2002).  However, ADAMTS1-
deficient mice did not show any defects in aggrecan turnover (Little et al., 2005). 
ADAMTS4 and -5 were first identified as aggrecanases (aggrecanase-1 and aggrecanase-2 
respectively) (Abbaszade et al., 1999; Tortorella et al., 1999). The ADAMTS4 activity is 
inhibited by fibronectin. The inhibition is mediated through the interaction of fibronectin with 
the spacer domain in the C-terminal region (Hashimoto et al., 2004). ADAMTS5 was 
identified as the main aggrecanase due to its abundant expression in cartilage and 
consequently considered prime candidate for a role in the etiology of arthritis (Stanton et al., 
2005). Yet, careful analyses of single and double deficient mice for ADAMTS4 and 
ADAMTS5, provided evidences that aggrecan turnover in vivo is not only dependent of 
ADAMTS4 or  ADAMTS5 processing (Ilic et al., 2007). 
In addition of their aggrecanase activity, recombinant ADAMTS1 and ADAMTS4 are able to 
process a synthetic expressed versican GAGβ peptide in vitro producing two fragments, 
corresponding to a cleavage at the Glu441-Ala442 bond in human versican V1 (Sandy et al., 
2001). Moreover, using neo-epitope antibodies, related fragments are detected in human 
aorta. ADAMTS4 is indeed expressed in the aortic intima suggesting an active hyalectanase 
activity for this protease in vivo. 
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 Moreover, in an in vitro assay, recombinant ADAMTS4 protease generates a 64 kDa and a 
55 kDa N-terminal fragment of brain-derived versican and brevican, respectively (Westling et 
al., 2004). Of note, the 64 kDa peptide of versican V2 had first been identified as the glial 
hyaluronate binding protein (GHAP). The putative role of ADAMTS1 and -4 in cleavage of 
brevican in vivo was as well proposed in a model of chemical induced brain injury (Yuan et 
al., 2002). In these experiments, ADAMTSs were up-regulated after kainate injection and 
strong increases of the typical ADAMTS-cleavage products of brevican (size 55 kDa) were 
observed. These fragments co-localised with the ADAMTS transcripts. 
A decade ago, ADAMTS-9, a new metalloprotease belonging to this family, was identified 
(Clark et al., 2000) and its expression was studied in detail during mouse development 
(Jungers et al., 2005). ADAMTS-9 displays a rather wide distribution in embryonic tissues 
and shows also a particularly strong expression in the limb buds. ADAMTS-20 composes 
together with ADAMTS9 a distinct subgroup among the ADAMTS being related to the 
Caenorhabditis elegans GON-1 enzyme (Somerville et al., 2003). The GON-1 
metalloprotease is required for cell migration during gonadal morphogenesis in the worm 
suggesting a particular role for these enzymes in development. Versicanase activities of 
ADAMTS9 and ADAMTS20 were demonstrated in in vitro assays, in which versican was 
incubated with conditioned media containing the recombinant enzymes expressed by 
transiently transfected cells (Silver et al., 2008; Somerville et al., 2003). The ancillary 
domains are likely to play an important role in substrate and catalytic specificities, since 
neither versican nor aggrecan were cleaved by a truncated ADAMTS9 including only the 
catalytic domain (Somerville et al., 2003). Apart from these two versicanases, ADAMTS5 is 
transiently expressed in various tissues during development and, like the other ADAMTS-
members, it is able to process versican in vitro (Longpre et al., 2009). In the last years, 
studies lead by Apte and colleagues brought some comprehensive inputs in regard to the 
functions of these three hyalectanases during development. By genetic analysis of the 
different mouse mutants, they demonstrated for instance a cooperative action of ADAMTS9, 
ADAMTS5 and ADAMTS20 in versican processing during the regression of interdigital webs 
(McCulloch et al., 2009b). The generation of the specific proteolytic fragments of versican 
appears to play a crucial role in this process, as the introduction of a recombinant peptide 
corresponding to an ADAMTS-cleavage product induced apoptosis in the webs of mice 
double-deficient for Adamts5 and Adamts20. Based on these data, they suggested an active 
role for the versican fragments as anti-adhesive factors in this tissue remodelling during limb 
morphogenesis. 
In a more recent study, they provided again strong genetic evidences for a similar functional 
association of ADAMTS9 and ADAMTS20 in cleaving versican during development of the 
secondary palate in mouse model (Enomoto et al., 2010). This structure separates the nasal 
 - 44 -
 and oral cavities to isolate the respiratory ways from the digestive ones. Versican processed 
by ADAMTS9 and ADAMTS20 contributes to the mesenchymal proliferation occurring during 
the palate closure. Knockout mice heterozygous for ADAMTS9 and homozygous for 
ADAMTS20 consistently display cleft palates. 
Two other ADAMTS members belonging to the hyalectanase cluster, ADAMTS8 expressed 
in cartilage and ADAMTS15 are only little characterised but may display aggrecanase activity 
(Cal et al., 2002; Collins-Racie et al., 2004).  
 
Nowadays, the turnover of versican during various developmental remodelling processes is 
still poorly understood. Especially the rapid disappearance during peripheral nervous system 
development has not been analysed in detail. According to current knowledge, the 
hyalectanases ADAMTS-1,-4, -5, -9 and -20 are good candidates to actively control the 
distribution of versican isoforms and, thus, contribute to the specific regulation of the versican 
function when the nervous system is being built. 
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 3. Aims of the project 
 During nervous system development, motor and sensory axons follow specific 
trajectories through permissive tissues delimited by non-permissive substrates. Previous 
work in our laboratory has shown that the hyalectan versican V0/V1, present in the barrier 
tissues to neural crest cell migration, inhibit the neurite extension from neural crest cells in 
vitro (Dutt et al., 2006). Moreover, versican V0/V1 isoforms are expressed in the whole hind 
limb before innervation of this structure, disappearing shortly later from the nerve pathways, 
while bordering the axons invading the limb bud of chick embryos (Landolt et al., 1995). 
Besides, particular metalloproteases from ADAMTS family have been described to 
specifically cleave hyalectan glycoproteins, such as versican (reviewed in (Apte, 2009)). In 
this context, we hypothesised that versican V0/V1 splice-variants and their turnover play a 
major role in axonal guidance of the peripheral nerve system. 
 
In a first part of my PhD project, I have participated in the completion of an ongoing study 
analysing the effect of versicans V0/V1 on axonal growth of peripheral nerves by stripe 
choice and three-dimensional collagen matrix assays in vitro, and by ectopic injection of 
purified chick versican V0/V1 isoforms in the nerve pathways of the developing chick hind 
limb in ovo.  
In the second and main part, I have focused on the identification and in vitro- and in vivo-
characterisation of putative versicanases potentially involved in the processing of versican 
throughout chick embryogenesis. 
 
We have formulated following aims for my PhD thesis: 
  
i) to supplement previous in vitro and in ovo studies on the function versicans in PNS 
development  and to complete this part of the project for publication; 
ii) to clone two versicanase candidates, ADAMTS1 and ADAMTS9 in chick and to monitor 
their expression patterns in chick embryos by in situ hybridisation;  
iii) to produce specific anti-sera against different epitopes of chick ADAMTS9; 
iv) to generate different expression vectors for recombinant chick ADAMTS9 and truncated 
ADAMTS9 variants to investigate their functionality on versican processing in vitro; 
v) to express chick recombinant ADAMTS9 in the hind limb and the spinal cord of chick 
embryos to elucidate its role in the turnover of versican in vivo. 
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 4. Studies of versican function in axonal guidance of peripheral 
axons 
 
4.I. Article 
 Versican V0 and V1 direct the growth of peripheral axons in the developing chick hind 
limb (Journal of Neuroscience - accepted). 
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 ABSTRACT 
Peanut agglutinin-binding disaccharides and chondroitin sulfate mark transient mesenchymal barriers 
to advancing motor and sensory axons innervating the hind limbs during chick development. Here we 
show that the vast majority of these carbohydrates are at the critical stage and location attached to the 
versican splice-variants V0 and V1. We reveal that the isolated isoforms of this extracellular matrix 
proteoglycan suppress axon extension at low concentrations and induce growth cone collapse and 
rapid retraction at higher levels. Moreover, we demonstrate that versican V0 and/or V1, recombinantly 
expressed in collagen-I gels or ectopically deposited in the hind limbs of chicken embryos in ovo 
cause untimely defasciculation and axon stalling. Consequently, severe disturbances of nerve 
patterning are observed in the versican-treated embryos. Our experiments emphasize the inhibitory 
capacity of versicans V0 and V1 in axonal growth and evidence for their function as basic guidance 
cues during development of the peripheral nervous system. 
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 INTRODUCTION 
 The establishment and stabilization of the neuronal circuitry during development and postnatal 
maturation greatly relies on a timely and spatially coordinated program regulating the delicate balance 
between axon growth-promotion and -inhibition. In the developing peripheral nervous system (PNS), 
the delineation of barrier tissues blocking axonal growth and forcing advancing axons into their 
designated trajectories constitutes one of the initial steps of the highly complex guidance process 
(Tosney, 1991). This early phase of motor and sensory innervation is at least partly accompanied by 
the selective deposition and turnover of inhibitory extracellular matrices (ECMs). Once pioneering 
axons have begun to invade permissive mesenchymal tissues and successive nerve fibers have 
followed by fasciculation, a refined system of diffusible and stationary attractants and repellents in 
combination with specific receptor sets on the advancing growth cones controls numerous branch 
point decisions and directs segregating axons towards their individual targets (Landmesser, 2001; 
Hanson et al., 2008). 
 The non-permissive mesenchymal tissues, consistently bordering the pathways of migratory 
neural crest cells and growing axons during early PNS development, are particularly rich in chondroitin 
sulfate proteoglycans (CSPGs) and peanut agglutinin (PNA)-binding glycoproteins (Tosney and 
Landmesser, 1985; Oakley and Tosney, 1991). In the trunk of the chicken embryo, these temporary 
boundaries include the posterior sclerotome, the perinotochordal region and the early subectodermal 
zone. CSPGs are also abundantly expressed in the developing hind limbs. The early limb bud tissue 
blocks innervation initially in its entirety and delays axonal extension from the plexus region by about 
24 hours (Wang and Scott, 2000). After this period most of the non-permissive areas have regressed 
and are ultimately confined to the condensing mesenchyme of the pelvic girdle and other pre-
chondrogenic areas. 
 Prominently represented in all these transient barriers of the trunk and limb anlage are the two 
largest splice-variants of the extracellular matrix CSPG versican, V0 and V1 (Landolt et al., 1995). 
Intriguingly, other members of the lectican/hyalectan family of CSPGs including the smaller versican 
isoform V2 are similarly expressed in non-permissive tissues of the developing or mature central 
nervous system (CNS) and exert potent axon growth inhibitory activity (Bandtlow and Zimmermann, 
2000; Schmalfeldt et al., 2000; Zimmermann and Dours-Zimmermann, 2008). Despite this apparent 
analogy to axon growth suppressing roles of CSPGs in the CNS, a functional link between the 
selective expression and turnover of versican V0 and V1 and the non-permissive character of matrices 
flanking axon trajectories during PNS formation has not been established so far.  
 Therefore, we have isolated intact versican V0 and V1, explored their inhibitory potential in a 
series of functional analyses with dorsal root explants in vitro and analyzed their impact on axonal 
patterning in the developing limb by ectopical deposition in vivo. 
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 MATERIALS AND METHODS 
 
Antibodies and versican preparations 
 Polyclonal antibodies against specific domains of bovine, human, mouse and chick versican were 
affinity-purified from rabbit antisera previously prepared by our laboratory (Zimmermann et al., 1994; 
Landolt et al., 1995; Schmalfeldt et al., 1998; Schmalfeldt et al., 2000). The anti-proteoglycan Di-6S 
monoclonal antibody 3-B-3 was obtained from Seikagaku. The monoclonal antibody RMO-270 against 
neurofilament-160 kD (anti-NF-M; Invitrogen) and goat polyclonal antibodies against axonin-1 (Ruegg 
et al., 1989) were used for axon and growth cone labeling. Lectin- staining of tissue sections was done 
with Peanut agglutinin (PNA) and goat anti-PNA antibodies (both Vector Laboratories). Fluorescent 
secondary antibodies included a) Alexa Fluor-488 goat anti-rabbit IgG and Fluor-594 goat anti-mouse 
IgG for cell culture stainings, b) Alexa Fluor-488 donkey anti-rabbit IgG, Fluor-555 donkey anti-mouse 
IgG and Fluor-647 donkey anti-goat IgG (Invitrogen) for triple stainings of tissues sections and c) Cy-3 
labeled goat anti-mouse secondary antibodies (Jackson ImmunoResearch) for whole mount NF-
stainings, respectively. Secondary antibodies for immunoblotting experiments were also from Jackson 
ImmunoResearch. 
 Versican isoforms employed in the in vitro and in vivo studies were purified from conditioned 
medium of the human glioma cell line U251MG and from calf aorta as described (Dutt et al., 2006). 
Versican core glycoproteins used in some experiments were obtained by removal of the 
glycosaminoglycan chains through digestion with chondroitinase ABC (Seikagaku). 
 
Blotting techniques 
 Extracts from Hamburger and Hamilton stage 21 to 22 (HH21/22, (Hamburger and Hamilton, 
1951) chick trunks and hind limbs, conditioned media from E13 chick embryonic fibroblast and 
U251MG cell cultures as well as control extracts of P30 brains of wild type and versican V0/V2 
knockout mice (Dours-Zimmermann et al., 2009) were analyzed by lectin- and immunoblotting. 
Samples were run on 4-15% Phastgels (GE Healthcare Life Sciences) and processed according to 
(Zimmermann et al., 1994). For the detection of PNA-binding proteins, proteoglycans and versicans 
we employed a DIG-Glycan Differentiation Kit (Roche Applied Science), a monoclonal antibody 
against chondroitin sulfate stubs or our polyclonal antibodies against versican, respectively. 
Neurite outgrowth assays 
 Stripe-choice analyses of neurites extending from intact or dissociated explants of dorsal root 
ganglia (DRG) of E10 to E11 chick embryos were essentially done as described (Vielmetter et al., 
1990; Schmalfeldt et al., 2000). In brief, surface-treated glass cover-slips were coated in alternating 
stripes covered with either test substrates admixed to 100 g/ml laminin-1 or with 20 g/ml laminin-1 
alone (Invitrogen). The test substrate solutions contained, apart from laminin-1, intact or 
chondroitinase ABC-digested versican V1 or a versican V0/V1-mixture at concentrations of 10-100 
µg/ml. The DRGs were placed onto the stripe pattern and cultured in DMEM/F12 1:1 medium 
containing 10% FCS, 2% chicken serum, 100 U/ml penicillin, 100 µg/ml streptomycin, 100 ng/ml nerve 
growth factor 7S (all Invitrogen), 10 mM cytosine arabinoside and 0.5% methylcellulose (both Sigma). 
After 2 to 3 days of incubation in a 5% CO2 atmosphere at 37°C, the explant cultures were fixed in 4% 
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 paraformaldehyde / 0.33% sucrose in PBS for 10 min and subsequently analyzed by 
immunofluorescence. For some experiments laminin-1 was replaced by fibronectin (Roche 
Diagnostics) as neurite growth-supporting substrate. 
 To test growth cone behavior in time-lapse video microscopy, half of a pre-treated glass cover-
slip was first manually covered with a mixture of 100 µg/ml versican V0/V1 and 100 g/ml laminin-1, 
followed by coating of the remaining surface with 20 g/ml laminin-1 alone. The border of the test 
substrate area was delineated on the back of the slide with a marker pen. DRGs from E10 chick 
embryos were placed near the versican coated area and neurites were allowed to grow under a Leica 
DM IRBE wide field microscope equipped with a culture chamber controlling temperature and CO2 
conditions (37°C and 5%). Images of growth cone movement towards the versican-coated region were 
captured with a Hamamatsu Orca ER camera using a phase contrast PH1 N Plan L 20X/ 0.40 
objective. Frames were captured every 30 seconds and analyzed with the Openlab 3.1.5 software. 
 
Co-cultures of DRGs and transfected COS cells 
 COS cells were transiently transfected with either an empty pSecTagA vector (Invitrogen; mock 
transfection) or with a pSecTagA-construct, in which the reconstituted full-length cDNA of the mature 
human versican V1 core protein including its native stop codon had been inserted into the vector after 
the Ig secretory leader sequence (Zimmermann and Ruoslahti, 1989). COS cell aggregates were 
prepared in hanging drops as described (Kennedy et al., 1994). For co-cultures COS cell aggregates 
were placed in solidifying collagen I gels in close vicinity to DRGs from E10 chick embryos (Lumsden 
and Davies, 1983) and subsequently incubated at 37°C in DMEM/F12 (1:1) medium containing 10% 
FCS, 2% chicken serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin and 
100ng/ml 7S NGF (all Invitrogen). After 3.5 to 4 days, the 3D-cultures were fixed in 4% 
paraformaldehyde / 0.33% sucrose in PBS and processed for immunofluorescence staining. 
 
In ovo injections of versican 
 Hisex chick embryos were staged according to Hamburger and Hamilton (Hamburger and 
Hamilton, 1951). In ovo injections were performed as described previously (Stoeckli and Landmesser, 
1995). After local removal of the extra-embryonic membrane, injections into the hind limb were done 
with a pointed glass capillary (tip diameter about 5 m) attached to Teflon tubing. The test substrates 
in PBS were mixed with Trypan Blue (Invitrogen; final concentration 0.04% v/v) to control localization 
and volume of the injection. Injections were done into the right hind limb at three different positions 
near the plexus region, two paraxial and one distal (Fig. 1). Less then 1l of the test solution with 
versican concentrations of 180 or 400 g/ml (V1 and V0/V1 preparations, respectively) was deposited 
at each time point. First injections were done at HH18 to 19 and subsequently repeated in regular 
intervals for three to four times until the embryo reached HH22 to 23. After every manipulation, the 
eggs were resealed with paraffin and a glass cover slip and incubated at 39°C. At the end of the in ovo 
experiment (HH25/26), embryos were collected, eviscerated, freed of residual blood and fixed in 4% 
paraformaldehyde prior to whole mount staining. 
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 Immunohistological and lectin-staining procedures  
 For the combined immunofluorescence- and PNA-stainings of chick embryo sections we adapted 
previously described protocols (Oakley and Tosney, 1991; Schmalfeldt et al., 2000). In brief, the 
isolated embryos were fixed overnight in 4% paraformaldehyde containing 0.5% cetylpiridinium 
chloride, afterwards dehydrated and paraffin-embedded. Glass slides carrying 4 m-thick tissue 
sections were dewaxed and antigens were retrieved in 10 mM tri-sodium citrate, pH 6.0, under 
controlled conditions (antigen-retrieval device FSG 120-T/T; Milestone). Sections were then blocked 
with Carbo-Free™ blocking solution for 90 min and incubated with 10 g/ml PNA in 10 mM HEPES, 
150 mM NaCl, 1 mM CaCl2, pH 7.5 for 3 h (all PNA-staining reagents from Vector Laboratories). The 
binding of the primary antibodies in PBS containing 0.5% BSA, 0.2% gelatin, 0.02% NaN3 was allowed 
to proceed overnight at 4°C. The antibody-dilutions were 1:400 for anti-PNA, 1:500 for the antibodies 
against versican GAG- and 1:2000 against neurofilament-M. The subsequent incubation with Alexa 
Fluor-labeled secondary antibodies (all 1:200 dilution, Invitrogen) for 1 to 2 hours was in some 
experiments followed by counterstaining with Hoechst H33258 bis-benzimide (Invitrogen). Primary and 
secondary antibody-binding of fixed dorsal root ganglia explant cultures was done analogously, 
however, antibodies were directly applied after initial blocking with 0.5% BSA, 0.2% gelatin, 0.02% 
NaN3 in PBS (Schmalfeldt et al., 2000). Stained cell cultures and tissue sections were finally mounted 
in fluorescence mounting medium (Dako). 
 For whole mount-staining of nerve fibers, fixed embryos were washed in PBS and permeabilized 
in 1% Triton/PBS for 1 h at room temperature. After rinsing in PBS, they were incubated for 1 h in 20 
mM lysine, 0.1 M sodium phosphate, pH 7.4, subsequently washed five times in PBS for 10 min and 
subjected to blocking in 10% fetal calf serum/PBS for at least 2 h at room temperature. Incubation with 
the monoclonal antibody against neurofilament-M (dilution 1:1500) was carried out for 48 h at 4°C. 
After five short and one last prolonged incubation in PBS (≥12 h), embryos were again submerged in 
blocking buffer for 2 h before binding of Cy3-labeled secondary antibodies (diluted 1:500) was done 
overnight at 4°C. Unbound antibodies were removed by six extensive PBS-washing steps at room 
temperature (at least 2 times for more than 2 h plus last incubation overnight). Finally, the embryos 
were dehydrated in an increasing methanol series (25%, 50%, 75% and 100%; each step for ≥30 min) 
and then transferred into 2:1-benzyl benzoate/benzyl alcohol.  
 Fluorescence photomicrographs were taken with an Olympus BX61 (cells / sections) or a SZX12 
microscope (whole mounts) equipped with a F-view camera. Image capture and analysis was 
performed using the AnalySISPro software (Soft Imaging System, Germany). Monochromatic 
fluorescence images were imported into separate color channels in Photoshop and superimposed. 
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 RESULTS 
 Independent histological studies by Oakley and Tosney and by our group have previously 
revealed strict complementarities between axonal growth patterns and the distribution of PNA-binding 
carbohydrates, chondroitin-6-sulfate (Oakley and Tosney, 1991) and the versican isoforms V0/V1 
(Landolt et al., 1995) during motor and sensory innervation of the trunk and limbs in the chicken. 
Although the originally monochrome stainings were suggestive of a close association of these 
mesenchymal components with axon growth-impeding boundary tissues, particularly the 
interconnection between the PNA-binding molecule and the chondroitin sulfate-carrying versicans 
remained rather obscure. For this reason we have first attempted to clarify this relationship before 
embarking on extensive functional studies in vitro and in vivo.  
 
Versicans are the major PNA-binding proteins in the developing trunk and limb buds 
 Our triple fluorescence stainings simultaneously detecting PNA-binding carbohydrates, 
versicans V0/V1 and neurofilaments, now clearly demonstrate a broad overlap of versican-specific 
immunoreactivity and PNA-binding sites in mesenchymal barriers and confirm the virtual absence of 
both components from the axonal pathways in the chick embryonic trunk and the developing hind 
limbs (Fig. 2). For instance, at stage HH22, when the growing motor and sensory axons have joined 
but are still locked within the plexus region, the entire hind limb is intensely labeled by both, PNA-lectin 
and versican-specific antibodies. At this time, considerable versican V0/V1 depositions are also found 
in the perinotochordal region, particularly in immediate vicinity to the notochord, whereas the staining 
of the PNA-lectin in this area appears more uniform and widespread. Unlike versican, PNA-binding is 
additionally detected within the neural tube and in the ectodermal layer. Later in hind limb 
development (HH26), versican and the PNA-binding carbohydrate become confined to the pelvic 
girdle, to the subectodermal region and to the condensing mesenchyme of the pre-chondrogenic 
zones. The trajectories of the advancing nerve fibers and the more distal areas of future axonal 
invasion are essentially free of PNA- and versican-staining. While PNA-binding carbohydrates are still 
present in the perinotochordal region, the versican V0/V1 immunoreactivity has greatly diminished in 
this area. At this stage, the PNA-binding activity also persists in the neural tube (except for the motor 
columns) and in the ectoderm. 
 The rather striking co-localization of PNA-binding molecules and the versican immunoreactivity 
within the early mesenchyme supports the hypothesis that the highly glycosylated versicans V0 and 
V1 might carry not only chondroitin sulfate but also galactosyl (-1,3) N-acetylgalactosamine, the 
oligosaccharide recognized by PNA. We have therefore extracted early embryonic trunks and hind 
limb buds (HH21/22) with a detergent-containing high-salt buffer to solubilize extracellular matrix and 
cell surface molecules and we have subsequently performed PNA-lectin-blotting and versican V0/V1-
specific immunoblotting (Fig. 3). Comparisons of these analyses demonstrate that versicans, and in 
particular the V0 isoform, in fact account for most of the PNA-binding activity in the early chick trunk 
and limb extracts. Moreover, nearly exclusive staining of versican V0 and V1 is observed on PNA 
lectin-blots of conditioned culture media from chick primary embryonic fibroblasts and from the human 
glioma cell line U251. Akin to the larger V0 and V1 isoforms, versican V2 seems to represent the 
major PNA-binding component of the mature CNS, as brain extracts of knockout mice selectively 
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 lacking this isoform (Dours-Zimmermann et al., 2009) have lost virtually all of the PNA-reactivity along 
with the V2-variant. 
 
Versican V0 and V1 are potent neurite outgrowth inhibitors in vitro 
 In order to examine the inhibitory capacity of the large versican isoforms, we have performed 
various functional assays with chick dorsal root ganglia (DRG) explants in vitro. In stripe choice 
experiments, we have first exposed the outgrowing sensory axons to alternating lanes coated either 
with the neurite growth-promoting ECM-glycoprotein laminin-1 alone or with mixtures of laminin-1 and 
intact versican V1- or versican V0/V1-preparations isolated as described (Dutt et al., 2006). In spite of 
the high laminin-level present on both surfaces, robust extension of DRG neurites is confined to the 
substrate-stripes that lack versican (Fig. 4). Versican overrides the axon growth promoting activity not 
only of laminin-1. Similar inhibitions can also be observed, when fibronectin (Fig. 5) or collagen-I (not 
shown) are used as growth promoting substrates in this assay. Because laminin-1 is the most effective 
substrate and therefore widely used for in vitro studies, we have performed the subsequent stripe-
choice experiments with this standard neurite outgrowth promoter. Even under these optimal 
conditions, a partial reversion of the laminin-induced growth can already be observed, when as little as 
10 g/ml versican V1 or V0/V1-mixture is included in the 100 g/ml laminin coating-solution (Fig. 6). 
At versican concentrations of 25 to 50 g/ml the avoidance by the neurites is nearly complete. This 
inhibitory activity of versican V0 and V1 is reduced, but not abolished, when the chondroitin sulfate 
side chains are removed by chondroitinase ABC digestion. In comparison to the intact proteoglycan 
preparations, the coating concentrations of the core glycoproteins have to be approximately doubled 
to achieve similar axonal avoidance reactions. 
 While lower versican V0 and V1 concentrations may provoke stalling and/or turning of the 
axonal tip, higher concentrations induce growth cone collapse and rapid retraction. We have recorded 
this latter behavior by time-lapse video microscopy (Fig. 7), in which we confronted DRG neurites 
growing on a 100 g/ml-coat of laminin-1 to a surface treated with laminin-1- and versican V0/V1 at 
dilutions of 100 g/ml each. In these experiments the neurites advance on the laminin-1 substrate at a 
speed of 120 to 150 m/hour and display extended growth cone morphologies. Once they have 
contacted the versican-containing zone however, the growth cones immediately collapse and the 
axons retract with a three to four times higher velocity. This retrograde movement slows down after a 
while, stops, the growth cones restore and axonal growth is re-initiated. Similarly, growth cones 
advancing on laminin-1 alone in the stripe-choice format constantly explore the neighboring lanes 
containing high versican concentrations, but invariably collapse, when they reach the end of the 
versican-free lane (Fig. 7). 
 In the final experiments of our in vitro series, we have analyzed the influence of versican 
deposition on axonal growth in three-dimensional collagen I matrices. Also in this more in vivo-like 
setting, we obtained clear evidence for a dominant inhibitory effect of versican overriding the axon 
growth promotion, this time exerted by the collagen substrate. In the collagen gel assay (Fig. 8) axons 
frequently extend from the DRG explants in form of robust nerve bundles. However, as soon as they 
approach the neighborhood of COS cells, which recombinantly express full-length versican V1, they 
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 begin to defasciculate and then stop before reaching the aggregates. In contrast, mock-transfected 
control aggregates devoid of versican expression do not affect neurite outgrowth. 
  
Ectopical deposition of versican V0 and V1 disturbs axon patterning in developing hind limbs 
in vivo  
 Untimely defasciculation and aberrant axon routings are also observed in vivo, when versican 
V1 or V0/V1 are ectopically deposited in the nerve pathways of the developing hind limb. Repeated in 
ovo injections of versicans between HH18 and HH23 resulted in aberrant branching of developing 
peripheral nerves at HH25/26. Whole mounts stained with anti-neurofilament antibodies were scored 
blind to the experimental condition for axonal branching in the developing hind limbs (Fig. 9). As main 
indicators, we scored abnormal exit points (criterion 1) and irregular branching of secondary nerve 
fibers (criterion 2) emerging from the dorsal trunk of the sciatic plexus. This way, we revealed 
moderate to severe disturbances (only one or both criteria fulfilled, respectively) of axonal growth 
behavior in the vast majority of the embryos, in which the natural formation of versican-free pathways 
was counteracted by our exogenous versican supply. Conversely, irregularities of sciatic nerve 
formation were only very rarely seen in control-injected embryos by the three independent observers 
of this blinded study.  
 In summary, all our analyses emphasize the inhibitory potential of versican V0 and V1 in axon 
growth regulation by inducing defasciculation, deflection and repulsion of neuronal processes 
depending on the concentration within the extracellular matrix. 
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 Discussion 
 The guidance process that directs sensory and motor axons with utmost precision towards their 
individual targets in the hind limb operates on multiple levels. At the lowest level, general cues divide 
the early mesenchyme into permissive and non-permissive areas for axon growth (Tosney, 1991; 
Landmesser, 2001). Through short-range contact, they roughly indicate the prospective nerve routes 
and transiently block inappropriate and/or pre-mature innervation of differentiating tissues. Although 
the axons following these basic pathways intermingle initially in the spinal nerves, they subsequently 
segregate within the plexus region into separate pools, which already bear the capacity to later 
respond differentially to region-specific cues within the developing limbs. Rhythmic electrical bursts 
originating from the early spinal cord appear to sustain this axonal pooling and hence, further influence 
subsequent pathfinding decisions (Hanson et al., 2008). Controlled by this second level and more 
sophisticated guidance mechanism axon bundles enter the hind limb and stereotypically bifurcate into 
ventral and dorsal nerve trunks. More distally, the growth cones encounter several additional choice 
points, where selected subsets of nerve fibers continue to branch off and finally defasciculate at their 
predetermined target destination. This last step of innervation is likely regulated by the most complex 
and hitherto still largely unknown interplay of multiple receptors and corresponding guidance cues. 
 Commonly, the identification of guidance molecules that function at any stage of limb 
development has been rather difficult. Best characterized so far are ligand-receptor systems that 
cooperate in dorsoventral pathfinding decisions at the entrance of the hind limb. This includes pairs of 
ephrinA:EphA4- and ephrinB:EphB-receptors controlling selective axonal growth by repulsion 
(Helmbacher et al., 2000; Eberhart et al., 2002; Luria et al., 2008) and the ligand-receptor combination 
of glial cell-line derived neurotrophic factor (GDNF):Ret mediating axon attraction (Kramer et al., 
2006). Mice lacking one or several of these signaling components indeed display different degrees of 
misrouting of motor axons at the dorsoventral choice-point, but the basic outline of the main nerve 
pathways remains unaffected (Helmbacher et al., 2000; Kramer et al., 2006; Luria et al., 2008). These 
findings clearly establish their role as specific cues yet, they indicate that other molecules operate on a 
more general level of axonal guidance.  
 Owing to their consistent association with barrier tissues, PNA-binding glycoproteins and 
chondroitin-6 sulfate (CS6)-carrying proteoglycans have generally been considered the prime 
candidates for such a universal role, namely as inhibitors of neural crest cell migration and axonal 
growth in the periphery (Oakley and Tosney, 1991; Oakley et al., 1994). The best match in the search 
for the CSPG component is versican, since its splice-variants V0 and V1 show a highly similar 
temporospatial distribution in the developing trunk and hind limbs (Landolt et al., 1995) and because it 
impedes the migration of neural crest stem cells in vitro (Dutt et al., 2006). We now demonstrate that 
these two versican isoforms are also the main carriers of PNA-reactive carbohydrates at the 
corresponding locations and therewith tie our versican findings to the knowledge of PNA-binding 
barrier components. This integration may as well encompass the only partly characterized growth 
cone collapse-inducing 48 and 55 kDa glycoproteins, which have previously been isolated by PNA-
affinity chromatography from extracts of cultured somitic strips (Davies et al., 1990). Considering our 
current lectin-blots with almost exclusive staining of the versican core glycoproteins in embryonic trunk 
extracts, it appears unlikely that these former preparations of PNA-binding protein contained no 
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 versicans. They must have rather evaded detection due to their large sizes and dispersion in gel 
electrophoresis. It seems therefore likely that at least parts of the growth cone collapsing activity 
ascribed to these smaller PNA-binding glycoproteins has emanated from 'contaminating' versicans. 
Whether the 48 and 55 kDa components represented chondroitin sulfate-free proteolytic fragments of 
versican remains presently open. 
 In a few tissues of the early trunk, such as the ectoderm and the neural tube, PNA-binding and 
versican V0/V1 immunostaining do not co-localize. Moreover, the initially expressed versicans, but not 
the PNA-affinity sites, disappear from the greater surrounding of the notochord after HH22 to 23. At 
this time and location, versican is progressively being substituted by its close relative, aggrecan 
(Oettinger et al., 1985; Domowicz et al., 1995). Like versicans, it carries chondroitin sulfate side chains 
and numerous mucin-type O-glycans, some of which might maintain the PNA-reactivity at this 
particular site. Yet, the early notochordal aggrecan of the trunk region seems to bind only little PNA 
according to our blotting experiments. Aggrecan and versican V0/V1 probably share some inhibitory 
functions during the initial stages of PNS formation. While aggrecan may prevent neural crest cells 
and neuronal projections from invading the perinotochordal region (Perris and Johansson, 1990; Snow 
et al., 1990), versicans V0 and V1 seem to be primarily responsible for the non-permissive properties 
of the posterior somite, the early limb bud and pelvic girdle. Only later in development, when versican 
V0/V1 has long been cleared from the axonal pathways and when cartilage begins to form, aggrecan 
and some other chondroitin sulfate proteoglycans, such as decorin and type IX collagen, replace 
versican in the skeletal primordia of the limb (Shinomura et al., 1984; Lennon et al., 1991; Yamagata 
et al., 1993). Of note, defects in versican turnover lead at this advanced stage to digit malformations 
(McCulloch et al., 2009). 
 Despite their intriguing association with barrier tissues during nervous system development, the 
exploration of the putative guidance roles of the two largest versican variants has long been hampered 
by their extraordinary structural and biochemical properties. In addition, attempts to approach 
functional aspects by gene knockout experiments in mice or by over-expression and knockdown in 
chick embryos have been frustrating due to the early lethality of versican null mice (Mjaatvedt et al., 
1998) and due to the relative inefficiency of in ovo electroporation of mesenchymal cells in the early 
limbs, respectively (own observations). Only the recent elaboration of protocols to isolate larger 
quantities of intact V0 and V1 isoforms (Dutt et al., 2006) has enabled us to study the inhibitory 
potential of versicans in peripheral axon growth in vitro and in vivo. In every assay of our present 
study, versican V0/V1 proved to override the axon growth promotion of extracellular matrix 
components such as laminin-1 and collagen-I. Most of this inhibitory potential appears to reside in the 
versican core protein structure, as complete removal of the chondroitin sulfate chains cannot 
neutralize this function. Nevertheless, the glycosaminoglycans and mucin-type O-glycans are certainly 
required for the structural integrity, which might explain the partial reduction of the inhibitory capacity 
of versicans after chondroitinase digestion.  
 The axonal response induced upon encounter of versican V0/V1-containing areas is highly 
concentration-dependent and ranges in our functional experiments from rapid retraction and deflection 
to defasciculation and growth arrest. These latter forms of attenuated versican inhibition are frequently 
observed in the collagen gel assays in vitro and in the injected hind limbs in vivo. In comparison with 
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 their endogenous counterparts, the ectopically positioned versicans V0/V1 are usually limited in 
quantity. Moreover, they are in vivo confronted with emerging proteolytic processes typically clearing 
the proteoglycans from future nerve pathways. By repeating the injections in regular intervals we could 
at least partly circumvent this problem as illustrated by the clear inhibitory effects of versican observed 
in our in ovo study.  
 Interestingly, a similar concentration-dependency of versican seems to control axonal behavior in 
the developing optic tectum of the chicken CNS (Yamagata et al., 1995). Here graded levels of 
versicans V0/V1 are involved in the pathway-restriction of retinal axons and in the regulation of 
lamina-specific arborization and presynaptic maturation.  
 Whether versican V0 and V1 act alone or in concert with other factors in the different boundary 
tissues is currently not known. However, concepts of direct functional links between these 
proteoglycans and semaphorins (Kantor et al., 2004; Huber et al., 2005) and/or ephrins (Wang and 
Anderson, 1997) in certain selective axonal barriers seem highly realistic and thus, should be included 
in future strategies to explore the guidance processes in the developing nervous system. 
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 FIGURES AND LEGENDS 
 
 
 
M_Figure 1. Chick embryo at HH21/22 before (A) and after in ovo-injection (B) of the Trypan Blue-
containing versican solution. 
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M_Figure 2. Temporospatial relationship of PNA-binding sites, versican V0/V1 and axonal growth in 
the developing hind limb. Triple lectin/immunofluorescence stainings of cross-sections of HH22 and 26 
chicken embryos at hind limb level reveal the largely overlapping patterns of PNA-ligands (dark blue in 
merged image) and versican V0/V1 (green). At HH22 both components are ubiquitously distributed in 
the perinotochordal region and the early limb bud, but absent from the pathways of motor and sensory 
axons (red), which have reached the plexus region and are momentarily hindered from entering the 
limb. At HH26 versican and PNA-binding sites have disappeared from the prospective axon routes, 
while persisting in the pelvic girdle precursor, in the forming dermis and the condensing mesenchyme 
adumbrating the future leg bones. Bar: 200 m. 
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M_Figure 3. Identification of versicans as major PNA-binding proteins. Extracts of hind limbs (A) and 
trunks (B) from HH21-chick embryos, supernatants of chick embryonic fibroblasts (C) and of human 
U251 glioma cell cultures (D) and brain-extracts of P30-wild type (WT) and versican V0/V2-knockout 
mice (E) were analyzed by lectin- and immunoblotting with PNA and antibodies against versicans and 
against chondroitin 6-sulfate stubs (Di-6S), respectively. Some of the samples were digested with 
chondroitinase ABC (+) to remove the GAG side-chains. The domain-specific antibodies against 
versican are reactive with the chick variants V0/V1 (chGAG), the chick and mouse isoforms V0/V2 
(chGAG, mGAG) or all proteoglycan variants of human versican (hGAG). The bands of the 
different core glycoproteins of versicans (V0, V1 and V2) and of aggrecan (Ac) are indicated by 
arrowheads.  
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M_Figure 4. Versican overrides the neurite growth promoting activity of laminin-1 in a stripe-choice 
assay. (A) Overlay of false color images of a triple immunofluorescence staining of laminin-1 (LN; 
blue), versican (VC; green) and neurofilaments (white). Despite the rather uniform distribution of the 
growth promoting substrate laminin-1, neurites from E10 chick dorsal root ganglions avoid stripes 
coated with laminin-1 plus versican V0/V1 (100 g/ml coating concentration) and advance on lanes 
coated with laminin-1 alone. The laminin- and the versican-specific stainings are also depicted 
separately in (B) and (C), respectively. Bar: 50 m.  
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M_Figure 5. Versican-mediated inhibition of neurite outgrowth on fibronectin. While neurites from an 
E10 chick dorsal root ganglion extend freely on alternating substrate-stripes coated with 20 and 100 
g/ml fibronectin (A), they are rapidly forced into versican-free lanes on alternating stripes of 
fibronectin alone (coated with 20 g/ml) and fibronectin plus versican V0/V1 (100 g/ml each) 
substrates (B). Phase-contrast and versican-specific immunofluorescence images. Bar: 100 m. 
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M_Figure 6. Inhibitory potential of versican V0/V1 on neurite outgrowth in stripe-choice assays. 
Neurites from E10 chick dorsal root ganglions grow on laminin-1 stripes, but avoid alternating lanes 
coated with laminin-1 plus intact or core glycoprotein preparations of versican V1 (B, C and G, H, 
respectively) or of a V0/V1-mix (D, E and I, J). For the coating of the test stripes a 100 g/ml laminin-1 
solution was supplemented with variable amounts of versican. The corresponding versican 
concentrations are indicated above the panels. On the versican-free control lanes 20 g/ml laminin-1 
was applied. The stripe patterns of the control assays (A, F) were prepared analogously, but versican 
was omitted in the test stripes; control (F) included in addition chondroitinase and enzyme buffer in the 
test lanes. Neurofilaments (red) and versican (green) have been visualized by double 
immunofluorescence staining. Ratios (±SD) of averaged grey values of the axon-specific red 
fluorescence in versican-free versus the adjacent versican-containing lanes are shown below the 
panels. Bar: 100 m. 
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M_Figure 7. Growth cone collapse and retraction of DRG neurites after contact with versican 
containing substrate. Still images from time lapse video microscopy (A-F) documenting the axon 
growth behavior of E10 chick DRG axons on a laminin-1 (LN) substrate either containing or lacking 
versican V0/V1 (VC). The boundary to the area coated with laminin plus versican V0/V1 (100µg/ml 
each) is marked with a stippled line. At 0 and 63 minutes the growth cone (arrowhead) is moving 
forward in direction of the versican containing region. Contacting versican after 69 min, it collapses 
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 and the axon rapidly retracts back towards the cell body. After 87 min the original position is reached 
(F). Bar (A-F): 25 m. Immunofluorescence-overlays of substrate-stainings of versican (G, H, J-L) or 
laminin-1 (I) and axonin-1-specific neurite-labelling reveal growth cones with partly to fully extended 
structures during advancement on a versican-free zone in between versican-containing stripes (G, H) 
or across the border of two differentially coated laminin-1 control areas (I; 100 g/ml coating above 
and 20 g/ml below arrowhead). A fully collapsed morphology is, however, invariably observed near 
the ends of versican-free lanes (arrowheads J, K). (L) A neuronal cell body near the versican-
containing surface projects a long neurite perpendicularly away from versican while a short second 
process extends strictly parallel to the border. Bar (G-L): 10 m. 
 
 
 
 
 
 
 
M_Figure 8. Inhibition of axonal outgrowth by versican V1-expressing COS aggregates in collagen-I 
gel. Neurites from E10 chick DRG extend radially within the collagen gel, but defasciculate and stop 
near the COS cell aggregate recombinantly expressing versican V1. No such effect is observed in the 
control experiment with a COS cell aggregate transfected with the empty vector. Neurofilaments (red) 
and versican (green) are visualized by double immunofluorescence staining. Hoechst nuclear stain 
(blue) reveals the cellular localizations in the control. Fluorescence profiles averaged over a bandwidth 
of 200 m reveal the decline of neurite density (red line in panel B) already 0.5 mm away from the 
versican-expressing (green line) COS cells in relation to the profile of a nearby control sector, where 
neurites pass by the aggregate unhindered (gray line). Profiles of neurites and COS aggregates are 
virtually non-overlapping contrasting the control experiment (A; Hoechst: blue line / neurites: red line). 
Bar: 400 m. 
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M_Figure 9. Consequences of ectopic deposition of versicans in developing chick hind limb in ovo. 
Whole mount immunofluorescence stainings of neurofilaments in HH25 embryos injected beforehand 
with PBS, versican V0/V1- or versican V1-preparations into the hind limb are compared to not-treated 
controls (NT). The ectopic deposition of versican V0/V1 and V1 interferes with the normal growth, 
fasciculation and branching of secondary nerve fibers emerging from dorsal trunk of the sciatic plexus. 
Normal branch-points are indicated with arrows and aberrations with arrowheads (Bars: 200 µm). The 
proportions of normal, moderately and severely disturbed growth patterns were recorded in a blind 
study revealing the clear effect of the versican injections. 
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 5. Identification of ADAMTS members in chick embryo: cloning and 
analysis of their expression patterns in developing hind limb. 
 
5.I. Introduction 
 The development of a functional nervous system requires in all organisms from 
invertebrates to vertebrates a highly coordinated organisation for the establishment of a 
specific and precise neuronal network. During this process the axonal growth is tightly 
controlled by numerous attractive and repellent guidance cues, permitting the neuronal 
extensions to find their corresponding pathways and to reach their proper targets (reviewed 
in (Tessier-Lavigne and Goodman, 1996)). In the particular case of the hind limb innervation, 
the trajectories of motor and sensory axons follow a series of pathfinding decisions. The 
axons growing out from the spinal cord extend first to the base of the limb. On their way they 
pass through the dorsal-anterior sclerotome while they avoid the posterior halves of the 
somites and the perinotochordal mesenchyme (Tosney and Oakley, 1990). After reaching 
the plexus region, the motor- and sensory axons first stall for about 24 hours. During this 
waiting period, the extracellular matrix of the early hind limb, which acts as barrier to the 
growing axons, is being remodelled (Tosney and Landmesser, 1985). Once this has 
occurred, axons then are able to enter the proximal limb mesenchyme, where they are 
directed either ventrally or dorsally at the first choice point they encounter in this tissue 
(Ferguson, 1983; Whitelaw and Hollyday, 1983). Among the non-permissive components of 
the extracellular matrix, the chondroitin sulphate proteoglycan (CSPG) versican V0/V1 is 
present all along the border of the nerve tracks. Landolt et al. have shown that this hyalectan 
is at an early stage of chick development highly expressed in the entire hind limb (Landolt et 
al., 1995), being finally only concentrated within the precartilage mesenchyme starting from 
Hamburger and Hamilton stage 25 (HH25; (Hamburger and Hamilton, 1951)). In addition to 
the presence in axonal barrier tissues, the early versican V0/V1 expression co-localised also 
with boundaries to neural crest cell migration in the developing trunk.   
The sequential disappearances of versican from the presumptive axonal pathways in the 
developing limb seems to be the result of an active proteolytic turn-over process, which may 
involve a novel family of metalloproteases, the ADAMTSs (a disintegrin and metalloprotease 
with thrombospondin type I motifs). These secreted enzymes are characterised by the 
presence of a zinc metalloproteinase domain and a C-terminal ancillary domain containing at 
least one thrombospondin type 1 repeat (reviewed in (Apte, 2009)). Some ADAMTS 
proteases, ADAMTS-1, ADAMTS-4, ADAMTS-5, ADAMTS-9 process a number of substrates 
within the ECM, including CSPGs such aggrecan and versican in vitro (Jungers et al., 2005; 
Kuno et al., 2000; Longpre et al., 2009; Rodriguez-Manzaneque et al., 2002; Sandy et al., 
2001). Recombinant ADAMTS-1 cleaves versican at the Glu441-Ala442 bond (Sandy et al., 
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 2001) and is widely expressed in embryonic tissues including the mesenchyme along the 
distal edge of the limb bud in mouse (Thai and Iruela-Arispe, 2002). During murine 
development ADAMTS-9 is expressed in several tissues and, for us of particular interest, 
within the developing limb bud (Jungers et al., 2005).  
Consequently, we have focused our work on ADAMTS members, which might be involved in 
the turnover of versican and could this way contribute to the remodelling of the axonal 
growth-impeding ECM during the chick hind limb development. For this purpose, we first 
identified and cloned the cDNAs encoding the chick orthologues of ADAMTS-1 and 
ADAMTS-9. We then studied the expression of these two ADAMTSs by in situ hybridisation 
and we finally compared their distribution with the changing versican localisation in the leg 
anlage of chicken embryos between HH23 and HH27 stages. 
 
 
5.II. Material and methods 
5.II.1 Cloning of ADAMTS1 and ADAMTS9 
5.II.1.a Identification and assembling of chick ADAMTS1 and ADAMTS9 cDNAs  
 In order to clone the chicken ADAMTS1 and ADAMTS9 cDNAs, the described 
sequences of the human and mouse orthologues (access numbers: human ADAMTS1 
ENSG00000154734; mouse ADAMTS1 ENSMUSG00000022893; human ADAMTS9 
ENSG00000163638; mouse ADAMTS9 ENSMUSG00000030022) were compared to the 
partially completed genome sequences of the Gallus gallus project (release 36) annotated in 
the Ensembl Genome Browser. Based on the putative exon sequences at the two locations 
identified in the chick genome (chick ADAMTS1: ENSGALT00000025465; 
ENSGALP00000025419 chick ADAMTS9: ENSGALT00000011955), primers for RT-PCR 
amplification of the corresponding cDNAs were designed with Oligo6 software. Total RNA or 
mRNA prepared from primary cultures of chick fibroblasts or total RNA from head of 
HH38/39 chick embryos (Hamburger Hamilton stage 38/39) served as templates. To isolate 
total RNA and mRNA, Midi Easy Protect and Oligotex mRNA kits (both Qiagen) were used, 
respectively. Some of the cDNA fragments could be directly amplified from total RNA or 
mRNA preparations with a Qiagen One-Step Step RT-PCR kit (Table.2), while a two-step 
RT-PCR protocol was required to isolate the others. In this case, the mRNA preparations 
were first reverse-transcribed with AMV reverse transcriptase (Roche) and a specific reverse 
primers mix and then PCR amplified with Taq Gold polymerase (Roche) and a specific 
primer pair. 
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 Table 2. Primers and conditions used to clone ADAMTS1 and ADAMTS9 cDNAs 
 Primer name  Primer sequence  Template Fragment 
name    
Annealing 
temp. °C 
Product 
length bp
RT‐PCR 
type      
Cycle 
number 
1_ADAMTS1  1_cATS1 forward 
1_cATS1 reverse 
CTGGAGCTGGAGCCCGAC 
GCCCCGCAACGAGAAGG  62  207  one‐step 
total RNA 
chick fibroblasts  35 
2_ADAMTS1 
  
2_cATS1 forward 
2_cATS1 reverse 
CCGGGAGACGACCTC 
CGGGGGCTGGAGACGAA  62  335  one‐step 
total RNA 
chick fibroblasts  40 
3‐ADAMTS1 
  
3_cATS1 forward 
3_cATS1 reverse 
CGCTGCGCCGTGACCGA 
GCAGACGAGCAGTCCTCCCGAA  68  915  one‐step 
total RNA 
chick fibroblasts  35 AD
A
M
TS
1 
4‐ADAMTS1 
  
4_cATS1 forward 
4_cATS1 reverse 
CCGGCACGCTGTATGAT 
CTAGGGCCTTCTCTGCTGA  66  1760  one‐step 
total RNA 
chick fibroblasts  35 
1_ADAMTS9 
  
1_cATS9 forward 
1_cATS9 reverse 
AGAAAGGGGCGAGAAAA 
CTGATGACGGCGGTGTG  58.6  586  two‐step 
mRNA 
chick fibroblasts  35 
2_ADAMTS9 
  
2_cATS9 forward 
2_cATS9 reverse 
ACCGGGGGCACGTCAAC 
CACCAAAGTCGCCGACA  60  1174  one‐step 
total RNA 
chick embryo  35 
3_ADAMTS9 
  
3_cATS9 forward 
3_cATS9 reverse 
TCATCAAGAACTTACGCT 
ATGTGCCACCTTAATTC  53.5  1325  one‐step 
total RNA 
chick fibroblasts  40 
4_ADAMTS9 
  
4_cATS9 forward 
4_cATS9 reverse 
CAGCCCGACCCAATAA 
CTTCCCACACGTTGC  58  834  one‐step 
total RNA 
chick fibroblasts  35 
5_ADAMTS9 
  
5_cATS9 forward 
5_cATS9 reverse 
AACAGTCCCGAAGCCAAG 
TCTCATCCACGCAGAAC  58.3  922  two‐step 
mRNA 
chick fibroblasts  35 
 A
D
A
M
TS
9 
6_ADAMTS9 
  
6_cATS9 forward 
6_cATS9 reverse 
GCAATGTGCAGGACTG 
CCTCTCCTCGGGTTTCA  61  530  two‐step 
mRNA 
chick fibroblasts  35 
7_ADAMTS9 
  
7_cATS9 forward 
7_cATS9 reverse 
GTGCCTGACCAACG 
ACACTTCCCACAGTAACC  55.7  658  two‐step 
mRNA 
chick fibroblasts  35 
 
Following steps and conditions were employed in the amplification experiments: 
One-step RT-PCR: mRNA template (200 ng) or total RNA template (400 ng) from total 
embryo or chick fibroblast or chick embryo legs was added to 1x OneStep RT-PCR buffer, 
400 µM dNTPs, 0.6 µM specific primers and 0.8 µl RT-PCR Enzyme mix in a 25 µl reaction 
volume (reverse transcription: 30 min at 50°C; inactivation of reverse transcriptase: 15 min at 
95°C; cycling conditions: 1 min at 95°C, 1 min at the corresponding annealing temperature 
(Table.2), 1 min at 72°C; final extension for 10 min at 72°C). 
Two-step RT-PCR: Reverse transcription was performed with 100 or 200 ng mRNA template, 
a mix of specific reverse primers at different ratios of primers to RNA (1/300, 1/1000 and 
1/3000), 1X reaction buffer, 5 mM MgCl2, 1 mM dNTPs, 1 µl RNAse Inhibitor (50U) and  0.8 
µl AMV reverse transcriptase (20U) in a 25 µl total volume (annealing: 10 min at 25°C, 
reverse transcription: 60 min at 42°C, AMV inactivation and denaturation: 5 min at 99°C). 
Subsequent PCR-amplification from 60 pg to 3 ng chick cDNA template was done in a 25 µl 
reaction volume containing 1X buffer, 2.5 mM MgCl2, 0.2 mM dNTPs, 0.2 µM primers, 1.25 U 
Taq GOLD Polymerase (initial denaturation: 10min at 95°C, cycling conditions: 1 min at 
94°C, 1 min at annealing temperature, 1 min 30 sec at 72°C, final extension: 8 min at 72°C). 
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 5.II.1.b Cloning, sequencing 
 The RT-PCR products were subcloned into pGEM ®T-Easy vector (Promega), 
propagated in XL_1 Blue Bacteria or Sure Bacteria strains (Invitrogen) and then Sanger 
sequenced and analysed with BLAST (Basic local alignment search tool) 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) to verify that no mutation artefacts were incorporated 
during PCR amplification.  
The full length sequence of ADAMTS9 was assembled from the overlapping cDNA fragments 
in a pGEM ®T-Easy vector. Briefly, the fragments were sequentially integrated into 
intermediate vectors using shared restriction enzyme sites. The vector A was constituted by 
ligation of the insert from the plasmid containing 3_ADAMTS9 and the vector containing 
4_ADAMTS9, both previously digested with NcoI and NruI enzymes. The insert from the 
plasmid 1_ADAMTS9 and the plasmid 2_ADAMTS9, both digested with SacII and BamHI 
were ligated together in vector B. The predicted sequence coding for the last five TSP-1 
submotifs presented some differences with what we obtained. For that reason, we first 
separately amplified the fragments 5_ADAMTS9 and 6_ADAMTS9. Afterwards, having 
functional primers in this region, we could obtain a long fragment corresponding to these two 
ones via One-Step RT-PCR (same conditions as described above, forward primer: 5_cATS9 
forward; reverse primer: 6_cATS9 reverse; annealing temperature at 61 °C). The RT-PCR 
product was finally subcloned into a pGEM ®T-Easy vector, the vector C. The vector D was 
constituted of the insert from vector C and the plasmid containing the fragment 7_ADAMTS9, 
both double digested with SacII and AvaI restriction enzymes. Vectors B and D were put 
together in vector E via digestion with SalI and BamHI restriction enzymes. Finally, the vector 
E containing the 5’ end and 3’ end of the ADAMTS9 cDNA was opened up with BamHI and 
the BamHI digested insert from the vector A containing the internal part of the sequence 
were ligated together into the vector F to obtain the full length ADAMTS9 cDNA. Previous 
subsequent digestions, the vector C and the plasmid containing 7_ADAMTS9 fragment were 
digested with EcoRI restriction enzyme in order to have their sequences right oriented. The 
summary of the intermediate steps and the respective restriction enzymes used for the 
construction of the full length cDNA are presented in the figure 19 (table B). 
To minimize the autoligation of the vector, each digested template used as host vector was 
dephosphorylated with 1 µl (150U) Bacterial Alkaline Phosphatase enzyme (Invitrogen) in 1X 
BAP buffer at 65°C for 1 hour in a 50 µl total volume and purified after agarose gel extraction. 
Then the ligation step was done at different ratios of vector to insert (2/5; 5/2;1/1) with 1 µl of 
the T4 ligase (10U) and 1X T4 ligase buffer (USB Europe) at 16°C for 16 hours in a 10 µl 
total volume. 
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Figure 19. Cloning strategy for assembling the full length ADAMTS9 cDNA. 
A) Representation of the full length ADAMTS9 cDNA integrated into the multiple cloning site (MCS) of 
the pGEM ®T‐Easy vector. 
The subcloned  fragments are depicted under  the schematic  representation of  the ADAMTS9 cDNA 
into the pGEM ®T‐Easy vector. The restriction enzyme sites used for the assembling of ADAMTS9 full 
length  are  mentioned,  in  bright  blue  the  cDNA  coding  for  ADAMTS9  and  in  turquoise  blue  the 
Multiple Cloning Site of pGEM ®T‐Easy vector are shown. 
B) Table presenting the  intermediate vectors generated  in order to obtain the full  length ADAMTS9 
cDNA. 
The  respective  intermediate  vectors  and  the  different  fragments  are  described,  as  well  as  the 
restriction enzymes used to obtain vector (V) and insert (I) parts. 
C) Agarose  gel  representing digestion  analysis of  chick ADAMTS9  cDNA  cloned  into pGEM  ®T‐Easy 
vector. 
The undigested plasmid containing 8.7 Kb ran around 6 Kb corresponding to the circular form of the 
vector. After digestion, the vector was cut into two fragments (6.7 Kb, 2 Kb) and into three fragments 
(3.3 Kb, 3 Kb, 2.37 Kb) with BamHI and EcoRI restriction enzymes, respectively. 
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 5.II.2 Distribution of chick ADAMTS1 and ADAMTS9 transcripts, localisation of 
versican in chick hind limb during development 
5.II.2.a Preparation of the probes 
 For expression analysis of ADAMTS1 and ADAMTS9, specific digoxygenin-labelled 
riboprobes were prepared from parts of the cloned cDNAs (Table.3). Briefly, plasmids 
containing cDNA fragment of interest were used as templates. Primer pairs with one primer 
carrying at the 5'end the T7 promoter sequence were designed and used to generate 
modified cDNA fragments by PCR. The PCR products were used as templates to produce 
DIG-labelled riboprobes with the DIG-labelling kit SP6/T7 (Roche Applied Science). 1 µg of 
each cDNA was mixed with 5 µl DIG RNA labelling mix (10 mM NTP), 5 µl 10x transcription 
buffer, 2.5 µl Protector RNase Inhibitor, 5 µl RNase polymerase T7 and RNase-free water up 
to a final volume of 50 µl. After incubation for 2 h at 37°C, the cDNA was eliminated by 
addition of 5 µl RNAse free DNAse I for 15 min at 37°C. The reaction was stopped by adding 
5 µl EDTA (0.2 M). The cRNA probes were precipitated with 7.5M LiCl and dissolved in 50 µl 
of DEPC-treated H2O. 
 
Table 3. Primers used for preparing templates in situ hybridisation (ISH) riboprobes 
Primer name 
(ISH probe prep)   Primer sequence  Probe 
ISH_cATS1 forward  TGCGTGAAGGCTGGCTGT  
 
T7_ISH_cATS1 reverse  CGAAATTAATACGACTCACTATAGGGAGACGGTTTCTTGGAAGGCTC  ADAMTS1 anti‐sense 
T7_ISH_cATS1 forward  CGAAATTAATACGACTCACTATAGGGAGATGCGTGAAGGCTGGCTGT  
A
D
A
M
TS
 1 
ISH_cATS1 reverse  CGGTTTCTTGGAAGGCTC  ADAMTS1 sense  
ISH_cATS9 forward  ACCGGGGGCACGTCAACG  
T7_ISH_cATS9 reverse  CGAAATTAATACGACTCACTATAGGGAGATCCTTCGGGGTGGTTCTG  ADAMTS9 anti‐sense  
T7_ISH_cATS9 forward  CGAAATTAATACGACTCACTATAGGGAGAACCGGGGGCACGTCAACG 
A
D
A
M
TS
 9 
TCCTTCGGGGTGGTTCTG  ADAMTS9 sense  ISH_cATS9 reverse 
 
5.II.2.b Preparation of tissue sections 
 Chicken embryos were collected at indicated embryonic HH-stages and dissected in 
PBS. After fixation in 4 % paraformaldehyde (PFA) in PBS for 1 to 2 h at room-temperature, 
the embryos were cryoprotected in 25% sucrose PBS over-night at 4°C. The cryo-protected 
embryos were embedded in Tissue-Tek OCT freezing compound (Sakura). 20 µm thick 
transversal sections were cut, mounted on SuperFrost Plus microscope slide (Menzel-
Glaeser) and stored at -20°C until further use. 
 
5.II.2.c In situ hybridisation (ISH) 
 The slides were dried for 10 min at room-temperature, post-fixed for exactly 30 min in 
4% PFA in PBS, rinsed twice in PBS and once in H20 for 5 min each. They were then 
acetylated for 10 min in 1% triethanolamine containing 0.25% acetic anhydride (vol/vol), 
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 rinsed twice in PBS for 5 min and once in 2X SCC (0.3 M NaCl, 0.03 M tri-sodium citrate, pH 
7) for 5 min. To block unspecific binding, the sections were pre-treated in hybridisation buffer 
(5X Denhardt’s solution, 250 ug/ul yeast tRNA, 500 ug/ml herring sperm DNA, 5X SCC, 50% 
formamide) for 3 h. Finally, the hybridisation was done by incubating 600 ng riboprobe 
diluted in 300 µl hybridisation buffer per slide for at least 15 h. Both, prehybridisation and 
hybridisation were done at 56°C in humidified chamber. To avoid evaporation, slides were 
covered with a parafilm previously treated with 7% H202 in H20. 
The hybridisation was followed by successive washings in 5X SSC (one short rinse and then 
another incubation for 5 min), in 2X SSC once for 5 min and in 0.25X SSC / 50% formamide 
for 20 min (all at 56°C). Finally, the slides were rinsed briefly in 0.2X SSC at room-
temperature.  
For probe detection, the sections were equilibrated in detection buffer containing 0.1 M tris-
base, 0.15 M NaCl, pH 7.5 (2 incubations for 5 min each) and then incubated for 1 h in 
blocking buffer (detection containing 3% dry milk). These and all subsequent steps were 
done at room-temperature. The sections were next incubated for 1 h in blocking buffer 
supplemented with anti-DIG-AP Fab fragments polyclonal antibody (Roche) at a dilution of 
1:5000. After this binding step, the preparations were rinsed by dipping shortly into detection 
buffer followed by two washings in the same buffer for 15 min. They were next equilibrated in 
1X alkaline phosphatase (AP) buffer (0.1M Tris-base, 0.1M NaCl, 50 mM MgCl2, pH 9.5).  
Afterwards the sections were covered with developing solution prepared by mixing equal 
volumes of Celvol 205 Polyvinyl alcohol (Celanese Chemicals) and 2X alkaline phosphatase 
(AP) buffer containing 100 mM MgCl2, 337.5 µg/ml nitroblue tetrazolium (NBT; Roche), 175 
µg/ml 5-bromo-4-chloro-3-indoyl- phosphate (BCIP, Roche), and 240 µg/ml levamisole 
(Sigma). Protected from light, the slides of the ADAMTS1 and the ADAMTS9 hybridisations 
were then incubated for 20 h and 16 h, respectively, until the colour reaction was stopped in 
TE buffer (one short dip and two 15 min washings). Finally, the sections were rinsed in H20 
before being cover-slipped with an aqueous mounting medium (Celvol). All the solutions 
used for pre- and hybridisation steps were prepared in RNase free-conditions. All 
developmental stages were processed identically. 
 
5.II.2.d Immunofluorescence staining 
 Double immunofluorescence staining was done on embryo sections successive to the 
sections previously subjected to ISH. The cryo-sections were prepared as described above. 
Rabbit serum against chick GAG-β domain versican previously prepared in our laboratory 
(Landolt et al., 1995) and mouse monoclonal antibody RMO-270 against neurofilament-
160kD (anti-NF_M; Invitrogen) were diluted in blocking buffer (0.2% gelatine, 0.5% BSA, 
0.02% azide sodium in PBS) to 1:500 and 1:2000, respectively. Secondary antibodies used 
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 in these stainings were goat anti-rabbit Alexa 488 and goat anti-mouse Alexa 594 (both 
Invitrogen) diluted to 1:200 in PBS. The cryo-sections were first dried for 15 min at room-
temperature, then post-fixed in 4% PFA for 30 min, rinsed once shortly and then washed 
twice for 10 min in PBS. They were subsequently blocked in blocking buffer for 40 min at 
room-temperature and incubated with the primary antibody-mix (500 µl /slide) for at least 16 
h at 4°C. Next, they were washed three times in PBS for 5 min and incubated with the 
secondary antibody-mix for 1 h under light protection (all at room-temperature). The sections 
were then rinsed again in PBS before counterstaining with Hoechst H33258 nuclear dye. 
After three washings in PBS for 5 min each, the sections were cover-slipped with 
fluorescence mounting medium (Dako). 
 
5.II.2.e Immunofluorescence pictures and in situ hybridisation images 
 The ISH sections were scanned with the NanoZoomer 2.0 scanner (Hamamatsu). The 
images were similarly adjusted for brightness and contrast in Photoshop CS4. The 
immunofluorescence pictures were taken with an Olympus BX61 microscope coupled to an 
F-view camera. Red, green and blue channels were collected separately. The image analysis 
was done with the AnalysiSIS Pro software (Soft Imaging System, Germany). The contrast 
and brightness of the channels were similarly adjusted and the images were overlaid in 
Photoshop CS4. 
 
 
5.III. Results 
5.III.1 Identification and cloning of chick ADAMTS1 and ADAMTS9 cDNAs 
 The well characterised cDNA sequences of human and mouse ADAMTS1 and 
ADAMTS9 were used to identify orthologous sequences in the provisory Gallus gallus 
genome data base. The sequence alignments formed the basis to set-up PCR-approaches 
for their cloning.  
 
5.III.1.a Chick ADAMTS1 
 In a first set of RT-PCR experiments with RNA from chick embryonic fibroblasts, we 
initially amplified two overlapping fragments containing in total 1653 bp of the chick 
ADAMTS1 cDNA including the translational stop codon. In subsequent RT-PCR rounds, we 
could extend this sequence towards the 5’ end by amplifying two smaller fragments, which 
covered an additional 422 bp of the cDNA sequence. The most 5' part of the coding 
sequence eluded amplification, however, even after multiple attempts employing random and 
specifically primed cDNA preparations as well as genomic DNA as PCR templates. Yet, the 
cDNA confirmed by our experiments encoded most of the pro-peptide and the entire 
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 sequence of the mature enzyme. Some differences were observed with the predicted 
sequence in the Ensembl data base (Fig.20).  
 
 
Figure 20. Putative cDNA and deduced peptide sequence of chick ADAMTS1. 
The putative ADAMTS1  cDNA was assembled by aligning  the Ensembl  sequences of  the predicted 
chick gene, the chick cDNA and the transcript of the human orthologue. The cloned and confirmed 
cDNA  sequence  is  typed  in  black  font.  Italic  letters  indicate  the  5’  and  3’  UTR  regions.  Putative 
sequences not covered by our clones are written in pink letters. Variations to the Ensembl sequences 
are depicted by blue characters (positions 677, 704, 1049, 1685, 1901 and 2108; all silent mutations). 
The position of a deletion (gccaga) observed in our cloned cDNA is marked by an asterisk. The yellow 
highlighted nucleotides display a two‐basepair insertion in the 3’UTR. The amino sequence deduced 
from  chick ADAMTS1 peptide  (922  residues)  is depicted below  the  cDNA  sequence. The predicted 
signal peptide is indicated in bold font. Single‐letter amino acid codes are used. 
 
The sequences of our cloned cDNA fragments were confirmed by analysing independent 
RNA preparations from different embryos. Furthermore, sequence alignments of the 
fragments to ADAMTS1 cDNAs of other species with the Clustal W2 program 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) validated the specificity and accuracy of our 
isolated chick cDNA clones. The putative chick ADAMTS1 cDNA shared 69% identity with 
the human and 57% with the mouse orthologues. The deduced peptide sequence showed an 
even closer relationship (73% identity with human ADAMTS1 peptide and 72% with the 
murine orthologue). The comparison of the peptide sequence of the catalytic domain 
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 revealed finally the highest similarity with an 82% and 78% identity with the corresponding 
domains in human and murine ADAMTS1, respectively (Fig.21). 
 
 
Figure 21. Comparison of the catalytic domains of human, mouse and chick ADAMTS1. 
The amino sequences of the catalytic domains of ADAMTS1 in human, mouse and chick were aligned. 
The  chick  catalytic  domain  exhibits  82%  and  78%  identity with  the  human  and mouse  domains, 
respectively. The active site is indicated by a blue box. 
 
5.III.1.b Chick ADAMTS9 
 The cDNA of chick ADAMTS9 was cloned in seven fragments (1_ADAMTS9 to 
7_ADAMTS9). These overlapping fragments covered the entire open reading frame. Similar 
to the ADAMTS1 cDNA, the ADAMTS9 cDNA clones differed slightly from the predicted 
Ensembl sequence (Fig.22). In particular, the coding sequence for the TSP like 1 motifs 
close to the 3’- end lacked 332 nucleotides encoding the TSP-1 domain 12 and the C- or N-
terminal halves of the TSP-1 repeats 11 and 13, correspondingly. The absence of these 
structural elements was confirmed by analysing multiple sub-clones originating from diverse 
embryo RNA templates. Consequently, the chick ADAMTS9 from embryonic fibroblasts 
contains only thirteen thrombospondin type-1 repeats instead of fifteen as described for the 
human and mouse orthologues.  
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Figure 22. cDNA and deduced peptide sequence of chick ADAMTS9. 
The ADAMTS9 cDNA was assembled by aligning the Ensembl sequences of the predicted chick gene, 
the  chick  cDNA  and  the  transcript  of  the  human  orthologue.  The  cloned  and  confirmed  cDNA 
sequence is typed  in black font. Italic  letters  indicate the 5’ and 3’ UTR regions. A portion of the 5'‐
UTR not covered by our clones is written in pink letters. Synonymous mutations are depicted by blue 
characters (positions 1248, 1470, 1539, 1761, 1899, 2025, 2067, 2235, 2931, 3636, 3645, 3825, 3960, 
4197,  4428,  4623,  4653,  4872;  all  silent mutations), while  non‐synonymous  variations  (positions 
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 4526, 5308) also found  in the Ensembl chick genome project and a mutation  in the 5’UTR (position 
100) are marked in green. Deletions indicated by an asterisk at positions 3285/3286 (ccctggcag) and 
4469/4470  were  observed  only  in  our  cloned  cDNA,  but  were  not  described  in  the  Ensembl 
prediction. The 332 bp‐stretch, which is absent at position 4469/4470 (asterisk), corresponds to the 
sequence encoding  the TSP‐1  repeat number 12 and half of  the domains 11 and 13 of  the human 
orthologue.  The  amino  acid  sequence  deduced  from  chick  ADAMTS9  peptide  (1818  residues)  is 
depicted below  the cDNA  sequence. The predicted  signal peptide  is  indicated  in bold  font. Single‐
letter amino acid codes are used. 
 
The chick ADAMTS9 shared at the cDNA and peptide levels 72% and 77% identity, 
respectively, with the human orthologue or 71% and 75% identity with the mouse orthologue. 
Although the chick catalytic domain was highly similar to the human and mouse enzymes (80 
and 81% identity, respectively), it included an insertion of two amino-acids and other minor 
variations within this element. The active site, however, was completely conserved (Fig.23).  
 
 
  
Figure 23. Comparison of ADAMTS9 catalytic domains in human, mouse and chick. 
The amino sequences of the catalytic domains of ADAMTS9 in human, mouse and chick were aligned. 
The  chick  catalytic  domain  shows  80%  and  81%  identity  with  the  human  and  mouse  domains, 
respectively. The active site  is  indicated by a blue box. The presumed chick catalytic domain  is two 
residues longer than the human or mouse counterpart. 
 
 
The location of the overlapping cDNA clones and the modular organisation of the deduced 
peptide sequences of chick ADAMTS1 and ADAMTS9 are shown in figure 24. 
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A) 
Chick ADAMTS1 
 
B) 
Chick ADAMTS9 
 
 
 
Figure  24.  Schematic  representation  of  cloned  PCR‐fragments of  chick ADAMTS1  and ADAMTS9 
cDNAs and the domain structures of the deduced peptides. 
The fragments for chick ADAMTS1 (A) and ADAMTS9 (B) cDNAs are aligned to the peptide domains 
they  encode.  The  chick ADAMTS9  characterised  in  our  cloning  experiments  lacks  two  TSP  type‐1 
motifs in relation to the human and mouse orthologues (see insert). The positions of the riboprobes 
employed in our in situ hybridisations are represented by a dotted line. 
 
 
5.III.2 Distribution of chick ADAMTS1 and ADAMTS9 transcripts  
 Previous studies in man and mouse described the expression of ADAMTS1 and 
ADAMTS9 in some adult and embryonic tissues. During mouse embryogenesis, the 
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 expression patterns of both enzymes appeared rather wide and mostly complementary to 
each other being present in developing organs such as lung, heart and kidney as well as in 
different mesenchymal tissues including the limb buds (Jungers et al., 2005; Thai and Iruela-
Arispe, 2002). However, despite indications that both enzymes exert some proteolytic activity 
towards versicans (Somerville et al., 2003), no comparative analysis of ADAMTS1 and 
ADAMTS9 expression in relation to the versican turnover have been described so far. 
Hence, we focused our ADAMTS expression studies on the developing hind limb, where the 
rapidly changing distribution of versicans inversely correlates with the routes taken by 
peripherally extending axons (Landolt et al., 1995). For our developmental expression 
studies, we chose the chicken as model organism because of obvious advantages in regard 
to easy timing and accessibility of differently staged embryos. The initial in situ hybridisations 
detecting ADAMTS1 and ADAMTS9 mRNAs were performed on embryos staged between 
HH23 to HH27.  
The transcripts of the two enzymes were both found in chick limb anlage, but not at the same 
development stages and not at the same level of expression (Fig.25 and 26). Surprisingly, 
ADAMTS1 mRNA was only minimally present in chick embryos at early stages of 
development. No expression was detectable at HH23. Later from HH25, the staining was 
weakly visible in the neural tube and in DRG, in the dermomyotomes and also in the hind 
limb bud, where it was found primarily around the condensing mesenchyme of the cartilage 
primordia (Fig.25B and C).  
 
 
Figure 25. ADAMTS1 is weakly expressed in hind limb of chick embryo during early development. 
The expression patterns of ADAMTS1  transcripts were analysed by  in  situ hybridisation on 20 µm 
cryosections  of  chick  embryos. No  expression of ADAMTS1 was observable  at HH23  stage  (A). At 
HH25  a  weak  expression  was  detectable  in  the  dermomyotomes  and  in  the  centre  of  the  limb 
mesenchyme (B, asterisk). This staining was slightly more pronounced at HH27 (C, asterisk). Panel D 
shows a control section of an HH25 embryo hybridised with  the corresponding sense probe. Scale 
bar: 200 µm. 
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In contrast, ADAMTS9 mRNA expression initiated already around HH23 in the 
dermomyotomes and became at the level of the hind limbs more prominent at later stages 
(Fig.26D). At HH25 the staining was particularly noticeable in the pelvic girdle precursor and 
in the dermomyotomes (Fig.26E). Finally, at HH27 a well defined signal detected ADAMTS9 
expression within the connective tissue localised between the epidermis and the precartilage 
mesenchyme of the hind limb (Fig.26F). 
Double immunofluorescence staining for versican V0/V1 and neurofilaments on sections 
successive to the ISH displayed a complementary distribution of versican protein and 
ADAMTS9 mRNA, while the neurofilament-positive axons were absent from versican-rich 
mesenchymal areas extending exclusively into the ADAMTS9 expressing zone. In detail, at 
an early stage of development (HH23), when ADAMTS9 expression is mainly absent, 
versican is abundant in the entire limb bud (Fig.26G) and to a lesser extent around the 
notochord and the neural tube. At this time, axons have extended into the plexus region, but 
are restrained from entering the limb bud (Fig.26J). Around HH25, the proteoglycan 
progressively disappears from the connective tissue of the limb (Fig.26H) and is, except for 
the pelvic girdle precursor and other prechondrogenic areas, finally cleared from the future 
axonal pathways (HH27; Fig.26I). During this period, ADAMTS9 is consistently expressed in 
the mesenchymal zones that loose the versican immunostaining (Fig.26E and F). Until HH27 
the axons have invaded the base of the limb, they have bifurcated into a ventral and dorsal 
branch and they continue to grow along ADAMTS9 expressing versican-free zones that 
border the condensing mesenchyme of the cartilage and bone primordia (Fig.26L). 
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Figure 26. Modulated expression of ADAMTS9  in correlation with the versican disappearance and 
the extension of axons in chick limb bud during development. 
Distribution of the ADAMTS9 expression detected by  in situ hybridisation  (ISH)  in chick embryos at 
HH23  (D),  HH25  (E),  HH27  (F)  and  comparison  with  the  localisation  of  versican  V0/V1  and 
neurofilaments  at  the  respective  stages  by  double  immunofluorescence  (Cifuentes‐Diaz  et  al.) 
stainings  (HH23: G,  J; HH25: H, K; HH27:  I, L,  respectively). Panels A, B, C  show  the corresponding 
sense probe control  for  the ADAMTS9  ISH. Successive 20 µm cryosections  from  the same embryos 
were processed for ISH labelling and IF staining. 
ADAMTS9 expression is detectable in the dermomyotomes starting from HH23 (D, asterisk). Between 
HH25 and HH27, it becomes more prominent in the dorsal and ventral mesenchyme near the pelvic 
girdle precursor (E, asterisk) and along the prechondrogenic condensations of the leg bone primordia 
(F, asterisk).  
Versican  is  rather  uniformly  distributed  in  the  limb  bud  of  chick  embryos  at  HH23  stage  (G).  It 
subsequently disappears from the dorsal and ventral mesenchyme (H) being finally restricted to the 
prechondrogenic  areas  and  a  narrow  subepidermal  zone  within  the  developing  hind  limb  (I). 
Motoraxons growing out from the neural tube and sensory axons extending from the DRG  join and 
invade the limb in areas that are cleared from versican (J, K, L). Scale bar: 200 µm.  
 
 
In summary, the temporospatial expression patterns indicate, that ADAMTS9 expression 
may function in the control of hind limb innervation, whereas an involvement of ADAMTS1 in 
this process appears rather unlikely. The ADAMTS9 expression correlates well with areas of 
versican clearance and outlines zones of future axonal growth in the limb.  
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 5.IV. Discussion 
 In the course of development, different timely and spatially coordinated processes have 
to occur to allow the neuronal network to be correctly formed. One of these crucial events 
consists in the specific remodelling of an originally non-permissive extracellular matrix in 
order to permit axonal growth along precisely delineated pathways. In this project, we were 
particularly interested in the potential link between the turnover of versican and the 
expression of distinct ADAMTS proteases in the embryonic hind limb during chick peripheral 
nervous system development. Indeed, steadily accumulating evidence has supported the 
hypothesis that, among the components present in axonal barrier tissues, versican may take 
an active part in the guidance of growing axons by acting as non-permissive guidance cue. 
On one hand, the isoforms V0/V1 co-localised with the barrier tissues in chick embryos, while 
growing axons move forward along paths freed from this hyalectan (Landolt et al., 1995). On 
the other hand, isolated versicans are potent axonal growth inhibitors in vitro and in ovo 
(Schmalfeldt et al., 2000; Dutt et al. see part IV of this thesis). Furthermore, also early neural 
crest stem cells migration is inhibited by versicans in stripe-choice assays in vitro (Dutt et al., 
2006). All these inhibitory functions seem to emanate from the core glycoprotein. The 
blocking capacity of various boundary tissues in the limb anlage is temporally restrained 
suggesting that the non-permissive properties of versican are accurately modulated 
alongside. Prime candidates for regulating the activity of versicans are different members of 
the ADAMTS metalloprotease family, which exert various levels of hyalectanase activity. 
Consequently, we have directed our main focus on ADAMTS1 and ADAMTS9, which are 
widely expressed in mouse embryos (Jungers et al., 2005; Thai and Iruela-Arispe, 2002) and 
have been described to cleave versican in vitro (Sandy et al., 2001; Somerville et al., 2003).   
To investigate the expression patterns of ADAMTS1 and -9 during the crucial phases of limb 
innervation, we started with the full-length cDNA cloning of the chick orthologues of the 
known human and mouse proteases. Comparisons of sequences of our chick cDNAs clones 
with the predicted sequences from the chick genome project and with the published human 
and mouse sequences displayed one major and several minor deviations. Some of the 
differences to the chick gene predictions might be explained by certain sequence errors in 
the database, which currently is incomplete and has not yet been manually curated. Even 
after the release of multiple updates during the elaboration of this study, the published 
sequences still appeared only partly accurate. Especially the predicted Exon I of the chick 
ADAMTS1 gene, theoretically including the 5’ UTR and the translational start codon, could 
only be aligned for a minimal stretch with its human counterpart. A putative start codon was 
listed in the annotation, but a suitable sequence carrying the Kozak sequence was missing 
and no TATA box could be identified in the predicted sequence. We therefore tried to 
circumvent this problem by manually aligning an upstream sequence in the chick Exon I with 
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 the well-described human and mouse ADAMTS1 sequences. In spite of the extensive testing 
of the selected guessmer primers under different RT-PCR conditions, we were still not able 
to completely elucidate the sequence corresponding to the 5’UTR of chick ADAMTS1. 
Nevertheless, even if the 5’- end of the chick ADAMTS1 cDNA is missing in our overlapping 
cDNA clones, it most likely lacks only a small portion at the 5'- end, which encodes the 
translational start codon, the secretory signal sequences and less then 20 N-terminal amino 
acids of the propeptide, but it contains the entire open-reading frame of the mature enzyme. 
In addition, we observed in our ADAMTS1 cDNA six silent mutations and one in frame-
deletion of six nucleotides in the translated part. Since the current annotation in Ensembl 
seems to be based on only a few genomic sequences and is not derived from a large cohort 
of different chicken breeds, it seems likely that the variations observed in our cDNAs reflect 
natural polymorphisms.  
The sequence of our chick ADAMTS9 cDNA clones, coding for the whole proenzyme, 
showed apart from annotated SNPs and hitherto unknown silent single nucleotide exchanges 
one major difference in comparison to the gene sequence published in the Ensembl 
database. Two predicted exons (29 and 30) were consistently skipped in our cDNA 
fragments independent of the embryonic RNA preparations tested. In consequence, our 
cloned cDNA is two TSP-1 motifs shorter than the predicted chick ADAMTS9 and to the 
curated human and mouse orthologues. Due to the genomic constellation the N-terminal half 
of the TSP-1 repeat 11 and the C-terminal half of the repeat 13 are fused, while the stretch in 
between is lacking. The shortened ADAMTS9 in chicken may either correspond to a not yet 
described splice-variant or may reflect a particularity of the chick HISEX breed or the chick 
genome in general, although the splice donors and receptors of the skipped exons appeared 
intact in the gene annotation. Further screening of different breeds coming from different 
hatchery should be performed in order to confirm this observation. Finally, another much 
smaller deletion was observed at position 3285/3286 affecting a nonamer sequence, which 
was duplicated in the Ensembl gene prediction.  
The chick genome annotation misses currently parts of the promoter region including the 
canonical TATA box, which was identified in the human gene, and around 30 bp of the 
transcribed portion up to the transcription initiation site (Yaykasli et al., 2009). Besides, the 
promoter sequence described in Ensembl for the chick ADAMTS9 promoter contains at least 
one putative binding site for the transcription factor, Nuclear Factor of Activated T cells 
(NFAT), with the consensus sequence (GGAAA) (Rao et al., 1997). In order to be able to 
analyse the regulation of the ADAMTS9 gene in detail and to establish a relation to the 
control of versican gene expression, the identification and cloning of the entire promoter 
would be required, however. Whether the chick ADAMTS9 expression is regulated by 
cytokines via the NFATc1 transcription factor, as described for human chondrocytes 
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 (Yaykasli et al., 2009), would have to be first verified, but may have consequences for the 
turnover of versican and/or aggrecan during morphogenesis and inflammatory process as 
arthritis.  
Finally, the primary structures deduced from the cloned cDNAs of both, chick ADAMTS1 and 
ADAMTS9, contained the characteristic catalytic domain with the specific active site, which 
was highly similar to the catalytic domain of their respective orthologues in human and 
mouse and to other members of the ADAMTS family.  
The analysis of the expression profiles by in situ hybridisation suggested a distinct regulation 
of ADAMTS1 and -9 in the developing chick limbs, which, particularly in regard to ADAMTS1, 
seemed to differ from the previously described pattern in mouse embryos. In mice, whole 
mount in situ hybridisations had revealed ADAMTS1 expression in the apical epithelial ridge 
starting from E9. At E11 the expression remained limited to the most distal part of the limb 
bud, and was finally restricted to the interdigital zone at E12 (Thai and Iruela-Arispe, 2002). 
At the corresponding stage in the chick (E12 mouse - HH27 chick), we detected in in situ 
hybridisation of thin sections only little ADAMTS1 transcripts in mesenchymal areas of the 
developing limb and none at the distal rim. In contrast, we observed a moderate staining in 
the DRG and in the neural tube starting from HH25. This location of ADAMTS1 expression 
has been described in mouse embryos too, albeit at later stages of development. These 
discrepancies between the mouse and the chick models could be first explained by the 
technique itself. The signal of our ADAMTS1 ISH experiments on cryo-sections was 
extremely weak. It is possible that our short riboprobe was staining less efficiently than the 
whole mount in situ probe of Thai and colleagues, which hybridised to almost the entire 
coding sequence of the mature peptide bearing however, an increased risk for cross-
hybridisations (Thai and Iruela-Arispe, 2002). Secondly, by analysing sections, we may have 
missed the proper plane that included the developing toes and their interdigital zones. 
Thirdly, the timing and distribution of ADAMTS1 expression might differ from one organism to 
another during development. In fact, we studied only a restricted period of the chick 
embryogenesis (up to HH27). It seems possible that the high levels of the ADAMTS1 
expression observed in mice become apparent only later in avian development. Finally, one 
could imagine that another member of the ADAMTS family has taken over the function of 
ADAMTS1 in the chick, because of a certain redundancy of the substrate specificities. 
Irrespective of the explanations mentioned above, the expression of ADAMTS1 initiates well 
after the time frame of the early limb innervation. It therefore seems rather unlikely the 
ADAMTS1 is the key enzyme that clears versican from the axonal pathways at this stage. 
No such species differences were evident regarding the spatial and temporal regulation of 
ADAMTS9 expression during limb development. Jungers et al., who previously determined 
the expression in mouse embryos (Jungers et al., 2005), showed a wide and timely 
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 distribution of ADAMTS9 throughout the development. Within the developing limbs, 
ADAMTS9 was predominantly expressed in the mesenchyme around the cartilage at E13.5. 
In the present study on chick embryos, the expression of ADAMTS9 was also confirmed in 
hind limb mesenchyme at comparable developmental stages. Moreover, 
immunofluorescence stainings for versican on sections successive to the sections processed 
for ADAMTS9-specific ISH revealed a clear correlation of ADAMTS9 expression and 
versican disappearance in the developing hind limb. Notably, ADAMTS9 expression was 
present on all future routes taken by the axons to innervate the limb. 
During development, the extracellular matrix undergoes an active remodelling permitting the 
growing axons to invade spaces that were previously non-permissive to their extension. 
Since ADAMTS9 was described to have versicanase activity in vitro, the nearly perfect 
complementarity of the distribution of ADAMTS9 transcripts and the proteoglycan 
disappearance may be of great significance. These findings let us therefore, speculate that 
the ADAMTS9 protease is crucial for the versican turnover during the mesenchymal 
remodelling in chick embryos and consequently may neutralise the inhibitory properties of 
early axonal growth barriers. Nevertheless, combined functional studies with versican and 
ADAMTS9 are necessary to confirm this intriguing hypothesis. 
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 6. In vitro and in vivo studies to analyse ADAMTS9 function on 
versican turnover 
 
6.I. Introduction 
 The ADAMTSs (a disintegrin and metalloproteinase with thrombospondin type 1 motifs) 
comprise a superfamily of extracellular proteases forming frequently an integral part of the 
extracellular matrix (ECM) themselves. They are involved in various biochemical and 
biological processes, such as maturation of von Willebrand factor and procollagen, as well as 
proteolysis of extracellular matrix proteoglycans in the context of ovulation, morphogenesis, 
angiogenesis, cancer and arthritis (Kuno et al., 2000; Levy et al., 2001; Shindo et al., 2000; 
Tortorella et al., 1999; Wang et al., 2003). Together with other proteases, the ADAMTS have 
a potential function in the degradation and turnover of ECM components in a broad range of 
tissues. Among them, ADAMTS1, -4, -5, -8, -9, -15 and -20 exert hyalectanase activity 
cleaving aggrecan, versican and/or brevican at specific sites (Abbaszade et al., 1999; Kuno 
et al., 2000; Somerville et al., 2003; Tortorella et al., 1999; Westling et al., 2004). 
In our previous experiments (part 5), we have shown that ADAMTS9 expression correlates 
particularly well with the disappearance of versican during chick development. Versican, 
which is strongly expressed in the entire hind limb mesenchyme at early stages of 
development, rapidly disappears between HH23 to HH25 to remain finally only present in the 
condensing mesenchyme of the future cartilage and bone forming tissues. This swift 
remodelling of the mesenchymal areas in the hind limb is likely connected to an active 
turnover of the versican proteoglycan. Due to its matching spatiotemporal expression, 
ADAMTS9 is the prime candidate for the initialisation of the versican degradation. Further 
evidence for this notion is provided by in vitro experiments, in which a versican preparation 
from bovine aorta was specifically processed at the Glu(441)-Ala(442) bond by incubation 
with COS-1 cells expressing recombinant human ADAMTS9 (Somerville et al., 2003). 
Moreover, different studies led by Apte and colleagues have recently shown a direct 
implication of versican cleavage in various morphogenetic processes. While homozygous 
ADAMTS9 knockout mice die early at E7.5, heterozygous Adamts9(+/-) mice survive, but 
display cardiac and aortic anomalies or, in case of ADAMTS9(+/-)/ADAMTS20(-/-) double 
knockouts, cleft palates (Enomoto et al., 2010; Kern et al., 2010). Both of these defects have 
been directly attributed to reduced versican processing and accumulation of this 
proteoglycan as a result of ADAMTS9 haploinsufficiency. Different combinations of partial or 
complete suppression of ADAMTS5, -9 and -20 have also been linked to defects in 
interdigital web regression during embryogenesis and consequent syndactyly (McCulloch et 
al., 2009b). Taken together, these observations suggest a potential role of ADAMTS9 in the 
regulation of versican functions during development of the hind limb in chick embryos via an 
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 active processing of its core protein. The aims of this part of our project were to verify the 
cleavage activity of ADAMTS9 towards versican and to study the function of this processing 
during peripheral nervous system development in vitro and in vivo. For this purpose, we 
prepared different expression vectors containing the full-length chick ADAMTS9 and its 
inactive form carrying a mutation in the active site (E427A). We established stable cell lines 
expressing the recombinant chick ADAMTS9 and the mutant E427A_ATS9. In parallel, we 
generated specific anti-sera recognising the chick ADAMTS9 peptide. We then examined the 
activity of these recombinant enzymes on purified chick versican and we attempted to test 
the in vivo effect of injections and electroporations of ADAMTS9 cDNA in early chick 
embryos. 
 
 
6.II. Material and methods 
6.II.1 Generation of antibodies against chick ADAMTS9  
6.II.1.a Preparation of recombinant ADAMTS9 fragments for immunization 
 Two different chick ADAMTS9 cDNA fragments covering nucleotides 1414 to 1740 
(fragment A) and 1474 to 1740 (fragment B) were PCR-amplified from a cloned cDNA 
template (construct F_Ab) (Fig.27). The construct F_Ab had previously been prepared by 
inserting a SacII and BamHI fragment from 2_ADAMTS9 into the 3_ADAMTS9 plasmid (ref 
Figure 19. Cloning strategy for assembling the full length ADAMTS9 cDNA). 
The primers for amplification were specifically modified for in frame insertion into the pDS9-
cassette expression vector (Zimmermann et al., 1994). The forward primers carried at their 5’ 
end a SfiI restriction site and the codons for the tetrapeptide of the factor Xa cleavage site, 
while the reverse primers included the inverse complementary sequence for a translational 
stop codon followed by a NotI site. PCR amplifications were done from 20 ng of F_Ab 
template in a 50 µl reaction volume containing 1 X TaqGOLD buffer, 2.5 mM MgCl2, 0.2 mM 
dNTPs, 0.2 µM primers, 1.25 U Taq GOLD Polymerase (Roche) (initial denaturation: 10 min 
at 95°C, cycling conditions repeated 25 times: 1 min at 94°C, 1 min at annealing 
temperature, 1 min 30 sec at 72°C, final extension: 8 min at 72 °C then final hold at 4°C, 
Table.4).  
The amplification products were digested with NotI and SfiI and inserted into the expression 
vector. The resulting constructs were verified by DNA sequencing and used for the 
production of recombinant peptides that served as antigens.  
The His-tagged fusion proteins were expressed in E.Coli M15 [pREPA] (Qiagen) grown in LB 
medium at 30°C (PepA) or at 37°C (PepB). The expression and purification under denaturing 
conditions was performed according to the manufacturer’s recommendations (Qiagen).  
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 Table 4. Primer sequences and conditions used for amplification of fragments PepA and PepB 
 Product   AnnealingFragment 
name  Primer name   Primer sequence  length   Temp. °C 
SfiI‐ATS9 2 up  taggccttattggccattgaaggtcgtAGGAAATACATCACTGAGTTT Fragment  
PepA  NotI‐ATS9 1 low  atgcggccgctcaATCCACCACCGGTGCCTCACG  370 bp  68.5 
SfiI‐ATS9 1 up   taggccttattggccattgaaggtcgtTCATCAAGAACTTACGCTTTG Fragment 
 PepB  NotI‐ATS9 1 low  atgcggccgctcaATCCACCACCGGTGCCTCACG  297 bp  71 
Nucleotides  complementary  to ADAMTS9  sequences  are written  in  capital  letters.  The  restriction 
sites are indicated in purple. 
 
In brief, the expression of recombinant peptides was induced by addition of IPTG to a final 
concentration of 2 mM in a 500 ml bacterial culture. 
After 1.5 hours, the bacteria were centrifuged at 6000 rpm for 18 min at 4°C. To extract the 
total proteins, the pellet was gently resuspended in buffer A containing 6M guanidium 
hydrochloride, 0.1M NaH2PO4, pH 8 and rocked for 1 hour at room temperature before 
centrifugation at 20.000 rpm for 10 min. Now cleared from bacterial debris, the supernatant 
containing the total protein extract was collected, supplemented with 20 mM imidazole and 
applied to the Ni2+-NTA agarose resin (Qiagen). This adsorption step was done by gentle 
mixing for at least 16 hours at 4°C. After assembling, the column was extensively washed 
with buffer B (50mM Tris-HCl, 50mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8). 
Before the final elution, the non-specifically bound components were washed off with buffer 
C (50mM Tris-HCl, 50mM NaH2PO4, 300 mM NaCl, 50 mM imidazole, pH 8). The 
recombinant His-tagged peptide was finally eluted with 250 mM imidazole in buffer E (50mM 
Tris-HCl, 50mM NaH2PO4, 300 mM NaCl, pH 8). After extensive dialysis against PBS at 4°C, 
the fractions were analysed on a 4-25% gradient PhastGel stained with Coomassie blue. 
 
 
Figure 27. Localisation of antigenic peptides. 
Antigenic peptides  (PepA and PepB) are depicted under  the respective domains of chick ADAMTS9 
peptide, the His‐Tag is shown in pink. 
 
6.II.1.b Generation of polyclonal antibodies against recombinant chick ADAMTS9 
fragments 
 The polyclonal antisera were prepared at the Institute of Animal Science of the 
University Zürich Irchel. Rabbits were immunized with 100 - 200 µg of purified antigen 
emulsified in incomplete Freund adjuvant. After one boost and seven bleedings the rabbits 
 - 93 -
 were sacrificed. Antisera from initial and final bleeding (anti-chick ATS9pepA, anti-chick 
ATS9pepB) were collected, supplemented with 0.02% sodium azide and stored at -20°C. 
Aliquots in use were kept at 4°C. 
 
6.II.2 Cloning of mutant form of chick ADAMTS9  
 A functionally inactive form of ADAMTS9 was prepared by introducing the mutation 
E427A into the catalytic domain via PCR-amplification/mutagenesis and replacement of the 
respective XmaI fragment in the wild type clone. The strategy was divided into three main 
steps (Fig. 28).  
 
Figure 28. Generation of the mutated chick ADAMTS9 form: E427A 
On the upper panel, ADAMTS9 cDNA  is represented  in blue, the MCS from pGEM ®T‐Easy vector  in 
white. The different primers and the fragments generated by PCR amplifications are depicted under 
their respective positions. The lower panel shows the mutated E427A cDNA in pGEM ®T‐Easy with the 
replaced fragment in orange. Point mutation: purple star. 
 
Firstly, two sub-fragments (A and B) overlapping the catalytic domain were amplified each 
with a primer carrying the mutation of the catalytic domain and a primer up- or downstream of 
the corresponding XmaI restriction site. Secondly, these overlapping PCR-products A and B 
were used as templates for a second ligation PCR-amplification now exclusively employing 
the primers close to the XmaI sites. The resulting PCR product carried the mutation E427A in 
the middle and the two XmaI sites near its 5’- and 3‘- ends. This product was then first 
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 subcloned in pGEM ®T-Easy (Promega) and further propagated. Following excision by XmaI 
digestion, the mutated fragment was finally inserted into the F construct, from where the wild 
type XmaI fragment had been removed previously. Thus, the plasmid F_E427A containing 
the full length ADAMTS9 with an inactivating point mutation in the catalytic site was 
reconstituted. Intermediate and final products were sequenced to verify that no spurious 
point mutation was introduced during the PCR amplifications.  
 
Following steps and conditions were employed in the amplification experiments:  
PCR amplifications of fragments A and B: 5 ng of plasmid F template was added to 1 X 
TaqGOLD buffer, 2.5 mM MgCl2, 0.2 mM dNTPs, 0.2 µM primers, 1.25 U Taq GOLD 
Polymerase in a 50 µl reaction volume (initial denaturation: 10 min at 95°C, cycling 
conditions repeated 20 times: 1 min at 94°C, 1 min at 57°C, 1 min 30 sec at 72°C, final 
extension: 8 min at 72 °C then hold at 4°C). 
PCR amplification of fragment F_E427A: 2 µl of the PCR products A and B were added 
together to 1 X buffer, 2.5 mM MgCl2, 0.2 mM dNTPs, 0.2 µM primers, 1.25 U Taq GOLD 
Polymerase  in a 50 µl reaction volume (initial denaturation: 10 min at 95°C, cycling 
conditions repeated 18 times: 1 min at 94°C, 1 min at 54°C, 1 min 30 sec at 72°C, final 
extension: 8 min at 72 °C then hold at 4°C). 
Primers used to generate the mutated form E427A: 
forward_ ATS9 XmaI: CAGCGAGTACGAGATCGTGA 
reverse_ ATS9 mutated: TATTAAATACATGGCCAAGTGCATGTGCTATTGTGAAAGC 
forward_ ATS9 mutated: TAGCACATGCACTTGGCCATGTATTTAATATG 
reverse_ATS9 XmaI: ACATTGTTTATTGACGTCAT 
The mutated nucleotides are written in orange, the overlapping complementary sequences 
amplified in fragments A and B are indicated in bold font. 
 
6.II.3 Generation of eukaryotic expression vectors 
 Different expression vectors have been used to express ADAMTS9 and its mutant form 
E427A in mammalian cells in vitro and in chick embryos in vivo (Fig.29). 
A modified pSecTag A vector (Invitrogen) under the control of CMV promoter previously 
prepared in our lab, has been used for the expression in mammalian cell cultures. It contains 
a cassette encoding the FLAG tag in the fragment flanked by unique XbaI and PmeI 
restriction sites. The cDNA is inserted upstream of this sequence. Thus, the proteins 
expressed from this vector are fused at their C-terminus to a FLAG-tag. 
To prepare the expression constructs, the full length sequence of ADAMTS9 was amplified 
by long-distance PCR (LD-PCR) to introduce at the 5’-end a NheI and at the 3'-end a XbaI 
restriction site (forward_ATS9_NheI and reverse_ATS9_XbaI primer). The PCR product was 
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 cloned into pGEM ®T-Easy vector and sequence-verified. Mutation artefacts caused by the 
LD-PCR amplification were corrected by exchanging mutated by non-mutated fragments 
from the F construct. The resulting cDNA was excised and ligated into the NheI/XbaI cleaved 
pSecTag FLAG vector. For the expression of the mutant E427A, the MstII_MstII fragment of 
the wild type ADAMTS9 cDNA was replaced by the corresponding fragment from the 
F_E427A plasmid (Fig.28) prior to subcloning into the pSecTag FLAG vector.  
 
 
Figure 29. Vectors prepared for eukaryotic expression.  
Vectors used for the expression of chick ADAMTS9 and its mutant E427A‐variant in mammalian cells 
(A) or in chick embryos (B and C). The cDNA encoding the ADAMTS9 or the E427A mutant is depicted 
in navy blue,  the FLAG  tag  in pink. The EGFP modified pIRES was used as marker  construct  in  co‐
transfection experiments. 
 
Conditions and primers used for LD-PCR amplification were the following: 
5 ng of vector F template was added to 1 X LA buffer II, 2.5 mM MgCl2, 0.2 mM dNTPs, 0.2 
µM primers, 2.5 U Takara LA Taq Polymerase in a 50 µl reaction volume (initial denaturation: 
2 min at 94°C; first cycling conditions repeated 14 times: 30 sec at 94°C, 10 min at 68°C; 
second cycling conditions repeated 16 times: 30 sec at 94°C, 10 min with 20 sec increment 
at 68°C; final extension: 10 min at 68 °C then hold at 4°C). 
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 Forward_ ATS9_NheI: TAGCTAGCGCAGCACCATGCAG 
Reverse_ ATS9_ XbaI: TATCTAGATAACACCTGCACGTCAAGGC 
Blue letters indicate the restriction sites, red the start codon; the bases corresponding to the 
ADAMTS9 cDNA are written in bold font.  
 
For the in vivo expression in chick embryos, vectors with the chick β-actin promoter instead 
of the CMV promoter were used. The pMES vector carrying two IRES sequences expresses 
green fluorescent protein (GFP) in addition to the inserted cDNA of choice (modified pIRES 
and pMES plasmids kindly provided by E. Stoeckli). 
For our purpose, we digested ADAMTS9_pSec Tag FLAG with NheI and PmeI. The pMES 
vector was open with BamHI and blunt-ended with the Klenow fragment of the DNA 
Polymerase I followed by digestion with XbaI. The pIRES vector was open with SmaI 
generating blunt-ends and then cut with XbaI. The ADAMTS9-FLAG insert was ligated into 
pMES or pIRES vectors via the NheI/XbaI site compatibility at the 5'- end and the junction of 
the two blunt ends at the 3'- end. The same procedure was employed for cloning of the 
variant E427A in these expression vectors.  
 
6.II.4 Cloning of C-terminally truncated ADAMTS9-variants 
 Different variants truncated at the carboxy-end were generated in pSecTag FLAG. The 
same cloning strategy as for the full length was followed. For each variant specific primer 
pairs were designed to incorporate at the 5’- end a NheI site and at the 3’- end a XbaI site. 
The variants were amplified from the F template by LD-PCR. Spurious mutations 
incorporated during the amplification were corrected by fragment replacement using non-
mutated subclones as a source. 
 
Conditions and primers used for LD-PCR amplification were the following: 
8 ng of vector F template was added to 1 X LA buffer II, 2.5 mM MgCl2, 0.2 mM dNTPs, 0.2 
µM primers, 2.5 U Takara LA Taq Polymerase in a 50 µl reaction volume (initial denaturation: 
2 min at 94°C; first cycling conditions repeated 10 times: 30 sec at 94°C, 10 min at 68°C; 
second cycling conditions repeated 15 times: 30 sec at 94°C, 10 min with 20 sec increment 
at 68°C; final extension: 10 min at 68 °C then hold at 4°C). 
Forward_ ATS9_NheI: TAGCTAGCGCAGCACCATGCAGCTTG 
Reverse_ ATS9.1_ XbaI: TATCTAGATGAGCACGGTTCAGTGTTGCA  
Reverse_ ATS9.2_ XbaI: TATCTAGACCCGCACTGGGCTGTGCACTCA 
Reverse_ ATS9.3_ XbaI: TATCTAGAGGCTTCGGGACTGT 
Blue letters indicate the restriction sites, red shows the start codon; the nucleotides 
corresponding to ADAMTS9 cDNA are written in bold font.  
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 6.II.5 Recombinant expression of ADAMTS9 in mammalian cell cultures  
6.II.5.a Transient expression of ADAMTS9, E427A and the ADAMTS9 variants 
 293 FT and 293 F cells (Invitrogen) were used for transient expression of ADAMT9 
pSecTagFLAG, E427A pSecTagFLAG and the variants ADAMTS9.1, ADAMTS9.2, 
ADAMTS9.3. 
The 293F cells were grown in complete medium (D-MEM medium, 10% FCS, 1X Glutamax, 
100 U/ml penicillin, 100 µg/ml streptomycin; all products from Invitrogen) to reach 80% 
confluence before transfection. The 293FT cells were cultivated in this complete medium 
supplemented with 1X MEM Non Essential Amino Acids (Invitrogen), 500 µg/ml Geniticin 
(Invitrogen). The cultures were kept at 37°C in a humidified atmosphere with 5% CO2. 
The transfections were done with the PolyFect transfection reagent (Qiagen) in 6-well plates.  
Before transfecting 293F cells, the complete medium was changed for serum-free medium 
and transfection mix was added to the 293F cells (per plate: 2 µg vector, 15 µl Lipofectamine 
transfection reagent (Invitrogen), 2 ml D-MEM). The next day, the culture medium was 
replaced either by complete medium with 5% FCS or by serum free D-MEM with 1X 
Glutamax, 100 U/ml penicillin, 100 µg/ml streptomycin. Both media were supplemented with 
50 µg/ml heparin (Sigma). After 48, 72 or 96 hours the conditioned media was collected and 
the cells were extracted. 
For transfection of 293 FT cells a transfection mix consisting of 1 µg vector, 20 µl PolyFect 
and 2 ml D-MEM with 5% FCS was used per 6-well plate. The next day, the culture medium 
was changed for fresh complete medium with 5% FCS supplemented with 50 µg/ml heparin. 
 
6.II.5.b Stable lines expressing chick ADAMTS9 and E427A pSecTag FLAG 
 To produce stable cell lines, 293 F cells were cultivated and transfected in a 10 cm dish 
as described above. 24 hours post-transfection, the cells were subjected to Zeocin 
(Invitrogen) selection, 100 µg/ml selection antibiotic was added to the medium containing D-
MEM supplemented with 10 % FCS, 1X Glutamax, 100U/ml penicillin, 100 µg/ml 
streptomycin and seeded as single clone in 96 well-plates. The isolated clones have been 
maintained under selection for 2 months. 
 
6.II.5.c Suspension culture of stable lines 
 Apart from maintaining the newly generated stable 293F cell lines in adherent 
monolayers, they were also cultivated in suspension to facilitate the production and 
purification of the potentially secreted recombinant enzymes. For this purpose, 293 SFM-II 
and FreeStyle 293 Expression media from Invitrogen were tested. All media were 
supplemented with 1X Glutamax, 100U/ml penicillin and 100 µg/ml streptomycin with or 
without addition of 50 µg/ml heparin.  
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 6.II.6 Immunofluorescence staining on cells 
 For immunofluorescence stainings stably transfected cells were cultivated in 
ChamberSlides (BD-Falcon). When the adherent cultures reached 80% confluence, they 
were carefully rinsed in PBS and fixed for 30 min in 4% PFA at room temperature. After a 
short rinsing and three successive washes for 5 min in PBS, the cells were permeabilized in 
methanol for 20 min at -20°C. They were then rehydrated in PBS and non-specific binding 
sites were blocked for at least 30 min in blocking buffer (0.5% BSA, 0.2% gelatine, 0.02% 
NaN3 in PBS) at room temperature. Primary antibody incubations (pepA anti-serum 1/100 
diluted in blocking buffer) were performed for at least 16 hours at 4°C in a humidified 
chamber. After successive washings for 10 min in PBS, the highly cross-absorbed Alexa 
Fluor 488 goat anti rabbit IgG (H+L) secondary antibodies (Molecular Probes, Invitrogen) 
were applied on the slides and incubated for 1 hour at room temperature under light-
protection. The preparations were subsequently rinsed again in PBS and counterstained with 
Hoechst H33258 bis-benzimide (Invitrogen). Finally the slides were washed three times in 
PBS for 5 minutes and cover-slipped with fluorescence mounting medium (Dako). 
The transiently transfected cells were imbedded in paraffin using a cell block technique 
(Schmid et al., 2010). 5 µm thick sections were cut on a microtome and mounted on 
SuperFrost Plus glass slides (Menzel Gläser). Standard dewaxing by xylene followed by 
rehydration in a descending ethanol series were performed. Epitopes were recovered by 
steam-cooking for two minutes in citrate buffer (1.8 mM monohydrated citric acid, 12,2 mM 
tri-sodium citrate, pH 6) in an antigen retrieval device (FSG 120_T/T from Milestone). The 
subsequent immunofluorescence staining was done as mentioned above. 
Fluorescence images were collected as described in the part V section “Immunofluorescence 
pictures and in situ hybridisation images”. 
 
6.II.7 Fast purification of chick versican 
 Conditioned medium from chick fibroblast primary culture was centrifuged at 10000 
rpm for 10 min to remove cellular debris. The NaCl concentration in the conditioned medium 
was adjusted to 300 mM. 25 ml of this solution was applied by gravity flow on a column 
previously packed with 1.5 ml Sepharose Fast Flow  DEAE resin (GE Healthcare), which had 
been equlibrated in wash buffer (300 mM NaCl, 50 mM Tris-Hcl, pH 7.5). The first 5 ml of 
wash buffer running through the column was collected for control. The washing step was 
continued until the UV-absorbance reached baseline. The bound versican-enriched 
proteoglycan fraction was finally eluted with 15 ml of elution buffer (NaCl 3 M, Tris-HCl 50 
mM, pH 7.5). The collected fractions were extensively dialysed against ATS buffer (150 mM 
NaCl, 50 mM Tris-HCl, 3 mM CaCl2, pH 7.5) for 16 hours at 4°C. The samples were then 
digested with chondroitinase ABC lyase (MP Biomedicals) before analysis by Phastgel 
electrophoresis and immunoblotting. 
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 6.II.8 Preparation and processing of cell extracts and conditioned medium of 
ADAMTS-expressing cell cultures 
 Conditioned media were collected and cleared from cellular debris by centrifugation at 
15000 rpm for 30 min at 4 °C. The proteins were then concentrated with Amicon Ultra-15 
Centrifugal Filter Units 10,000 NMWL (Millipore) according to manufacturer’s 
recommendations. The samples destined for activity assays were dialysed against ATS 
buffer and processed without delay. 
After trypsinization and washing with PBS, cells were lysed and extracted for 10 min on ice 
with extraction buffer (10 mM Tris, 1 mM EDTA, 2% SDS, pH 8). The lysates were 
centrifuged at 14 000 rpm for 30’ at 4°C. The supernatant was transferred to a fresh tube.  
 
6.II.9 Assay to test the potential versican-cleavage activity of recombinant ADAMTS9 
 To test the activity of the recombinant enzyme and its variants, 20 µl of purified chick 
versican dialysed against ATS buffer (150 mM NaCl, 50 mM Tris-HCl, 3 mM CaCl2, pH 7.5) 
was combined with concentrated conditioned media (total protein content 20-40 µg) from 
stable or transiently transfected cells in digestion buffer (1X ATS buffer, 1 µM leupeptin, 1 µM 
pepstatin, 1 mM pefablock, pH 7.5) supplemented with 10 or 250 µM ZnCl2 in a final volume 
of 30 µl. These samples were incubated at 37 °C for 16-20 hours. The glycosaminoglycan 
chains were removed by chondroitinase ABC lyase digestion (MP Biomedicals) either 
simultaneously or subsequently to the ADAMTS treatment. The processed samples were run 
on a Phastgel system and analysed by immunoblotting. 
 
6.II.10 Electrophoresis and Immunoblotting 
 Protein samples from cell extracts or conditioned media were denatured in loading 
buffer (100 mM Tris-HCl, 10 mM EDTA, 20 % SDS, 3 % β-mercaptoethanol, 0.1 % 
bromophenol blue) for 5 min at 95°C. Following electrophoresis on PHAST polyacrylamide 
gels (Pharmacia), proteins were detected with immunoblotting. For this purpose, the proteins 
were transferred onto Immobilon P membranes (Millipore) by diffusion blotting at 70 °C for 30 
min. The membranes were then blocked in blocking buffer (3 % milk in PBS) for 1 hour and 
incubated with primary antibody solutions in blocking buffer for at least 12 hours at room 
temperature. After three washes in PBST buffer, the alkaline-phosphatase conjugated 
secondary antibodies were incubated for 1 hour. After three successive washes in PBST, the 
blots were subjected to chromogenic detection with WesternBlue substrate (Promega). 
Following antibodies and dilutions were used in these immunoblotting experiments: anti-chick 
versican GAG α, anti-chick versican GAG β, anti-chick ATS9pepA, anti-chick ATS9pepB (all 
rabbit polyclonal antibodies produced in our lab; diluted 1:1000), anti-FLAG M2 monoclonal 
antibody (purified IgG; 1:1000; Sigma) and alkaline phosphatase conjugated goat anti-mouse 
and goat anti-rabbit IgG (both 1:15000 diluted; Jackson ImmunoResearch Europe). 
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 6.II.11 In vivo injections into the hind limb and into the central canal of the spinal cord 
6.II.11.a Embryos preparation  
 Fertilised eggs (Hisex, Hendrix Genetics) were obtained from a local hatchery. After 3 
days of incubation at 38.5 °C a small hole was made at either end of the eggs and 5 ml of 
egg white was withdrawn with a syringe. The holes were then sealed with paraffin. After that, 
a window of about 1.5 x 1.5 cm was cut into the side of the eggshell. Subsequently, the 
window was closed with tape allowing monitoring of the development and repeated opening 
and closing of the egg for in ovo manipulations.  
 
6.II.11.b Injection of plasmids and electroporation in ovo 
 All embryos were staged according to Hamburger and Hamilton (Hamburger and 
Hamilton, 1951). The injection procedures followed the protocol previously described by 
Stoeckli et al. (Stoeckli and Landmesser, 1995). Briefly, the shell windows were opened and 
the extra-embryonic membrane was cut and removed from the hind limb region of the 
embryo. The injections were done with pointed glass capillaries with a tip diameter of about 5 
μm. Test samples (1 to 5 μg plasmid in 10 μl injection mix) were mix supplement with 0.04% 
(vol/vol) Trypan Blue (Invitrogen) to control volume and localisation of the injection. In a small 
extra test series 0.5 or 4 μl lipofectamine transfection reagent was additionally included in the 
injection mix. 
Injections at stage 18 to 23 were targeted to the right hind limb mesenchyme near the upper 
part of the plexus region (injection volume at least 1 μl). Alternatively, less than 1 μl were 
injected directly into the central canal of the spinal cord at stage HH14/15. Platinum 
electrodes (BTX, Genetronics) of 4 μm length were positioned next to the injection spot. The 
number of pulses and the applied voltage was adapted to the age of the embryos. Usually 10 
pulses of 50 ms duration with 1 second interpulse interval were delivered at 25 V for the hind 
limb experiments in HH20 embryos, only 5 to 7 pulses at 22 V were applied to the embryos 
injected into the central canal. Before and after electroporation a few drops of cold, sterile 
PBS were added to cool the embryos. The eggs were again closed after every injection and 
incubated at 38.5 °C until the embryo reached the desired stage for analysis. Embryos 
injected with the marker plasmids encoding EGFP or YFP (under control of the β-actin 
promoter) alone were used as controls. 
 
6.II.12 Whole mount staining of chick embryos 
 Chick embryos were sacrificed and dissected under the dissecting microscope at stage 
22 to 26. They were placed into a silica agar plate containing PBS, the membranes around 
the embryos were removed. After decapitation, the embryos laying on their back were pinned 
down at the neck, tail and fore limbs. The hind limbs were kept intact for further analysis. The 
embryos were opened from the ventral side, cleaned of all the internal organs and blood, 
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 fixed in 4% PFA at 4°C overnight and then subjected to whole mount immunofluorescence 
staining. After fixation in 4% PFA at 4°C overnight, the embryos were washed in PBS, 
subsequently transferred to a 24 well plate and permeabilized with 1% Triton in PBS for 2 h 
at room temperature. This and all following incubations were done under gentle and constant 
shaking. The embryos were then rinsed with PBS and incubated in 20 mM lysine in 0.1 M 
sodium phosphate, pH 7.4 for 1 h. After washing the embryos 5 times for 10 min each in 
PBS, blocking step was performed with 10% FCS in PBS for 2 h at room temperature. The 
incubation with primary antibodies diluted in blocking buffer (mAb RMO-270 against 
neurofilaments, 1:1500; Invitrogen and FITC-conjugated goat anti-GFP, 1:500; Rockland 
Immunochemicals) was done at 4°C for at least 48 h. After washing with 5 changes of PBS 
and an additional incubation in PBS for 12 h, embryos were incubated again with blocking 
buffer for 2 h prior to the addition of secondary Cy-3 conjugated AffiniPure goat anti-mouse 
IgG antibody (diluted 1:500 in blocking buffer, Jackson ImmunoResearch Europe) overnight 
at 4°C. This incubation was followed by 5 times extensive PBS-washing steps, two of which 
proceeding for more than 2 h, and a sixth incubation in PBS overnight. Finally the embryos 
were dehydrated with successive incubations in 25%, 50%, 75% and 100% ethanol for at 
least 30 min and then transferred to glass vials containing BBBA (benzyl benzoate and 
benzyl alcohol 2:1). Embryos were analysed under the fluorescence microscope while still in 
BBBA solution.  
 
 
6.III. Results 
6.III.1 Generation of polyclonal antibodies against chick ADAMTS9 
 For the immunological detection of the chick ADAMTS9 protein, we first had to 
generate monospecific antibodies. To direct the antibody-binding to a unique sequence near 
the catalytic domain, we prepared peptide fragments in a bacterial expression system. This 
way, we ascertained that the antibodies would specifically recognise the enzymatically active 
form of ADAMTS9 even after propetide- and putative C-terminal cleavage, but would not 
cross-react with other ADAMTS family members. Furthermore, by selecting epitopes in close 
proximity to the highly conserved catalytic site, we increased the chances that the antibodies 
would eventually exert some ADAMTS9-specific function blocking activity. Two rabbit 
antisera against a longer (PepA) and a shorter recombinant antigen (PepB) were generated 
and initially tested on immunoblots containing the bacterial fusion peptides (Fig.30). Both 
antisera reacted strongly with their respective HIS-tagged fusion peptides, while the pre-
immune sera displayed only weak interactions with a few bacterial proteins unrelated to the 
fusion peptides pepA or pepB. Slower migrating components exclusively detected in extracts 
of bacteria expressing the fusion proteins most likely represented multimeric forms. To verify 
the reactivity and specificity of our antisera against the complete zymogen and the mature 
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 enzymatic forms of ADAMTS9, we analysed extracts of 293FT cells transiently transfected 
with a full length cDNA construct (see below). 
 
  
Figure  30.  Characterisation  of  antisera  against  bacterially  expressed  chick  ADAMTS9  fusion 
peptides. 
The  anti‐pepA  and  anti‐pepB  rabbit  antisera were  tested  against  their  purified  peptides  and  the 
crude  extracts  of  bacteria  carrying  the  pDS9_A  or  pDS9_B  expression  vectors.  Pre‐immune  sera 
showed some reactivity against bacterial proteins but not against the fusion proteins. The anti‐pepA 
antiserum detected the purified pepA of 13.2 kDa (arrow) and the anti‐pepB antiserum the purified 
pepB of 10.8 kDa (arrowhead).  The proteins were separated under reducing conditions. 
 
 
6.III.2 Recombinant expression of chick ADAMTS9 and its mutant E427A_ATS9 
6.III.2.a  Analysis of ADAMTS9 and E427A_ATS9 protein production in transiently and 
in stably expressing mammalian cells 
 The full length ADAMTS9 and the mutant form E427A_ATS9 were cloned into the 
pSecTagFLAG plasmid for expression in mammalian cells. First, HEK293 FT cells were 
transiently transfected with these constructs and analysed by immunoblotting using either our 
ADAMTS9 specific polyclonal antibodies or a monoclonal antibody against the C-terminal 
Flag-tag (Fig.31). In crude cell extracts, the anti-Flag and the anti-chick ATS9pepA 
antibodies reacted exclusively with the recombinant zymogen (calculated molecular mass: 
204 kDa; activated enzyme after propetide cleavage: 173 kDa), whereas the anti-chick 
ATS9pepB antiserum recognised an additional band migrating on SDS-PAGE faster than the 
full-length pro-enzyme. This unspecific reactivity was also observable in the untransfected 
sample. Consequently, only the mono-specific anti-chick ATS9pepA antiserum was used for 
further experiments.  
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Figure 31. Characterisation of antisera against eukaryotically expressed chick ADAMTS9. 
The  anti‐pepA  and  anti‐pepB  antisera  were  tested  against  the  cell  extracts  from  transiently 
transfected 293FT cells. The monoclonal antibody anti‐FLAG detecting the FLAG tag at the C‐terminal 
end of the recombinant enzymes was used to verify the expression of the transfected plasmids. Both 
antisera  recognised  the  recombinant  enzymes  (arrowhead),  but  the  serum  anti‐pepB  showed  an 
additional unspecific reactivity. SDS‐PAGE was run under reducing conditions. 
 
Stable expression lines were then established in 293F cells. The choice of 293F cell line was 
based on a previous work with human recombinant ADAMTS9 (Koo et al., 2007). After two 
months of selection, total cell extracts were prepared and analysed by immunoblotting with 
the rabbit antiserum anti-chick ATS9pepA (Fig.32).  
 
   
Figure 32. Analysis of ADAMTS9 and mutant E427A_ATS9 expressions in cell extracts of transiently 
transfected or stable cell lines by immunoblotting with the anti‐pepA antiserum. 
293F  cells were  transiently or  stably  transfected with  the  expression  vectors  encoding ADAMTS9, 
E427A_ATS9 or the control vector alone. The 204 kDa proenzyme was recognised in extracts of both 
ADAMTS9  and  E427A_ATS9  expression  systems  (arrowhead).  SDS‐PAGE  was  run  under  reducing 
conditions. 
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 The analyses revealed that both, wildtype and mutant cell lines, stably expressed the 
zymogen form of ADAMTS9. Unlike in cell extracts of transiently transfected cells, other 
smaller fragments were detectable in the stably expressing mutant line with our antiserum. 
These smaller peptides may reflect either breakdown products or result from random 
linearisation and cDNA fragmentation followed multicopy genomic incorporation of the 
expression construct in these cells. 
We also examined the expression in the different cell lines by immunofluorescence stainings 
of cell preparations (Fig.33). The recombinant chick ADAMTS9 and the mutant form 
E427A_ATS9 were primarily detected as strong punctate stainings in the perinuclear area 
and with decreasing intensity towards the cellular membrane expected for synthesis and 
transport via endoplasmatic reticulum and secretory pathway. 
 
  
Figure 33. Analysis of ADAMTS9 and mutant E427A_ATS9 expressions  in transient and stable cell 
lines by immunofluorescence staining of permeabilised cells. 
The  enzyme was  detected  intracellularly  in  stable  and  transiently  transfected  293F  cells with  the 
antiserum anti‐pepA combined with the Alexa 488‐conjugated secondary antibody (green). Nucleus 
were stained in blue with the Hoechst nuclear counterstain. 
 
This pattern was observed in all 293F cell lines stably expressing ADAMTS9 or 
E427A_ATS9 confirming the proper incorporation of the expression vector and the 
homogeneity of the selected clone. In contrast, only a minor proportion of the transiently 
transfected 293FT cells showed a clear staining. These few cells seemed to express 
however, substantial amounts of recombinant protein as judged by the strong 
immunofluorescence signal. 
 
 - 105 -
 6.III.2.b Analysis of the expression of ADAMTS9 and E427A_ATS9 in conditioned 
ext, we attempted to detect the expression of the enzyme and its mutant form in 
ia of the suspension cultures were collected, fifty times 
media 
 N
conditioned media of adherent cell cultures, which required FCS in the medium (at least 5% 
for 293FT cultures). Under these conditions, the level of secreted protein turned out too low 
to be detectable with the monoclonal anti-FLAG M2 antibody. Besides, the identification with 
our antiserum was difficult. Furthermore, a concentration of the medium was hampered by 
the presence of serum proteins. Consequently, we had to adapt the cells to different serum-
free suspension culture media.  
The different conditioned med
concentrated and together with the corresponding cell extracts subjected to analysis by 
immunoblotting. Under all culture conditions tested, the 200 kDa-band of the zymogen was 
again detectable in the cell extracts of stably expressing ADAMTS9 and E427A_ATS9 cell 
lines (Fig.34A). In addition, a band of around 150 kDa was present in the extracts. Both, wild-
type and mutant cell lines also secreted several immunoreactive ADAMTS9 fragments 
independent of the medium (serum-free DMEM, SFMII or FreeStyle media) utilised for the 
suspension culture. The proportion and fragment pattern of the secreted fraction differed 
according to the culture condition, however. For instance, cultures maintained in FreeStyle 
medium retained most of the recombinant ADAMTS9 within the cells, while cells grown in 
SFMII medium appeared more adapted for the secretion of the enzyme. We therefore 
continued to focus onto the SFMII-cultures. Although a 170 kDa- fragment (expected size for 
the enzyme form after removal of N-terminal propeptide) was not detectable in the 
conditioned SFMII medium of the wild type ADAMTS9 cell line, strongly immunoreactive 
bands were always perceptible around 100, 50 and 37 kDa and to a smaller extent also 
around 150 and 75 kDa (Fig.34B). In the medium of the mutant line, the 100 kDa-band was 
particularly prominent.   
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Figure 34. Analysis of the expression of ADAMTS9 and E427A_ATS9  in different culture media by 
immunoblotting with the antiserum anti‐pepA. 
293F cells were stably transfected with the expression vectors encoding ADAMTS9 or E427A_ATS9. 
A) Cell extracts. The ADAMTS9 proenzyme and its E427A_ATS9 mutant form with a size of about 200 
kDa are stronger expressed when cells are cultivated in FreeStyle medium (arrowhead). 
B) Conditioned media. Several fragments of about 150, 100, 75, 50 and 40 kDa size were detected in 
the different conditioned media from ADAMTS9 stable  lines and more  intensively  in SFMII medium 
(arrowheads).  In conditioned media of  the mutant  form, only  the bands of 150 and 100 kDa were 
consistently detected. 
 
Since we repeatedly detected these fragments in the conditioned media, we assumed that 
they originate from a physiological process. Consequently, we tried to match the fragment 
sizes with our deduced peptide sequence in order to locate the potential cleavage region and 
to possibly identify protease recognition sites (Annexe 1). As all fragments contained the 
epitopes near the catalytic site, we concluded that they most likely represent C-terminally 
truncated forms of ADAMTS9, which might maintain the proteolytic activity. In relation to the 
deduced peptide sequence, the 150 kDa-band detected in media would, for instance, 
correspond to a fragment, from which the N-terminal pro-peptide has been removed and an 
additional cleavage has occurred between the last thrombospondin-like repeat and the GON-
1 homology domain. Similarly, the prominent product around 100 kDa could be generated by 
furin processing at positions 277 (pro-peptide cleavage) and 1168 (between 6th and 7th 
thrombospondin-like repeat). A third putative furin cleavage site, which has been identified 
near the N-terminus of the pro-peptide, is most likely not present anymore in this fragment. 
 
6.III.3 Enzymatic activity assays: chick ADAMTS9 / versican substrate 
 We subsequently tested the versicanase activity of chick recombinant ADAMTS9 on 
versican purified from the supernatant of chick embryonic fibroblast cultures. These versican 
preparations, containing mainly the largest V0 isoform, were incubated in ATS buffer with 
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 concentrated and dialysed conditioned SFMII-media from ADAMTS9 or E427A_ATS9 293F 
cells cultures. Similarly processed media from 293FT cells stably expressing a recombinant 
fragment of mouse ADAMTS4 with known versican cleavage activity (Matasci et al. 
unpublished data) was used as positive control and its mutant E358A_ATS4.3 form as 
supplementary negative control. Subsequent or in parallel to the ADAMTS treatment, the 
samples were subjected to enzymatic removal of the glycosaminoglycan chains and putative 
core protein processing by the ADAMTSs was assessed by immunoblotting (Fig.35). As 
expected, samples incubated with the recombinant mouse ADAMTS4.3 fragment, showed a 
major proteolytic fragment well above the 250 kDa marker and some remaining traces of the 
intact V0 and V1 versican core proteins. Neither the samples treated with medium 
preparations from E358A_ATS4.3 cells nor from E427A_ATS9 cells gave rise to additional 
bands. Unexpectedly, however, also the medium from ADAMTS9 293F cells did not exhibit 
any versicanase activity. Only the intact chick versican substrate was detected by the rabbit 
antiserum against the GAGβ domain in samples treated with the medium fraction.  
 
  
Figure  35.  Analysis  of  proteolytic  activity  of  recombinant  ADAMTS9  and  E427A_ATS9  mutant 
towards purified chick V0/V1 versican. 
Medium‐treated chick V0/V1 versican (VC) samples were recognised with a rabbit antiserum against 
the GAG‐β domain of chick versican. Samples were chondroitinase‐digested before running  in SDS‐
PAGE  under  reducing  conditions.  Cleaved  versican  was  detected  in  ADAMTS4.3‐treated  sample 
(arrow), while the mutant form of ADAMT4.3  (E358A_ATS4.3) did not cleave versican.  In this assay 
neither  ADAMTS9  in  the  cell  extracts  nor  in  the  conditioned  media  showed  versicanase  activity 
(arrowhead).  
 
6.III.4 Expression of truncated variants ADAMTS9.1, ADAMTS9.2, ADAMTS9.3 
 As no versicanase activity could be demonstrated using our full length ADAMTS-9 
construct and as different sub-fragments were regularly present in conditioned media, we 
focused on the recombinant expression of truncated ADAMTS9 mimetics. In fact, similar 
approaches performed with C-terminally truncation of human ADAMTS1 and -4 showed 
previously clear aggrecanase and/or versicanase activities of some of these fragments (Gao 
et al., 2004; Kuno et al., 2000, Matasci et al unpublished data). According to our analysis 
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 described in section 6.III.2.b the location of the chick ADAMTS9 fragments observed in the 
conditioned media were estimated (Fig.36).  
  
Figure 36. Schematic representation of ADAMTS9 fragments potentially secreted into the medium. 
Different  variants  ADAMTS9.1  to  ADAMTS9.4  are  depicted  below  the  deduced  full‐length  chick 
ADAMTS9  (zymogen: 204  kDa,  active  form  after  removal of  the propeptide:  173  kDa). Respective 
fragment sizes before and after propeptide processing are indicated. Putative furin cleavage sites are 
marked with an orange asterisk. The numbers on  the  top  represent  the amino‐acid positions. The 
carboxy‐ terminal amino‐acids and the total number of residues are mentioned under each variant. 
The sequence of  the active site and  the met‐turn  (VMA) are noted on  top of  the catalytic domain. 
Further details about ADAMTS9 domain features are described in annexe 1. 
 
For the expression experiments, we concentrated our efforts on the variants ADAMTS9.1 to 
ADAMTS9.3. One of the truncated forms (ADAMTS9.1) corresponded structurally to the 
ADAMTS4 fragment ADAMTS4.3, which displayed versicanase activity in previous 
experiments of our lab (Matasci et al., unpublished data) and was therefore regularly used as 
positive control of the assay. In human ADAMTS1, the aggrecanase activity was shown to be 
dependent on the presence of the spacer domain (Kuno et al., 2000). Due to this observation 
and due to the existence of a corresponding secretion fragment, we generated the 
intermediate ADAMTS9.2 truncation-mimetic carrying the spacer domain and the adjacent 
TSP-1 motif number 2. Finally, the ADAMTS9.3 variant ending at the potential furin cleavage 
site between the TSP-1 repeats six and seven was included in the test series. 
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 These three variants were cloned into pSecTagFLAG vector and transiently expressed in 
293F cells. The zymogen forms of the three variants were clearly detected with the rabbit 
anti-pepA antiserum on immunoblots of cell extracts (Fig.37). The predicted sizes of 71 kDa 
(ADAMTS9.1), 106 kDa (ADAMTS9.2) and 131 kDa (ADAMTS9.3) matched well with the 
corresponding migration properties in SDS-polyacrylamide gels (arrowheads in Fig.37A). 
Similarly, the pro-peptide lacking forms of ADAMTS9.1, ADAMTS9.2 and ADAMTS9.3 with 
expected molecular masses of 40kDa, 75 kDa, 100 kDa, respectively were recognised on 
blots of conditioned medium preparations (arrowheads in Fig37.B). In all cell extracts and 
media samples, intermediary fragments were consistently detected with the anti-serum anti-
pepA in addition to the predicted recombinant products. For ADAMTS9.1, the band in the cell 
extract migrating around 40 kDa was strongly reactive against the anti-pepA serum (arrow in 
Fig.37A). This band was always seen with different intensities in cell extracts and conditioned 
media of all three mimetic cultures. Furthermore, a 70 kDa-component was present in 
extracts of ADAMTS9.2 and ADAMTS9.3 cells, and an additional 100 kDa peptide was 
detected in the ADAMTS9.3 preparation. These bands correspond in size to processed 
forms of the distinct recombinant variants. In conditioned media of the ADAMTS9.2 and 
ADAMTS9.3 cultures, the additional 70 kDa-component was consistently present suggesting 
that the enzyme has been subjected to intra- or pericellular C-terminal cleavage. Some 
differently processed minor products of chick recombinant ADAMTS9 are apparently also 
released into the medium. For instance, we often observed that bands weakly 
immunostained with the anti-serum anti-pepA were migrating above the predicted mature 
enzyme forms in the medium preparations providing evidence that a small proportion of the 
variants carry still their propeptides. Whether this release of the nascent forms results from a 
physiological process or is caused accidentally by limited cell lysis during culturing remains 
open. 
Regarding the immunoblots with the anti-FLAG antibody, only the full length proteins in cell 
extracts of the three variant cultures (Fig.37A) and the secreted forms of ADAMTS9.1 and 
ADAMTS9.3 in conditioned medium preparations (Fig.37B) were detectable. The secreted 
form of ADAMTS9.1 became always visible, while the other forms were not reproducibly 
observed. In conclusion, the weak sensitivity of the monoclonal anti-FLAG antibody did not 
allow us to identify the precise nature of the intermediary fragments present in cell extracts 
and media. 
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Figure 37. Analysis of the expression of the truncated chick ADAMTS9 variants in cell extracts and 
conditioned media by immunoblotting. 
The  three  variants  cloned  into  pSecTagFLAG  vector were  transiently  expressed  in  293F  cells  and 
detected  with  the  rabbit  anti‐pepA  antiserum  or  the  monoclonal  anti‐FLAG  M2  antibody.  The 
zymogen  forms were  all detected  in  cell extracts  (arrowheads  in A), while  the  conditioned media 
contained  faster migrating  fragments most  likely  lacking  the N‐terminal propeptide  (arrowheads  in 
B).    In cell extracts and  in media, additional  intermediary fragments were recognised with the anti‐
serum  anti‐pepA.  The  different  variants  were  weakly  detected  by  the  monoclonal  anti‐FLAG 
antibody. Calculated sizes of ADAMTS9.1: zymogen 71.6 kDa, secreted  form 40.1 kDa; ADAMTS9.2: 
zymogen 106.4 kDa, secreted form 74.9 kDa; ADAMTS9.3: zymogen 131.5 kDa, secreted form 100.1 
kDa. 
 
 
6.III.5 Enzymatic activity assays: chick ADAMTS9 variants / versican substrate 
 In order to test the versicanase activity of the three mimetics, the same protocol as 
described in the subpart 6.II.9 was used. Briefly, conditioned and concentrated media of 
293F cells transiently transfected with the pSecTagFLAG vectors coding for the variants 
ADAMTS9.1, ADAMTS9.2 or ADAMT9.3 were incubated in presence of purified versican and 
then choindroitinase treated before analysis on SDS gels. As controls, the media from stable 
293FT lines expressing the ADAMTS4.3, the mutant form E358A_ATS4.3 and the medium 
from the transient transfected 293F with the ADAMTS4.3_pSecTagFLAG vector were 
processed under identical conditions. In all samples treated with the shorter variants of chick 
ADAMTS9, the intact versican was present (arrowhead Fig.38). Versican was undetectable 
in both media containing the ADAMTS4.3 peptide, while in the negative control using the 
mutant E358A_ATS4.3 form, the intact versican core glycoprotein was detected by the rabbit 
antiserum against the chick GAGβ domain of versican. Hence, we found no evidence for a 
versicanase activity of recombinant full-length ADAMTS9 and its smaller mimetics under 
these experimental conditions. 
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Figure 38. Analysis of the proteolytic activity of recombinant variants ADAMTS9.1, ADAMTS9.2 and 
ADAMTS9.3 towards purified chick V0/V1 versican. 
Medium‐treated chick V0/V1 versican (VC) samples were recognised with a rabbit antiserum against 
the GAG‐β domain of chick versican. Samples were chondroitinase‐digested before running on SDS‐
PAGE under  reducing  conditions.  In ADAMTS4.3‐treated  samples  from  transiently  (T) or  stably  (S) 
transfected  cells, no  intact  versican  core proteins were detected  (empty  lanes), while  the mutant 
form  of  ADAMT4.3  (E358A_ATS4.3)  did  not  cleave  versican.  In  this  assay  ADAMTS9  variants 
expressed in the conditioned media did not show any versicanase activity (arrowhead).  
 
 
6.III.6 In vivo studies of the effect of ADAMTS9 over-expression on axonal guidance 
in chick embryos. Preliminary data with ADAMTS9 DNA injection and electroporation 
 
6.III.6.a ADAMTS9 injection and electroporation into the hind limb bud 
 In parallel to the functional studies in vitro, we investigated the function of ADAMTS9 in 
vivo in chick embryos. We hypothesised that a preterm ADAMTS9 expression in the hind 
limb during development would result in an early processing of versican and consequently in 
a premature extension of axons. For this purpose, pIRES and pMES expression vectors 
containing the full-length chick ADAMTS9 and/or a fluorescent marker protein (eGFP, YFP) 
were injected into the right hind limb bud next to the sciatic plexus and electroporated into 
the cells of the region. Different stages of development at the time of injection and diverse 
parameters utilised for limb bud electroporation were tested (Table.5). The non-injected limb 
bud served as control. To assess the efficiency of the electroporation and to visualize 
possible effects on axonal growth, the embryos were processed by whole mount staining of 
GFP-expressing cells and neurofilaments.  
The survival rate was variable depending on the egg batches. We observed that the injection 
of the plasmids was easier at stage HH20/22, as embryos older than HH22 reacted by briskly 
moving, when the pipette was introduced into the hind limb. In all development stages tested, 
the diffusion of the injected mix within the whole hind limb was very fast and wide-spread.  
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 Table 5. Conditions tested for injection and electroporation of plasmids into cells of the hind limb  
Injection conditions  Observations  
vectors ‐ development stage ‐ electroporation parameters  development stage ‐ survival ratio ‐ green cells 
control eGFP_pIRES or ADAMTS9_pMES  HH19  25 V ‐ 10 pulses  HH25/26 ‐ 18.5% ‐ few cells with control vector 
control eGFP_pIRES + Lipofectamine  HH18  25 V ‐ 5 pulses  HH25/26 ‐ 45% ‐ few cells  
control YFP_pIRES  HH21/22  25 V ‐ 5/7 pulses  HH25/26 ‐ 75% ‐ few cells  
control YFP_pIRES or 
ADAMTS9_pIRES and E427A_pIRES   + 
eGFP_pIRES 
HH19/20  25 V ‐ 5/7 pulses  HH25/26 ‐ 80% ‐ few cells with eGFP_pIRES 
control eGFP_pIRES or ADAMTS9_pMES  
or ADAMTS9_pIRES + eGFP_pIRES  HH19/20  25 V ‐ 5/7 pulses  HH25/26 ‐ 64% ‐ few cells with each construct 
ADAMTS9_pMES or E427A_pMES  HH21/22  25 V ‐ 5/7 pulses  HH25/26 ‐ 30% ‐ few cells with each construct 
ADAMTS9_pMES or E427A_pMES  HH22/23  26 V ‐ 5/10 pulses  HH26 ‐ 27% ‐ few cells with each construct 
 
Among the embryos injected and electroporated with the ADAMTS9_pMES construct only 
3% survived and displayed green epifluorescence (Fig.39). Despite the co-expression of 
ADAMTS9 in these fluorescent cells, no obvious difference in axonal growth was noticeable 
in the injected versus the control leg anlage. In general, it appeared that only a few cells had 
incorporated the plasmid and that the GFP expression was limited to the surface of the limb 
bud. Unfortunately, even though the functionality of the tested plasmids could be confirmed 
by detecting the GFP expression, the classical electroporation technique was under the 
various conditioned tested in this series too inefficient for an over-expression of our 
constructs in the developing hind limb.  
 
  
Figure 39. Injection and electroporation of ADAMTS9_pMES into the chick limb bud. 
The ADAMTS9_pMES  construct was  injected  and  electroporated  into  the  right  hind  limb  of  chick 
embryo  (HH19).  Epifluorescence  of GFP was  detected  at  the  surface  of  the  hind  limb  above  the 
plexus  region  (panel A)  in  the HH21  chick embryo.  In panel B,  the expression of ADAMTS9_pMES 
detected  by  whole  mount  staining  for  the  GFP  revealed  a  weak  expression  in  the  hind  limb 
(arrowhead). The whole mount  immunostaining of neurofilaments  showed no difference between 
the  injected, electroporated hindlimb and the non‐treated  limb bud (panel C). The hind  limb of the 
embryo in panel A is outline by a dotted line. Scale bar 200 µm. 
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 6.III.6.b ADAMTS9 injection and electroporation into the central canal of the spinal 
cord 
Since the standard electroporation method was inappropriate for over-expressing our 
constructs in the mesenchymal cells of the limb, the injection and electroporation of the 
expression vectors into the central canal of the spinal cord was used as alternative approach. 
This way, we investigated the effect of ADAMTS9 over-expression by the neurons 
themselves. We hypothesised that the forced ADAMTS9 expression in neurons would help to 
directly clear versican from the presumptive nerve pathways and thus, would permit their 
axons to extend earlier than normal into the limb bud. Among the injected embryos 67% 
survived. Despite the moderate GFP-expression observable by epifluorescence along the 
spinal cord (Fig.40A), GFP was not detectable in the neural cell bodies by the less sensitive 
immunofluorescence staining of cryosections or whole-mounts (data not shown). Of note, 
these embryos did not show any particular changes of axonal growth during limb innervation 
(Fig.40B-E). For these analyses treated and untreated sides of the electroporated embryos 
were compared. 
 
  
Figure 40. Injection and electroporation of ADAMTS9_pMES into the spinal cord. 
The ADAMTS9_pMES construct was  injected and electroporated  into the central canal of the spinal 
cord at stage HH15. The epifluorescence of GFP expressed in the spinal cord was observed at HH22 
(panel A). Whole mount  staining of  the neurofilaments was processed  in  embryos  at  stage HH22 
(panel B), HH23 (panel C), HH26 (panels D and E). In panel C, a control embryo at HH23 is shown. The 
chick embryo is outlined by a dotted‐line in panel A. Scale bar 200 µm. 
 
From these different in ovo experiments, it appears that the classical injection/electroporation 
method is not yet optimally adapted to over-express our constructs in the hind limb. Further 
experiments with a more efficient gene transfer system such as sonoporation should also be 
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 considered to finally achieve an effective ectopic expression of recombinant DNA in 
mesenchymal tissues in vivo (Ohta et al., 2008).  
 
 
6.IV. Discussion  
 During development of the peripheral nervous system, active remodelling of the 
extracellular matrix occurs to allow the extension of growing axons through previously non-
permissive regions (reviewed in (Barros et al., 2010)). In the previous chapter, the exact 
correlation between ADAMTS9 expression and the distribution of versican proteoglycan has 
been clearly demonstrated in hind limb throughout development of chicken embryos. 
Besides, different members of the ADAMTS metalloprotease family including ADAMTS9 
were described to display hyalectanase properties in recent in vitro studies (reviewed in 
(Apte, 2009)). In this context, we hypothesised that ADAMTS9 plays a major role in the 
turnover of versican when expressed in barrier-tissues to growing axons. Thus, in this study, 
we focused our efforts on ADAMTS9 protease function in a regulated and active catabolism 
of versican.  
First, expression vectors for the chick recombinant ADAMTS9 and the respective 
E427A_ATS9 mutant form were cloned and stable lines expressing these constructs were 
established. In order to detect the recombinant chick ADAMTS9, specific rabbit anti-sera 
(anti-pepA and anti-pepB antisera) directed against an epitope close to the catalytic domain 
of ADAMTS9 were developed. After testing the two antisera on purified peptides and on cell 
extracts of transiently transfected cells in western blot, the highly specific anti-pepA 
antiserum was selected for all subsequent analyses. A former E.coli exposure of the rabbit 
immunized with our peptide B might explain the reactivity of the anti-pepB antiserum against 
bacterial host proteins.  
The expression of ADAMTS9 and its mutant variant in transient and stable mammalian cell 
lines were subsequently controlled by western-blot analyses and immunofluorescence 
staining. 
The full length form of the enzyme and the inactive variant were detected in cell extracts of 
transient cell lines by two antibodies directed against different regions of the peptide, the 
anti-FLAG antibody recognising the C-terminal flag-tag of the recombinant proteins and the 
specific anti-pepA antiserum. In stable cell lines, additional non-characterised bands were 
detected by the anti-pepA antiserum in cell extracts of ADAMTS9 and E427A_ATS9 cell 
lines. These bands probably corresponded to degradation products of the recombinant 
protein. The integrity and homogeneity of the selected clones were demonstrated by an 
invariably ubiquitous fluorescent immunostain of ADAMTS9 or mutant peptides in stable cell 
lines preparations. 
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 Afterwards, the expression of the enzymes in the selected stable lines was analysed in more 
detail in order to pursue functional studies. Among the different tested culture media, the 
SFMII medium appeared to be the most appropriate medium to express recombinant 
ADAMTS9. However, even though the full-length ADAMTS9 was expressed in cell extracts 
and different peptides were repeatedly identified in the media with the anti-pepA antiserum, 
the expected fragment corresponding to the pro-peptide lacking active form could not be 
detected in any of the tested media. Besides, the expression of the recombinant proteins was 
too weak to allow detection by the monoclonal anti-FLAG antibody in the cell extracts and 
concentrated media of stable lines. Consequently no purification via FLAG tag was feasible. 
It should be noted that in a recent study, similar problems to purify the full-length form of 
recombinant human ADAMTS9 has been reported (Koo et al., 2007). 
To investigate the putative catalytic activity of the recombinant ADAMTS9, activity assays 
were designed with concentrated conditioned media of stable lines cultivated in suspension. 
The functionality of the activity assay was confirmed by the use of the medium of stable cells 
expressing the recombinant mouse ADAMTS4.3 variant, previously tested in our laboratory 
as a positive control. The concentrated medium containing recombinant mouse ADAMTS4.3 
variant displayed proper hyalectanase activity towards chick purified versican. However, no 
activity could be demonstrated with ADAMTS9 medium. This unexpected result can partly be 
explained by insufficient levels of active peptide expressed in conditioned media. As 
mentioned above, the expression of recombinant ADAMTS9 was extremely weak in 
conditioned media from stable line, making its detection by immunoblot rather challenging 
even after medium concentration. The recombinant full-length ADAMTS9 is a 200 kDA long 
peptide. This large size may affect expression efficiency of the transfected cells. Expression 
might be enhanced in other alternative expression systems e.g employing adenoviruses, 
which are well known to confer high protein level expression levels in mammalian cells.  
Hence, we decided to orientate the functional studies of ADAMTS9 to the expression of 
mimetics corresponding to potentially active truncated forms of the enzyme. In our previous 
experiments, diverse fragments were constantly detected in media of stable cells cultivated 
in suspension. The detailed analysis of these peptides revealed that they might correspond 
to products from specific processes of ADAMTS9. Indeed, different putative furin cleavage 
sites (at arginine residues n° 67, 277 and 1168) were identified in the chick ADAMTS9 
peptide sequence. Moreover, previous works led by different groups have shown catalytic 
activity for shorter variants of the ADAMTS1, ADAMTS4 (Flannery et al., 2002; Gao et al., 
2002; Kuno et al., 2000). In this context, the corresponding truncated variants (ADAMTS9.1, 
ADAMTS9.2 and ADAMTS9.3) carrying a FLAG-tag at their carboxyl terminus were cloned 
and transiently expressed in 293F cells.  
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 As confirmed by immunoblots with the anti-pepA antiserum and the monoclonal anti-FLAG 
antibody, the zymogen forms of ADAMTS9.1, ADAMTS9.2 and ADAMTS9.3 were present in 
cell lysates. According to the fragment sizes, the respective mature enzymes corresponding 
to the pro-peptide lacking forms were also constantly recognised in media with the anti-pepA 
antiserum. However, only the putative ADAMTS9.1 mature form was always detected with 
the monoclonal anti-FLAG antibody, probably due to weak sensitivity of the anti-FLAG 
antibody. In the cell extracts of ADAMTS9.1, ADAMTS9.2 and ADAMTS9.3, additional 
smaller bands corresponding in size to the variants depleted of their pro-peptides were also 
identified with the anti-pepA antiserum. In addition, a band of about 70 kDa was visible in 
ADAMTS9.2 and ADAMTS9.3 cell extract preparations. These smaller fragments always 
present in cell extracts let suppose that intracellular or peri-cellular processing occurred for 
the recombinant forms of chick ADAMTS9 variants. 
Apte and co-workers suggested a completely new mechanism regarding the processing 
regulation of the human ADAMTS9 enzyme (Koo et al., 2006). Like for other proteases, the 
ADAMTS9 pro-domain is removed from the zymogen form by the furin proprotein 
convertase. However, conversely to previous furin-mediated cleavages that have hitherto 
been described for other metalloproteases, the cleavage of human ADAMTS9 protease 
seems not to occur in the trans-Golgi compartment, but at the cell-surface of the 293F cells. 
Moreover, no intracellular processing of the prodomain could be identified in different cell 
types. These results were obtained with the recombinant full-length and a truncated form of 
human ADAMTS9 including the signal peptide, the prodomain and the catalytic domain, 
suggesting that the processing regulation was independent of the ancillary domain. 
To confirm the nature and to precisely establish the origin of the diverse fragments of chick 
ADAMTS9 variants in cell lysates and media preparations, complementary experiments are 
needed. The immuno-precipitation with the anti-pepA antibody of peptides present in cell 
extracts and media preparations, followed by an immuno-detection with the anti-FLAG 
antibody would allow to identify which fragments are subject to C-terminal processing. 
Furthermore, it would allow a more sensitive detection of potential forms present, which are 
only weakly or not all visualised by the anti-FLAG antibody in conjunction with direct 
immunoblotting. Further experiments would be required to assess, whether the processed 
forms identified in cell extracts of all three chick recombinant variants are physiological 
products from furin and/or other proprotein convertases. For instance, use of specific 
proprotein convertases inhibitors such as dec-RVKR-cmk could be considered. 
Since bands corresponding to the expected secreted forms were robustly recognised by the 
anti-pepA antiserum in media of all three variant cultures, we performed activity assays to 
test versicanase function of the variants with the respective concentrated conditioned media. 
Unexpectedly, none of the variants (ADAMTS9.1, ADAMTS9.2 or ADAMTS9.3) displayed 
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 protease activity towards chick purified versican. While human ADAMTS9 has been 
described to cleave versican, no versicanase activity could be demonstrated with the diverse 
recombinant variants of chick ADAMTS9 in our various assays.  
Initially, Apte and co-workers provide evidences of versicanase property for human 
recombinant ADAMTS9 in a cell-assay (Somerville et al., 2003). In this experiment, cells that 
transiently expressed ADAMTS9 or the truncated catalytic variant were rinsed and put in 
fresh serum free medium before adding purified bovine versican. The cleavage product, a 
processed versican fragment of 70 kDa was detected after overnight incubation. In another 
set of experiments (Koo et al., 2007), either conditioned media from transient cultures to test 
activity of the different ADAMTS9 constructs towards versican containing medium were used 
or a comparable cell-assay was employed. This frequent alteration of the experimental 
procedures used by this group may point to some difficulties they have encountered in 
handling ADAMTS9 protease and in analysing its putative activity. Furthermore, analyses of 
versicanase activity emanating from different constructs for human ADAMTS9 revealed a 
unique characteristic regarding metalloprotease activity regulation that has not been 
described yet (Koo et al., 2007). The recombinant full-length ADAMTS9 zymogen was 
catalytically active and even more efficient in cleaving versican than the processed form 
missing the N-terminal propeptide domain, although the propetide-lacking forms usually 
correspond to the active form of metalloproteases. Again, this astonishing result showed the 
unpredictability and the complexity of mechanisms controlling ADAMTS9 functions. In a 
recent study, an original mechanism for ADAMTS9 proenzyme processing regulation has 
been suggested (Koo and Apte, 2010). In this paper, they showed that ADAMTS9 
proenzyme and furin convertase associate together at the cell surface in a complex including 
members of the HSP90 chaperones family. Furthermore, these chaperone proteins 
participate by interacting very likely with furin in modulating the propeptide domain cleavage 
and in the secretion of the ADAMTS9 catalytic form.     
In summary, these data and our results lead to the hypothesis that ADAMTS9 is subject to a  
unique regulation mechanism differing from the activation pocess known from other 
metalloproteases. Furthermore, we can assume that its versicanase function should be 
accurately regulated. 
Beside the functional in vitro studies, we investigated in parallel the putative role of 
ADAMTS9 in vivo during development of chicken embryos. In the second chapter, we have 
demonstrated an obvious correlation between ADAMTS9 expression and versican 
distribution in developing hind limb, at particular points in time when nerve invasion should 
take place. Thus, we hypothesised that an early induced expression of ADAMTS9 in the hind 
limb would engender premature versican cleavage and therefore provoke precocious 
extension of axons in the limb bud.  
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 For this purpose, different expression vectors containing our deduced chick ADAMTS9 or the 
E427A_ATS9 mutant construct under control of the chick β-actin promoter were generated. 
Then the vectors were injected and electroporated into the hind limb of chicken embryos at 
different stages of development. Either our construct was expressed simultaneously with a 
fluorescent marker protein (eGFP) from a bicistronic vector (pMES), or a separate vector 
coding for a fluorescent marker protein (YFP_pIRES or eGFP_pIRES) was used in parallel of 
our construct to visualise the site of injection/electroporation. Despite multiple attempts 
employing different parameters of injection and electroporation, only a few cells in some 
embryos displayed green epifluorescence. Analyses of injected embryos by whole mount 
staining of GFP-expressing cells and neurofilaments did not reveal any difference between 
the injected limb bud and the non-treated side of embryos. Because no evidence of a 
potential ADAMTS9 effect on axon growth could be established by these means, another 
experimental approach was tested to evaluate the impact of ADAMTS9 over-expression in 
vivo. The expression vectors were injected into the central canal of the spinal cord. In this 
setting, we hypothesised that ADAMTS9 overexpressing neurons would clear up their routes 
from versican and in consequence extend their axons earlier than usually observed in normal 
hind limb. Despite the fact that the functionality of expression vectors was again proven by 
the presence of green-cells, no consequence on axon growth was observed, when 
comparing axon routing on both sides of the spinal cord at the entrance of limb buds. 
In our set of in vivo experiments, different technical problems were regrettably encountered, 
making the observations and drawing conclusions from this part of the study rather difficult. 
Even though the functionality of expression vectors was proven by the presence of green 
cells in electroporated regions, the epifluorescence coming from cells transfected with the 
eGFP_pIRES or eGFP_pMES vectors were less intense than that one observed with the 
YFP_pIRES control vector. Thus, use of the YFP_pIRES vector in parallel of the tested 
construct should be preferred in future trials. In spite of numerous injected and 
electroporated embryos, only a small number survived and could be processed up to the final 
whole mount staining treatment, restraining considerably the panel of analysable specimens. 
Another major difficulty seemed to be associated with the technique itself. Injections and 
electroporations of the plasmids in the hind limb were largely inefficient. Indeed, the 
mesenchymal tissue permits considerable and rapid diffusion of the preparation mix into the 
extracellular space, thus impeding the correct and precise integration of the plasmids into 
cells. Another gene transfer approach should be seriously considered in order to efficiently 
express specific constructs into mesenchymal tissues of the limb bud. Lately, a couple of 
studies emphasized the efficiency and accuracy of gene transduction by sonoporation in 
different types of cells, tissues and organisms (Fischer et al., 2006; Li et al., 2009; Liu et al., 
2006). Interestingly, the injection of DNA-microbubble mixture preparation into the region of 
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 interest followed by exposure of the ultrasound to the targeted tissues, allowed to obtain 
successful gene expression especially in the developing limb bud of chicken embryos 
(reviewed in (Ohta et al., 2008)). Therefore, the use of sonoporation might be of great 
interest to express recombinant cDNAs and to study roles of specific proteins in axonal 
guidance, in particular in the hind limb during chick development. 
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 7. General discussion 
 
 During the development of vertebrates, the migrating neural precursor cells and 
growing axons are orientated towards their appropriate target regions through a coordinated 
action of repelling and attracting guidance forces. Among the different signals playing a role 
in these processes, the hyalectan versican is believed to participate as a non-permissive 
component for growing axons in development of chick embryos.  
Indeed, previous work from our laboratory showed that versican V0/V1 isoforms are 
selectively expressed in barriers tissues of neural crest cells and outgrowing axons (Landolt 
et al., 1995). In addition, versicans V0/V1 were shown to inhibit the migration of neural crest 
cells in vitro, and this function was mostly triggered by the core protein of the hyalectans 
(Dutt et al., 2006). Together, these studies provided evidence for a versican role in guiding 
neural crest cells and extending axons throughout embryonic trunk development. 
Thus, the general aim of the presented project was to assess more specifically the putative 
role of versican in axonal guidance of the peripheral nervous system during development of 
chick embryos. Towards this aim, functional studies regarding sensory-motor innervation of 
the hind limb were carried out in in vitro assays and in in vivo experiments.  
We confirmed that versican was the main proteoglycan expressed in transient mesenchymal 
barriers from limb bud and trunk of chick embryos. Furthermore, the stripe choice assays and 
analyses by time-lapse microscopy of neurite growth clearly proved the overriding inhibitory 
effect of versican on axonal growth of DRG neurons in vitro, whereas neuronal cells were 
cultivated in neurite growth promotion supporting substrates. Likewise in vivo, we could 
demonstrate that repeated ectopical deposition of versican V1 and V0/V1 splice-variants in 
the nerve pathways caused severe disturbances of growing nerves in the hind limb, such as 
aberrant axon routings and defasciculation of extending neurites from the sciatic nerve in 
ovo. 
The inhibitory property of versican V0/V1 induced, in a concentration dependent way, 
conformational changes leading to growth cone collapse and axonal retraction. This 
observation suggests that versican does not only act as a simple physical barrier but might 
activate downstream signalling pathways involved in the rapid remodelling of the 
cytoskeleton at the leading edge. Especially, downstream effectors/modulators of the 
RhoGTPases pathways have been shown to mediate inhibitory effects of the chondroitin 
sulphates proteoglycans (CSPGs). For instance, CSPG activation of the Rho pathway 
resulted in the expression of different protein kinase C isoforms which transduced the 
inhibitory signal blocking axonal regeneration (Sivasankaran et al., 2004). Besides, the 
activation of RhoA by versican V2 via independent p75NTR/NgR pathways was also shown 
to inhibit axonal growth (Schweigreiter et al., 2004). Currently, no specific receptor for 
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 versican has been identified. Versican might interact with the epidermal growth factor 
receptor (EGFR) by the EGF-like sequence in the G3 domain. The EGFR has also been 
proposed to mediate the inhibition of axon regeneration by CSPGs (Koprivica et al., 2005). 
However in another study, the expression of the recombinant versican G3 domain alone 
promoted neurite growth by activation of the EGFR (Xiang et al., 2006), suggesting that other 
domains might be involved in evoking the inhibitory response towards versicans.  
From our experiments, it appears that the core protein of versican is mainly conferring the 
inhibitory property, while the GAG chains possibly modulate the versican function by 
interacting with putative partners and by preserving structural stability. Moreover, the 
distribution of versican is tempo-spatially inversely related to the extension of growing axons 
from the crural and sciatic plexi into the hind limb. Indeed, the distribution of versican 
appears to be specifically regulated throughout the development, since in early chick 
embryos, the entire limb bud expresses the V0/V1 isoforms, while only a few stages later, the 
versican localisation is restricted to the prechondrogenic zone of the forming pelvic girdle and 
the femur (Landolt et al., 1995). These data let us hypothesise that an active turnover by 
specific proteases might regulate the function of the versican core protein and therefore 
influences the axonal guidance processes. Additionally, specific ADAMTS metalloproteases 
were described to cleave hyalectans in in vitro assays (reviewed in (Apte, 2009)). 
Interestingly, ADAMTS1 and ADAMTS9, potential versicanases, were shown to be 
expressed in embryos throughout mouse development (Jungers et al., 2005; Thai and Iruela-
Arispe, 2002). 
In this context, we first determined the expression patterns of the ADAMTS candidates in 
chick embryos with in situ hybridisation. Akin to the expression pattern of ADAMTS9 in mice, 
we detected a wide expression of ADAMTS9 in chick embryos. As described before (Landolt 
et al., 1995), we confirmed by immunofluorescence stainings that versican disappeared from 
the limb anlage, while nerve fibres from the plexus regions grew into the limb bud. 
Furthermore, the ADAMTS9 expression profile was perfectly matching with the distribution of 
versican during limb bud development. Since ADAMTS1 expression in chick embryos was 
not relevant after analysis by in situ hybridisation, we focused our attention on the putative 
role of ADAMTS9. After cloning the full-length of chick ADAMTS9 cDNA, differences were 
observed between our sequence and the reported cDNA sequence in the chick genome 
(ENSGALT00000011955). Although ADAMTS9 is the most highly conserved member of the 
ADAMTS-family (Somerville et al., 2003), these discrepancies between the sequences might 
be explained by inter-hatchery strain variability. 
In order to identify ADAMTS9 as a specific protease of versican, recombinant full-length 
ADAMTS9 or variants were expressed together with versican in vitro. Although the 
versicanase function of recombinant human ADAMTS9 was demonstrated in vitro 
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 (Somerville et al., 2003) and the profile expression of the metalloprotease correlated with the 
distribution of versican in chick embryos, no enzymatic activity of our recombinant full-length 
ADAMTS9 or variants could be observed towards purified chick versican. This might be 
linked to the possibility that chick ADAMTS9 is only a minor protease involved in versican 
turnover or that this metalloprotease interacts with other ADAMTS members to process 
versican. Indeed, recent genetic studies in mice revealed a cooperative function of Adamts9 
and two other versicanases, the close homologues Adamts20 and Adamts5 (Longpre et al., 
2009; Silver et al., 2008). Silver and colleagues showed that Adamts20 mediated survival of 
neural crest derived melanoblasts via Kit signalling and that Adamts9 also participated in the 
development of the melanoblasts in the trunk and in the head (Silver et al., 2008). Besides, 
they demonstrated that medium from cells expressing recombinant ADAMTS20 cleaved 
versican and that Adamts20 was required for versican processing in the skin. Analyses of 
single and double deleted mice for Adamts9 and Adamst20 provided evidence for the 
collaborative function in the closure of the secondary palate (Enomoto et al., 2010). The 
authors suggested that ADAMTS9 expressed in capillaries and ADAMTS20 expressed in the 
mesenchyme collaborate in the proteolysis of versican to ensure correct palatogenesis. In 
another development process, the combinatory functions of Adamts5, Adamts9 and 
Adamts20 were demonstrated to be involved in interdigital web regression (McCulloch et al., 
2009b). In this publication, they showed that these three metalloproteases interacted to 
cleave versican and generate active versican fragments that mediate apoptosis to eliminate 
cells in the interdigital web. Interestingly, versican cleavage appears to be required in web 
regression and in palatogenesis at the same developmental age.  
From analysis of ADAMTS5 expression patterns in mouse, ADAMTS5 appears to be the 
most promising partner of ADAMTS9 in limb bud remodelling and appears to constitute the 
sole metalloprotease directly involved in versican turnover during limb innervation 
(McCulloch et al., 2009a). Actually, ADAMTS5 is associated to several peripheral nervous 
system components. During development, it is expressed in trunk segmental nerves, from 
E12.5 to E14.5 in emerging nerves in hind limb, in developing root ganglia, and in neural-
associated Schwann cells precursors (McCulloch et al., 2009a). In adults, ADAMTS5 is 
present in dorsal root ganglia and their associated spinal nerve roots, in the perinerium and 
in nerve fibres of the sciatic nerve and in Schwann cells (McCulloch et al., 2009a). In the 
chick, innervation of the hind limb starts after HH24, corresponding to stage E12.5 in the 
mouse. In parallel, versican disappears from HH24-25 to be extremely restricted at stage 
HH27, which is comparable to E13.5. From these data, we speculate that ADAMTS5 
expressed by peripheral nerves contributes towards cleavage of versican and regulation of 
axonal guidance. This ADAMTS5 function might take place through interaction with 
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 ADAMTS9 expressed in mesenchymal tissues. Thus, ADAMTS5 represents an interesting 
candidate for future investigation. 
 
Using the chick model for studying the different processes during development has many 
advantages, due to the easy access to embryos (reviewed in (Stern, 2005)). However, the 
incomplete sequencing of the chick genome still forms a certain obstacle, which we were 
also confronted with during this project. Once the chick genome sequencing is completed, it 
should be easier to study the exact role of different genes, in particular those which are fine-
tuned during embryogenesis. The findings collected from the chick-model could be of general 
importance to understand the development of a functional neuronal network which could also 
pertain to vertebrates including humans. 
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 8. Abbreviations 
 
ADAM A Disintegrin And Metalloprotease 
ADAMTS A Disintegrin And Metalloprotease with Thrombospondin type 1 motifs 
BDNF Brain-Derived Neurotrophic Factor 
BMP  Bone Morphogenic Protein 
CAM  Cell Adhesion Molecule 
CHL1 Close Homologue of L1 
Comm Commissureless 
COS  CV-1 in Origin and carrying the SV40 
Cos2  kinesin Costal 2 
CNS  Central Nervous System 
CRP  Complement Regulatory Protein 
CS  Chondroitin Sulphate 
CSPG Chondroitin Sulphate Proteoglycans 
DCC  Deleted in Colorectal Cancer 
DRG  Dorsal Root Ganglia 
DREZ Dorsal Root Entry Zone 
DS  Dermatan Sulphate 
DSCAM Down Syndrome Cell Adhesion Molecule 
ECM  Extracellular Matrix 
EGF  Epidermal Growth Factor 
EGFR Epidermal Growth Factor Receptor 
ERK  Extracellular-signal-Regulated Kinase 
FGF  Fibroblast Growth Factor 
FGFR Fibroblast Growth Factor Receptor 
Fu  Fused protein 
Fz  Frizzled 
GAG  Glycosaminoglycan 
GDGF Glial-Derived Growth Factor 
GHAP Glial Hyaluronate binding protein 
GPI  Glycosylphosphatidylinositol 
HA  Hyaluronic Acid 
HEK  Human Embryonic Kidney  
HGF  Hepatocyte Growth Factor 
HH  Hamburger and Hamilton 
HS  Heparan Sulphate 
HSPG Heparan Sulphate Proteoglycans 
KS  Keratan Sulphate 
LMC  Lateral Motor Columns 
LMCm medial Lateral Motor Columns 
LTP  Long Term Potentiation 
mdDA mesodiencephalon DopAminergic neurons 
NCC  Neural Crest Cell 
NGF  Nerve Growth Factor 
Npn  Neuropilin 
NRG  Neuregulin 
NT  Neurotrophin 
PCP  Planar Cell Polarity 
PKC  Protein Kinase C 
PI3K  Phosphatidylinositol 3-kinase 
PNA  Peanut Agglutinin   
PNN  Perineural net 
PNS  Peripheral Nerve System 
Ptc  Patched 
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 p75NTR p75 neurotrophin receptor 
RGC  Retinal Ganglion Cells 
Robo Roundabout 
SCF  Stem Cell Factor 
SFK  Src-Family Kinase 
Sfrp  Secreted frizzled-related protein 
Shh  Sonic hedgehog 
Smo  Smoothened 
SLRP Small Leucin-Rich Protein 
TGFβ Transforming Growth Factor β 
TN  Tenascin 
TSP-1 Thrombospondin type-1 like repeat 
Trk  Tropomyosin-related kinase 
UNC  Uncoordinated 
vWF  von Willebrand Factor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 126 -
 9. Lists of figures and tables 
 
9.I. List of figures 
Different guidance molecules control the trajectories of the axons to their targets. 6Fig.1 
Fig.2 Bi-functionality of Netrin-1 is mediated through the interactions with UNC-5 and    
 DCC receptors in the CNS. ------------------------------------------------------------------------ 7
Fig.3 Comm controls the coordinated actions of Slit/Robos and Netrin at the Drosophila  
 midline. ------------------------------------------------------------------------------------------------- 9
Fig.4 Coordinated actions of Slit/Robos and Netrin to control the midline crossing of   
 commissural axons. --------------------------------------------------------------------------------- 10
Fig.5 Coordinated actions of Sema3F/Npn-2, ephrinBs/EphBs, ephrinAs/EphAs and   
 GDNF/c-Ret control the ventral and dorsal pathfindings of motor axons    
 innervating the limb. --------------------------------------------------------------------------------- 13
Fig.6 Morphogens signalling pathways involved in the cell specification. --------------------- 15
Fig.7 Shh signalling components involved in axon guidance. ------------------------------------ 17
Fig.8 Wnt signalling pathway involved in axon guidance of post-commissural axons. ---- 18
Fig.9 Wnts gradient controls post-commissural axons guidance. ------------------------------- 19
Fig.10 BMP signalling components involved in axon guidance. ---------------------------------- 20
Fig.11 Types of dissacharide repeat units of glycosaminoglycans (GAGs). ------------------- 26
Fig.12 Tetrasaccharide linker region of the proteoglycans. ---------------------------------------- 27
Fig.13 Examples of HSPGs family members. --------------------------------------------------------- 28
Fig.14 Depiction of NG2 and receptor-like protein tyrosine phosphatase β isoforms. ------- 30
Fig.15 The lectican-family. ---------------------------------------------------------------------------------- 33
Fig.16 Gene structure of versican isoforms V0, V1, V2 and V3. ---------------------------------- 36
Fig.17 Domains structure of metzincin families MMP, ADAM and ADAMTS. ----------------- 40
Fig.18 The human ADAMTS family, organisation and functions. --------------------------------- 42
Fig.19 Cloning strategy for assembling the full length ADAMTS9 cDNA. ---------------------- 75
Fig.20 Putative cDNA and deduced peptide sequence of chick ADAMTS1. ------------------ 79
Fig.21 Comparison of the catalytic domains of human, mouse and chick ADAMTS1. ------ 80
Fig.22 cDNA and deduced peptide sequence of chick ADAMTS9. ------------------------------ 81
Fig.23 Comparison of ADAMTS9 catalytic domains in human, mouse and chick. ----------- 82
Fig.24 Schematic representation of cloned PCR-fragments of chick ADAMTS1 and   
 ADAMTS9 cDNAs and the domain structures of the deduced peptides. -------------- 83
Fig.25 ADAMTS1 is weakly expressed in hind limb of chick embryo during early   
 development. ------------------------------------------------------------------------------------------ 84
Fig.26 Modulated expression of ADAMTS9 in correlation with the versican disappearance  
 and the extension of axons in chick limb bud during development. --------------------- 86
Fig.27 Localisation of antigenic peptides. --------------------------------------------------------------- 93
Fig.28 Generation of the mutated chick ADAMTS9 form: E427A. -------------------------------- 94
Fig.29 Vectors prepared for eukaryotic expression. -------------------------------------------------- 96
Fig.30 Characterisation of antisera against bacterially expressed chick ADAMTS9 fusion  
 peptides. ----------------------------------------------------------------------------------------------- 103
Fig.31 Characterisation of antisera against eukaryotically expressed chick ADAMTS9 ---- 104
Fig.32 Analysis of ADAMTS9 and mutant E427A_ATS9 expressions in cell extracts of   
 transiently transfected or stable cell lines by immunoblotting with the anti-pepA   
 antiserum. ---------------------------------------------------------------------------------------------- 104
Fig.33 Analysis of ADAMTS9 and mutant E427A_ATS9 expressions in transient and   
 - 127 -
  stable cell lines by immunofluorescence staining of permeabilised cells. ------------- 105
Fig.34 Analysis of the expression of ADAMTS9 and E427A_ATS9 in different culture   
 media by immunoblotting with the antiserum anti-pepA. ----------------------------------- 107
Fig.35 Analysis of proteolytic activity of recombinant ADAMTS9 and E427A_ATS9   
 mutant towards purified chick V0/V1 versican. ----------------------------------------------- 108
Fig.36 Schematic representation of ADAMTS9 fragments potentially secreted into the   
 medium. ------------------------------------------------------------------------------------------------ 109
Fig.37 Analysis of the expression of the truncated chick ADAMTS9 variants in cell   
 extracts and conditioned media by immunoblotting. ---------------------------------------- 111
Fig.38 Analysis of the proteolytic activity of recombinant variants ADAMTS9.1,   
 ADAMTS9.2 and ADAMTS9.3 towards purified chick V0/V1 versican. ---------------- 112
Fig.39 Injection and electroporation of ADAMTS9_pMES into the chick limb bud. ---------- 113
Fig.40 Injection and electroporation of ADAMTS9_pMES into the spinal cord. --------------- 114
 
Figures article: 
M_Fig.1 Chick embryo at HH21/22 before (A) and after in ovo-injection (B) of the Trypan  
 Blue-containing versican solution. -------------------------------------------------------------- 62
M_Fig.2 Temporospatial relationship of PNA-binding sites, versican V0/V1 and axonal  
 growth in the developing hind limb. ------------------------------------------------------------- 63
M_Fig.3 Identification of versicans as major PNA-binding proteins. ------------------------------- 64
M_Fig.4 Versican overrides the neurite growth promoting activity of laminin-1 in a stripe- 
 choice assay. ----------------------------------------------------------------------------------------- 65
M_Fig.5 Versican-mediated inhibition of neurite outgrowth on fibronectin. ---------------------- 66
M_Fig.6 Inhibitory potential of versican V0/V1 on neurite outgrowth in stripe-choice  
 assays. ------------------------------------------------------------------------------------------------ 67
M_Fig.7 Growth cone collapse and retraction of DRG neurites after contact with versican  
 containing substrate. ------------------------------------------------------------------------------- 68
M_Fig.8 Inhibition of axonal outgrowth by versican V1- expressing COS aggregates in  
 collagen-I gel. ---------------------------------------------------------------------------------------- 69
M_Fig.9 Consequences of ectopic deposition of versicans in developing chick hind limb  
 in ovo. -------------------------------------------------------------------------------------------------- 70
 
 
 
9.II. List of tables 
 
Different identified cleavage-sites in hyalectans and the respective  Table 1  
 hyalectanases ---------------------------------------------------------------------------------------- 43
Table 2 Primers and conditions used to clone ADAMTS1 and ADAMTS9 cDNAs ------------ 73
Table 3 Primers used for preparing templates in situ hybridisation (ISH) riboprobes --------- 76
Table 4 Primer sequences and conditions used for amplification of fragments PepA and   
 PepB ---------------------------------------------------------------------------------------------------- 93
Table 5 Conditions tested for injection and electroporation of plasmids into cells of the   
 hind limb ------------------------------------------------------------------------------------------------ 113
 - 128 -
 10. Annexes 
 
Ensembl ADAMTS9 MQLAPLALALTTLFIDGLRTGARRQKLHPRQAKLLEKLSEYEIVTPTRVNEFGEPFPTDV 60 
cloned ADAMTS9  MQLAPLALALTTLFIDGLRTGARRQKLHPRQAKLLEKLSEYEIVTPTRVNEFGEPFPTDV 60 
                ************************************************************ 
 
Ensembl ADAMTS9 HFRRRRRSTNAAPDAWTAAAASSSSSPKAHYRLSAFGQQFLFNLTASSAFIAPLFTVSIL 120 
cloned ADAMTS9  HFRRRRRSTNAAPDAWTAAAASSSSSPKAHYRLSAFGQQFLFNLTASSAFIAPLFTVSIL 120 
                ************************************************************ 
 
Ensembl ADAMTS9 GEPAAEQRNLYAETADTDVKHCFYRGHVNARPRHTAVISLCSGMLGTFKSDDGDYFVEPL 180 
cloned ADAMTS9  GEPAAEQRNLYAETADTDVKHCFYRGHVNARPRHTAVISLCSGMLGTFKSDDGDYFVEPL 180 
                ************************************************************ 
 
Ensembl ADAMTS9 LSLEQEYEEEHNKPHLVYRHRTPPTNSSGDRQTCDTPDHEHSHKKSKRKHWRKQWVESSL 240 
cloned ADAMTS9  LSLEQEYEEEHNKPHLVYRHRTPPTNSSGDRQTCDTPDHEHSHKKSKRKHWRKQWVESSL 240 
                ************************************************************ 
 
Ensembl ADAMTS9 LSDTEMLKHSLEVNPFSADSNETGNASEKKSHRRTKRFLSYPRFVEVMVVADSRMVAYHG 300 
cloned ADAMTS9  LSDTEMLKHSLEVNPFSADSNETGNASEKKSHRRTKRFLSYPRFVEVMVVADSRMVAYHG 300 
                ************************************************************ 
 
Ensembl ADAMTS9 ANLQHYVLTLMSIVASIYKDPSIGNLINIVIVKLVVIHNEQDGPAISYNAQTTLKNFCQW 360 
cloned ADAMTS9  ANLQHYVLTLMSIVASIYKDPSIGNLINIVIVKLVVIHNEQDGPAISYNAQTTLKNFCQW 360 
                ************************************************************ 
 
Ensembl ADAMTS9 QQSQNHPEGSHLQHDTAVLVTRQDICRAHDKCDTLGLAELGTVCDPYRSCSISEDNGLST 420 
cloned ADAMTS9  QQSQNHPEGSHLQHDTAVLVTRQDICRAHDKCDTLGLAELGTVCDPYRSCSISEDNGLST 420 
                ************************************************************ 
 
Ensembl ADAMTS9 AFTIAHELGHVFNMPHDDNHKCKEDGGKNQQHVMAPTLNFYTNPWMWSKCSRKYITEFLD 480 
cloned ADAMTS9  AFTIAHELGHVFNMPHDDNHKCKEDGGKNQQHVMAPTLNFYTNPWMWSKCSRKYITEFLD 480 
                ************************************************************ 
 
Ensembl ADAMTS9 TGYGECLLDEPSSRTYALPQQLPGLIYDVNKQCELIFGPGSQVCPYMMQCRRLWCINIDG 540 
cloned ADAMTS9  TGYGECLLDEPSSRTYALPQQLPGLIYDVNKQCELIFGPGSQVCPYMMQCRRLWCINIDG 540 
                ************************************************************ 
 
Ensembl ADAMTS9 AHKGCRTQHTPWADGTECEPGKHCRFGMCVPKEREAPVVDGAWGTWSPFGTCSRTCGGGI 600 
disintegrin 
cloned ADAMTS9  AHKGCRTQHTPWADGTECEPGKHCRFGMCVPKEREAPVVDGAWGTWSPFGTCSRTCGGGI 600 
                ************************************************************ 
 
Ensembl ADAMTS9 KTAIRECNRPEPKNGGKYCVGRRMKFKSCNTEPCSKLKKDFRDEQCADFDGKHFNINGLP 660 
TSP-1 1
cloned ADAMTS9  KTAIRECNRPEPKNGGKYCVGRRMKFKSCNTEPCSKLKKDFRDEQCADFDGKHFNINGLP 660 
                ************************************************************ 
 
Ensembl ADAMTS9 TNVRWVPKYSGILMKDRCKLFCRVAGNTAYYQLRDRVIDGTPCGPDTNDICVQGLCRQAG 720 
cloned ADAMTS9  TNVRWVPKYSGILMKDRCKLFCRVAGNTAYYQLRDRVIDGTPCGPDTNDICVQGLCRQAG 720 
                ************************************************************ 
 
Ensembl ADAMTS9 CDHVLNSKARRDKCGVCGGDNSSCKTVAGTFNTVHYGYNVVVRIPAGATNIDVRQHSYSG 780 
cloned ADAMTS9  CDHVLNSKARRDKCGVCGGDNSSCKTVAGTFNTVHYGYNVVVRIPAGATNIDVRQHSYSG 780 
                ************************************************************ 
 
Ensembl ADAMTS9 KPEDDNYLALSNSQGDFILNGDFVVSMFKREIKVGNAVIEYSGSDNAIERINSTDRIEQE 840 
cloned ADAMTS9  KPEDDNYLALSNSQGDFILNGDFVVSMFKREIKVGNAVIEYSGSDNAIERINSTDRIEQE 840 
                ************************************************************ 
 
Ensembl ADAMTS9 ITLQVLSVGNLYNPDVRYTFNIPIEDKPQQFYWNAYGPWQPCSKLCQGERKRKPVCTRES 900 
cloned ADAMTS9  ITLQVLSVGNLYNPDVRYTFNIPIEDKPQQFYWNAYGPWQPCSKLCQGERKRKPVCTRES 900 
                ************************************************************ 
 
Ensembl ADAMTS9 DQLTVSDQRCDRIPQPDPITEPCGTECELRWHIARRSECTAQCGLGYRMLEIYCSKYNRL 960 
cloned ADAMTS9  DQLTVSDQRCDRIPQPDPITEPCGTECELRWHIARRSECTAQCGLGYRMLEIYCSKYNRL 960 
                ************************************************************ 
spacer 
2
3 
 
Ensembl ADAMTS9 EGKTEKVDDRFCSSQAKPSTREKCTGDCNVGGWRYSAWTECSKSCGGGTRRRRAMCVSTY 1020 
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 cloned ADAMTS9  EGKTEKVDDRFCSSQAKPSTREKCTGDCNVGGWRYSAWTECSKSCGGGTRRRRAMCVSTY 1020 
                ************************************************************ 
 
Ensembl ADAMTS9 NDVLDDSKCSQQEKLTVQRCSDFLCPQWKTGDWSEPWQCLVTCGKGHKHRQTWCQFGEDR 1080 
4
cloned ADAMTS9  NDVLDDSKCSQQEKLTVQRCSDFLCPQWKTGDWSE---CLVTCGKGHKHRQTWCQFGEDR 1077 
                ***********************************   ********************** 
 
Ensembl ADAMTS9 LNDRFCDPETKPESVQTCQQQECAAWQVGPWGQCTMTCGQGYQMRAVKCVVGTYMSVVDD 1140 
5
cloned ADAMTS9  LNDRFCDPETKPESVQTCQQQECAAWQVGPWGQCTMTCGQGYQMRAVKCVVGTYMSVVDD 1137 
                ************************************************************ 
 
Ensembl ADAMTS9 NECNAATKPTDTQDCEIAACPPHPNSPEAKRSVSGVHRTQWRFGSWTPCSATCGKGTRMR 1200 
6
cloned ADAMTS9  NECNAATKPTDTQDCEIAACPPHPNSPEAKRSVSGVHRTQWRFGSWTPCSATCGKGTRMR 1197 
                ************************************************************ 
 
Ensembl ADAMTS9 YVSCRDEQGSVADESACFHLPKPSATEMCTVTPCGQWKALEWSSCSVTCGQGKATRQVIC 1260 
7
cloned ADAMTS9  YVSCRDEQGSVADESACFHLPKPSATEMCTVTPCGQWKALEWSSCSVTCGQGKATRQVIC 1257 
                ************************************************************ 
 
Ensembl ADAMTS9 IDYSDQLVDRSECDPDDLPATEQDCSMSPCHPNSHDYGRPIHPFLYPDHRLKLHPGGSPN 1320 
8
cloned ADAMTS9  IDYSDQLVDRSECDPDDLPATEQDCSMSPCHPNSHDYGRPIHPFLYPDHRLKLHPGGSPN 1317 
                ************************************************************ 
 
Ensembl ADAMTS9 RNRAHIPGGNQWRIGPWGACSSTCAGGFQRRVVVCQDENGYTANNCDEKTKPMEQRSCES 1380 
cloned ADAMTS9  RNRAHIPGGNQWRIGPWGACSSTCAGGFQRRVVVCQDENGYTANNCDEKTKPMEQRSCES 1377 
                ************************************************************ 
 
Ensembl ADAMTS9 GPCPQWAYGNWGECTKPCGAGTRTRLVVCQRPNGERFTDLSCEILDKPPDREQCNVQDCP 1440 
9
cloned ADAMTS9  GPCPQWAYGNWGECTKPCGAGTRTRLVVCQRPNGERFTDLSCEILDKPPDREQCNVQDCP 1437 
                ************************************************************ 
 
Ensembl ADAMTS9 RDAAWSAGPWSSCSVSCGRGQRHRTVYCLTKEGRHVEEDYCKHLVKPNVQKKCRGGRCPK 1500 
10 
cloned ADAMTS9  RDAAWSAGPWSSC----------------------------------------------- 1450 
                *************                                                
 
Ensembl ADAMTS9 WKSGDWGQCSVSCGRGVQQRAVQCHGGAPTAACDPASQPAAQRDCQLPECPTHRWAAGEW 1560 
1211
cloned ADAMTS9  ------------------------------------------------------------ 
                                                                             
13 
Ensembl ADAMTS9 QAQCLKTCGEAVRYRKVFCVDESKQVQSSAHCDASKRPLEMESCGLPPCEYIWITGEWSE 1620 
cloned ADAMTS9  ----LKTCGEAVRYRKVFCVDENKQVQSSAHCDASKRPLEMESCGLPPCEYIWITGEWSE 15061 
                    ******************.************************************* 
 
Ensembl ADAMTS9 CSVTCGKGYRQRLVSCSEIYTGKDHYEYGYQNTVSCPGTQPPNIQPCYLGECPVSASWRV 1680 
14
cloned ADAMTS9  CSVTCGKGYRQRLVSCSEIYTGKDHYEYGYQNTVSCPGTQPPNIQPCYLGECPVSASWRV 1566 
                ************************************************************ 
 
Ensembl ADAMTS9 SNWGSCSVTCGVGVMHRSVQCLTNDDQLSSLCHADLKPEERRTCHNVHDCELPRSCNDVK 1740 
15
cloned ADAMTS9  SNWGSCSVTCGVGVMHRSVQCLTNDDQLSSLCHADLKPEERRTCHNVHDCELPRSCNDVK 1626 
                ************************************************************ 
 
Ensembl ADAMTS9 SLKGVTEDGEYFLKVKGKTLKVYCSGMQTDSPKEYVTLVNGDAENFSEVYGYRLHNPTEC 1800 
GON-1
cloned ADAMTS9  SLKGVTEDGEYFLKVKGKTLKVYCSGMQTDSPKEYVTLVNGDAENFSEVYGYRLHNPTEC 1686 
                ************************************************************ 
 
Ensembl ADAMTS9 PYNGSRREDCQCRKDYTAAGFSTFSKVRLDLNTMQIITTDLQFSRTHDGRPVPYATAGDC 1860 
cloned ADAMTS9  PYNGSRREDCQCRKDYTAAGFSTFSKVRLDLNTMQIITTDLQFARTHDGRPVPYATAGDC 1746 
                *******************************************:**************** 
 
Ensembl ADAMTS9 YSAAKCPQGRFSIDLYGTGLSLTGTAKWLSQGNYAVSEIQKSPDGTKVVGRCGGYCGKCT 1920 
cloned ADAMTS9  YSAAKCPQGRFSIDLYGTGLSLTGTAKWLSQGNYAVSEIQKSPDGTKVVGRCGGYCGKCT 1806 
                ************************************************************ 
 
Ensembl ADAMTS9 PSSGTGLDVQVL 1932 
cloned ADAMTS9  PSSGTGLDVQVL 1818 
                ************ 
 
Annexe 1. Alignment of the chick ADAMTS9 translated sequences obtained from predicted cDNA 
sequence  from  Ensembl  and  from  cloned  cDNA.  The  prodomain  is  indicated  in  bold  font,  the 
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consensus sequence of the catalytic site  is written  in blue and the start of the different subsequent 
domains  are  identified with  an  arrow  under  the  corresponding  sequence.  TSP1:  Thrombospondin 
type 1 like domain with the related number.  GON‐1 domain is underlined in orange. GON‐1 refers to 
the product of gon‐1 gene in C.Elegans. The putative furin cleavage sites are indicated by an asterisk. 
The mismatched amino‐acids between the predicted sequence from Ensembl and the obtained cDNA 
in chick are shaded. The TSP sequence corresponding to the missing part  in the cloned ADAMTS9  is 
written in light blue. Single letter code is used for amino‐acids sequences. 
 
 
 
  
Annexe 2. The domain structure and features of chick deduced ADAMTS9 peptide. 
The schematic shows the structural motifs in chick ADAMTS9 with corresponding theoretical Mr, number of amino acids and cysteine residues, the zinc‐binding 
sequence and putative furin cleavage sites. The location of the epitope recognized by the rabbit anti‐pepA antiserum is depicted by an antibody symbol. Amino 
acid  sequences  are written  in  single‐letter  code. Abbreviations: ADAMTS,  a disintegrin  and metalloproteinase with  thrombospondin motifs; Mr, molecular 
weight; TS‐1, thrombospondin type 1 motif (named as well TS like repeat domain or TSP‐1). 
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